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Abstract 
Tests of verbal learning and memory have frequently been used to examine 
memory performance in frequent 3,4-methylendioxymethamphetamine (“ecstasy”) 
consumers, and meta-analyses have identified verbal learning and memory as the 
cognitive domain most adversely affected by regular ecstasy use (eg. Kalechstein, et 
al., 2007; Zakzanis, Campbell & Jovanovski, 2007). Tests of verbal memory are 
diverse however and include prose recall, multi-trial free recall and recognition tests. 
As such, it is unclear which specific measures of verbal learning and memory are 
most impaired by ecstasy use. Ascertaining which measures are most affected by 
chronic ecstasy use can inform as to which neural networks may be more likely 
candidates for explaining ecstasy related cognitive impairments. Study 1 therefore 
aimed to clarify which measure was most impacted by ecstasy use, by separating the 
domain of verbal learning and memory into three dependent variables that are 
commonly reported in the ecstasy and memory literature; Trial 1, Total and Delayed 
recall. This meta-analysis showed that ecstasy use does not impact on these three 
measures equally, with only a trivial effect of ecstasy use (g = -.15) found for Trial 1 
(immediate recall), and moderate magnitude effects for Total (g = -.71) and Delayed 
recall scores (g = -.67) scores. 
The Working with Memory model (Moscovitch & Winocur, 1992; 
Moscovitch & Winocur, 2002; Moscovitch, 2008) posits that networks in the 
prefrontal cortex work with the hippocampus to organise information to enhance 
encoding and retrieval efficiency. Using this model as a framework, Study 2 sought 
to examine the relative contributions of frontal and hippocampal cognitive processes 
contributing to the Total and Delayed recall deficits for ecstasy and poly-drug users. 
This was achieved by recruiting regular consumers of ecstasy only (n = 15), cannabis 
only (n = 17) regular consumers of both ecstasy and cannabis (n = 20) and drug 
naïve participants (n = 17). Participants completed two multi-trial word learning 
tasks; one of which consisted of non-related words and the other comprised of 
semantically related words. Indices of semantic and subjective clustering were 
calculated to ascertain the involvement of frontal/strategic processes to memory 
scores, as well as several non-traditional memory indices that specified which words 
were gained and lost between list learning trials and assessed patterns of forgetting 
over multiple trials. Results showed moderate to large magnitude effects of ecstasy 
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use for traditional measures such as Total recall (unrelated list; g = -.92, related list; 
g = -1.10) and Delayed recall (unrelated list only; g = -1.02) and these effects were 
independent of the effects of cannabis and other drug use. A clear inter-trial 
consolidation deficit was also apparent for ecstasy users, who lost more words 
between each learning trial than non-users (g = -.67) however ecstasy users did not 
make fewer gains relative to the other drug groups. The lack of difference in gains 
suggests intact acquisition/encoding for ecstasy users, however the higher number of 
“losses” on the subsequent trial indicate these gains were not able to be consolidated 
and hence were “lost.” This poor consolidation was also evident on the measures of 
forgetting, with ecstasy users more likely to forget words that had previously been 
recalled once (g = .73) and twice (g = -.63) compared with non-users. Strategic 
organisation of to-be-remembered words were also associated with moderate to large 
magnitude effects for ecstasy (g = -.53 for the unrelated list and g = -.97 for the 
related list) and not cannabis use, implicating deficient engagement of the prefrontal 
cortex as a contributor to verbal memory deficits associated with ecstasy use.  
In Study 3, two source memory tasks which differed in degree of difficulty 
were used to assess source memory performance for ecstasy users for the first time. 
Source judgements require the specific recollection of the context in which the 
encoding occurred, such as the colour a word was presented in. Poor source 
judgements have been observed in drug-naïve volunteers during acute tryptophan 
depletion, suggesting episodic recollection processes may be sensitive to reduced 5-
HT functioning (McAllister-Williams, Massey & Rugg, 2004). The pattern of results 
for ecstasy users resembled source judgements of older adults, with no differences 
apparent on the easier version of the task between drug groups, however a significant 
moderate ecstasy related effect was observed for the more difficult, strategic version 
of the task (g = -.57).  This result was thus consistent with the previous finding that 
ecstasy users are deficient in strategic processes that assist memory performance, and 
also suggest that source binding associated with the hippocampus may be impaired 
by ecstasy exposure.  
With regard to poly-drug use, this thesis found limited evidence for an effect 
of cannabis use on the various memory measures, with one notable exception; the 
number of specific words lost between the final learning trial and delayed recall was 
significantly greater for both cannabis and ecstasy users, suggesting the often 
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reported Delayed recall deficit for ecstasy users may be confounded by concomitant 
cannabis use.   
Overall,  the current thesis has found significant strategic/organisational 
deficits which are associated with impaired prefrontal functioning, as well as 
consolidation and source memory deficits associated with hippocampal dysfunction 
for regular ecstasy users, and these deficits were best accounted for by ecstasy rather 
than poly-drug use. As such, conclusions that verbal memory deficits reported for 
regular consumers of ecstasy are primarily a consequence of poly-drug use are at 
present, premature.   
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Chapter 1. 
The Pharmacology, Patterns of Use, Acute and Long-term Effects of Ecstasy  
 
 “Ecstasy” is a popular recreational drug in various countries, and is the 
second most used illicit drug in Australia. For the preceding twenty years however, 
there has been an accumulation of evidence suggesting that MDMA, the main 
psychoactive ingredient of “ecstasy” can cause changes to the serotonin system in 
humans. In addition to serotonergic alterations, ecstasy use is often associated with 
cognitive deficits, the most prominent being deficits in verbal memory recall. In this 
thesis, these verbal memory deficits are further examined in a sequence of studies 
that aim to better understand the global, as well as more specific cognitive 
components of memory that are most affected by ecstasy use.  
 
Chemical classification of MDMA 
MDMA is an abbreviation of 3,4-methylenedioxymethamphetamine, which 
is the main psychoactive ingredient in the popular illicit drug, ‘ecstasy’. MDMA is a 
ring substituted amphetamine derivative that is structurally related to mescaline, 
amphetamine and to the monoamine neurotransmitters (Capela et al., 2009).  In 
humans, MDMA is well absorbed when taken orally, and studies of humans 
following ingestion of MDMA show maximum concentration appears at 1.5 – 3 
hours post consumption (de la Torre et al., 2000; Farre et al., 2004). In the present 
thesis, the term ‘MDMA’ will be used to refer to pure MDMA administered in 
research settings and  the term ‘ecstasy’ will be used to refer to tablets purchased by 
regular ecstasy consumers.   
 
Current use of ecstasy in Australia 
According to the 2010 National Drug Strategy Household Survey Report, 
after cannabis, ecstasy is the second most commonly used illicit drug in Australia, 
with 3.0% of people aged 14 years or older using ecstasy in the previous 12 months 
in 2010. Among 18-19 year olds, 9.8% reported having ever used ecstasy, and 6% 
had used it in the last 12 months. Ecstasy use was highest among people aged 
between 20–29 years, with 24.2% of participants reporting they had used ecstasy, 
and 9.9% reporting having used ecstasy in the last 12 months.  
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An annual survey of 574 regular ecstasy users across Australia (Ecstasy and Related 
Drugs Reporting System-EDRS) reported that people who use ecstasy are typically 
young (mean age of 24) heterosexual (88%) and a higher proportion of recreational 
ecstasy consumers are male (69%). They are typically tertiary educated (46%) or in 
part time or full time employment, with minimal contact (5%) with drug treatment 
programs. Regular ecstasy users preferred to swallow ecstasy in tablet form on 
occasional weekends at nightclubs or pubs. The median number of tablets taken per 
session of use was two.  People who regularly take ecstasy also regularly use other 
drugs, with 98% of the sample having used alcohol in the preceding six months, 85% 
had used cannabis during this time and 60% had used some form of 
methamphetamine (Sindicich & Burns, 2011). 
 
Patterns of use and purity of ecstasy in Tasmania  
Due to the variation in ecstasy purity and patterns of use between cities and 
over time, it is important to consider the characteristics of ecstasy use within the 
region where the research sample was acquired. The data presented later in this 
thesis was collected from regular ecstasy users from Hobart, Tasmania during 2008-
2009. In 2009, the Tasmanian EDRS interviewed 100 ecstasy users who had used 
ecstasy fortnightly on average during the preceding six months. They had all used 
ecstasy in tablet form and their preferred route of administration was swallowing. 
Consistent with trends nationally, these participants used a median of two ecstasy 
pills per session. Poly drug use was also the norm; during the six months preceding 
the interview 99% of the sample had used alcohol, 76% of the sample had used 
cannabis and 46% had used methamphetamine in powder form.  
 
Ecstasy seizures are reported under “phenethylamines” seizures in the Illicit 
Drug Data Report (IDDR, 2008-2009) although the majority of seizures analysed for 
purity were ecstasy related. Not all ecstasy seizures were analysed, so the purity data 
is not representative and only provide an indication of ecstasy purity in Australia. 
Between 2007 and 2009, the median purity in Tasmania remained stable at 
approximately 25% and the Tasmanian EDRS sample of 2009 usually reported that 
ecstasy purity was “medium” and had remained so for the preceding six months. In a 
review of the purity of ecstasy tablets internationally, Parrott (2004) demonstrated 
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that almost all ecstasy tablets contain MDMA as their active ingredient and this is 
consistent with testing of Australian police seizures (Quinn, 2009). 
 
The effects of MDMA administration  
MDMA affects peripheral and central nervous system functions mainly via 
the monoaminergic system. Several studies in rats have shown that MDMA inhibits 
monoamine oxidase, the enzyme which is responsible for the breakdown of 
serotonin, resulting in a reduction of metabolic breakdown. MDMA also inhibits 
tryptophan hydroxylase, the rate limiting enzyme for serotonin synthesis (Cadet, 
Jayanthi & Lyles, 2007). At the serotonergic synapse and neuronal terminal, MDMA 
interacts with the serotonin transporter (SERT) to enter the neuronal terminal and 
elicit an acute and rapid release of up to 80% of stored serotonin from the 
presynaptic neurons, almost depleting the vesicular neurotransmitter stores (see 
Figure 1.1). Through its interactions with SERT, MDMA increases the extracellular 
concentration of serotonin in multiple brain regions and also releases smaller 
amounts of dopamine and norepinephrine (Green et al., 2004; Lyles & Cadet, 2003; 
Yamamoto, Nash, & Gudelsky, 1995).  Microdialysis experiments in rats show that 
MDMA increases extracellular serotonin and dopamine levels in the brain, with the 
effects on serotonin having the greatest magnitude (Gudelsky & Nash, 1996; 
Yamamoto & Spanos, 1988). MDMA has an affinity for several  serotonin receptors, 
including, the activation( 5-HT2A, 5-HT1B/1D) or inhibition (5-HT2C) of which  are 
believed to underlie the subjective, behavioural and neurochemical reactions 
associated with MDMA exposure (Cadet, Jayanthi & Lyles, 2007; Fletcher, Korth, 
Robinson & Baker, 2002). MDMA also has a high affinity of similar magnitude to 
that of SERT, for brain nicotinic and acetylcholine receptors which may account for 
cholinergic neurotransmission alterations associated with ecstasy use (Cadet et al.). 
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Figure 1.1. Functioning of the serotonergic system (Stahl, 2008). Serotonin is produced in a pre-
synaptic neuron and then taken up by synaptic vesicles (left). When the neuron is activated, serotonin 
is released into the synaptic cleft where it binds to serotonin receptors on a post-synaptic neuron 
(centre). Excess serotonin is cleared from the synaptic cleft by the serotonin transporter, which 
releases serotonin out of the synapse and back into the pre-synaptic neuron. Alternatively, excess 
serotonin is broken down by enzymes such as monoamine oxidase (right). 
  
Acute effects of MDMA on humans 
Typical recreational doses of MDMA range from 50-150mg, and several 
studies have administered these doses (usually 1.5mg per kilogram) to healthy 
volunteers to examine the acute effects of ecstasy.  MDMA increases intracellular 
serotonin and dopamine levels for several hours, leading to pleasurable subjective 
effects as well as increased stress on the immune, metabolic and cardiovascular 
systems, and changes to regional cerebral blood flow (De La Torre et al., 2000).  
 
When given in typical recreational doses to human participants, double-blind 
placebo controlled studies have demonstrated that MDMA increases cardiovascular 
activity, including heart rate and blood pressure, which peak 1-2 hours post MDMA 
consumption (De La Torre et al., 2000a, Downing, 1986; Freedman et al., 2005; 
Grob et al., 1996; Lester et al., 2000; Mas et al., 1999; Vollenweider et al., 1998;) 
and continue to be observed four hours post MDMA consumption (Gouzoulis et al., 
1993. Gouzoulis-Mayfrank et al., 1999). MDMA administration has also caused 
changes to regional cerebral blood flow, with increases reported for ventromedial 
frontal and occipital cortex, inferior temporal lobe and cerebellum, and a decrease in 
the motor and somotasensory cortex and temporal lobes (Gamma, Buck, Berthold, 
Liechti, & Vollenweider, 2000).  
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The same doses have been shown to result in neuroendocrine changes, such 
as increased plasma levels of oxytocin, vasopressin, corticotropin, 
dehydroepiandrosterone and a reduction in sodium concentrations (de la Torre et al., 
2000; Harries et al., 2002; Wolff et al., 2006). The most consistently reported 
reductions are found in cortisol and prolactin levels (Dumont & Verkes, 2006). The 
hypothalamic–pituitary–adrenal axis secretes cortisol throughout the day and this 
secretion is increased during times of increased stress. MDMA (0.5mg) has been 
demonstrated to increase cortisol levels to 100% above baseline in the laboratory and 
this effect appears to be increased to around 800% over baseline when MDMA is 
taken during dance clubbing, which may be due to increased physiological stress as a 
result of the combined effects of prolonged dancing, higher ambient temperature, 
loud music and dehydration (Cole & Sumnall, 2003; Parrott, 2002; Parrott, Lees, 
Garnham, Jones, Wesnes, 2006; Parrott, Lock, Conner, Kissling & Thome, 2008 ). 
The chronic release of cortisol via the HPA suppresses hippocampal functioning and 
has been demonstrated to negatively impact cognition, in particular episodic memory 
(Geoffrey, Hertzman, Li & Power, 2012; Herbert et al., 2006). 
 
The increase in MDMA mediated cortisol release has also been shown to 
induce immunosuppression and thus lead to impaired immunocompetence (Pacifici 
et al., 2001; Connor, 2004; Connor et al., 2005). Immunocompetence is the ability of 
an organism to react defensively against antigens. Nelson et al. (2008) demonstrated 
reduced immunocompetence in MDMA treated mice compared with drug free 
controls after being infected with a pathogen. MDMA consumption appears to be 
followed by a period of impaired immunocompetence, leading people who use 
ecstasy to have an increased susceptibility to infection.  
 
Acute MDMA intoxication is also associated with inappropriate antidiuretic 
hormone secretion and hyponatraemia (low concentrations of sodium ions in the 
blood) which can be brought on by excessive fluid intake as a result of increased 
temperature and physical activity (Cole & Sumnall, 2003; Parrott, 2002). This 
condition can be exacerbated due to MDMA induced urinary retention (Delagdo, 
Caruso, Waksman, Hongiman & Stillman, 2004; Inman & Greene, 2003; Bryden, 
Rothwell & O’Reilly, 1995).  
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Another acute effect of MDMA use is hyperthermia, which may be one of the 
mechanisms by which changes to the serotonergic system occur after repeated 
ecstasy use (eg. Parrott, 2001; 2004; 2006). Although non-human studies previously 
indicated that MDMA-induced hyperthermia was dependent on ambient temperature 
(Green et al., 2004) several studies have reported a modest increase in body 
temperature (between 0.2-0.3 degrees Celsius) in human volunteers post MDMA 
administration, regardless of ambient temperature (eg. Ciohen & Cocolres, 1997; 
Kolbrich et al., 2008; Vollenweider et al., 1998). In one study (Freedman et al, 
2005), human volunteers were administered MDMA under climate controlled 
conditions in ambient temperatures of 18 and 30 degrees Celsius. MDMA 
consumption was shown to increase core body temperature by 0.3 and 0.6 degrees 
respectively, and the authors suggested these elevations were likely due to the 50-
100% increase in metabolic rate (Freedman, Johanson & Tancer, 2005). Further, 
ecstasy users often don’t report increase in body temperature or heart rate as 
uncomfortable (Capela, 2009) which may result in prolonged physical activity, thus 
increasing the risk of poor thermoregulation and changes in metabolic rate. These 
factors can combine to increase oxidative stress, which has been suggested to 
exacerbate serotonergic cellular damage during the acute phase of MDMA 
intoxication (Miranda et al., 2007).  
 
To account for the variations of symptoms associated with regular ecstasy 
use, Parrott (2006) postulated a bioenergetic stress model of MDMA . This model 
predicts that drug related factors such as disrupted thermoregulation, acute 
neurotransmitter release, oxidative stress, cortisol release and co-use of other drugs 
interact with non-drug factors such as the environment in which time is spent 
intoxicated, ambient temperature, physical activity, and other factors such as 
immune-competence, sleep and genetics. For example, the increase in cardiovascular 
activity as a result of dancing could contribute to MDMA induced cortisol release 
and hyperthermia. Immunocompetence may be additionally impaired by becoming 
dehydrated while on the drug and due to loss of appetite and sleep in the following 
days (Pacifici, et al., 2002; Connor, 2004). This model therefore partially accounts 
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for discrepancies in ecstasy related findings by considering various factors other than 
MDMA itself that can contribute to the sequale of regular ecstasy use.  
Subjective effects of MDMA 
The most frequently reported subjective effects of MDMA intoxication 
within the first 24 hours include improved mood, increased confidence and energy, 
increased social interaction, euphoria, warmth, friendliness, feeling thirsty, 
heightened perception of sound, colour, touch and increased heart rate (Cohen & 
Cocores, 1997; Davison & Parrott, 1997; Verheyden, Henry & Curran, 2003; 
Vollenweider et al., 1998). With increasing duration of ecstasy use, reports of 
positive effects decline (Murphy, Waring & Fisk. 2006) and common subjective 
experiences include becoming drug tolerant, poor concentration and feeling 
depressed (Verheyden et al., 2003). Subjective effects have been demonstrated to be 
related to the pharmacological content of tablets sold as ecstasy, as assessed by self-
reports by regular ecstasy users who handed in their tablets for chemical analysis. 
MDMA dose was positively related to positive effects (Odds ratio, 1.01, 95% CI: 
1.009 – 1.014, p <.001) and logistic regression with different doses as the categorical 
variable further showed that the probability of experiencing positive effects 
increased until 81 – 100mg of MDMA and then slowly decreased with higher doses 
of MDMA. The probability of experience adverse effects rapidly increased at doses 
higher than 120mg (Brunt , Koeter, Niesink & Van den Brink, 2012). MDMA 
releases serotonin approximately 10 times more potently than methamphetamine, 
and releases dopamine approximately six times less potently than methamphetamine 
(Sarkar & Schmued, 2010)  and subjective effects are consistent with this variation 
in neurotransmitter release, with increased empathy and feeling close to others being 
specific to MDMA, whereas subjective effects of dopaminergic drugs such as 
methamphetamine and cocaine appear to be related to the mesolimbic pathway, and 
include feeling a rush, liking the drug, craving the drug, and later an experience of 
“crashing” (Walsh, Stoops, Moody, Lin & Bigelow, 2009).   
 
In summary, MDMA is a popular illicit drug in Australia, with nearly a 
quarter of all illicit drug users having used it in Australia in 2010.  Although the 
amount of MDMA sold as ecstasy in Australia varies, police seizure evidence 
indicates that pill purity was relatively stable in Tasmania in 2008-2009, which was 
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the period of recruitment for this study. The subjective effects of ecstasy, including 
euphoria, increased empathy and increased confidence probably arise as a 
consequence of its action on the brain serotonin, and to a lesser extent dopamine. 
MDMA has also been demonstrated to cause neuroendocrine alterations including 
increased cortisol and prolactin release, as well as hyperthermia, increased 
cardiovascular activity in humans. Although some of these acute effects are a 
consequence of MDMA’s actions on neurotransmitters, variations in symptoms, and 
in particular, discrepant reports of ecstasy related memory deficits,  may be due to 
interactions between drug and non-drug factors such as poly-drug use, genetics, 
increased physical activity, dehydration or excessive fluid intake, and higher cortisol 
levels during time spent on the drug.   
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Chapter 2 
The Prevalence and Effects of Cannabis use amongst Regular Ecstasy Users 
  
The use of cannabis in Australia 
The 2010 National Drug Strategy Household Survey Report found cannabis 
to be the most commonly used illicit drug in Australia. Of people over the age of 14, 
35.4% reported having ever used cannabis, and 10.3% had used cannabis in the past 
12 months. For the preceding 12 months, 23.1% of people aged between 18 and 19, 
and 25% of persons aged between 20 and 29 had used cannabis. Amongst frequent 
(at least monthly) ecstasy users in Australia in 2011, 31% had also used cannabis in 
the previous month, and 85% had used cannabis in the preceding six months 
(Sindicich & Burns, 2011). A high percentage (49%) of these ‘regular’ ecstasy users 
used cannabis and ecstasy concomitantly, and 58% reported using cannabis when 
coming down from a heavy session of ecstasy. These high rates of concomitant 
ecstasy and cannabis use are not always adequately controlled for in the ecstasy 
literature (Curran, 2000; Parrot, 2006) and the present thesis attempts to address this 
by including a Cannabis-only group in the design as an independent variable. As 
such, a brief review of the neuroanatomical and neuropsychological effects of 
cannabis use follows.  
 
Acute effects of cannabis  
Cannabis is a plant derived illicit drug containing 70 types of cannabinoids, 
which interact with endogenous cannabinoid receptors in the human body. The most 
potent psychoactive cannabinoid is ∆9-tetrahydrocannabinol (THC). Neuronal 
cannabinoid receptors CB1 and CB2 have been found in rat, guinea pig, dog, 
monkey, pig and human brains. CB1 is found on presynaptic terminals and 
modulates neurotransmission through inhibiting adenylyl cyclase and modulating 
adenosine 3′,5′-cyclic monophosphate (a metabolic regulator)  production 
(McAllister & Glass, 2002; Pacher, Batkai & Kunos, 2006). The distribution of CB1 
is mostly localised to the CNS, including the cerebral cortex, hippocampus, 
amygdala, basal ganglia, cerebellum, thalamus and brainstem. CB2 receptors are 
mostly present in some immune cells (Ashton, 2001). In non-human animals, 
consumption of THC results in binding at CB1 and CB2, and increases the release of
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dopamine from the nucleus accumbens and prefrontal cortex. The increase in 
dopamine is believed to cause some of the pleasant subjective acute effects of THC 
consumption in humans (Green, 2006) such as euphoric mood, relaxation, increased 
sociability and enhanced sensory perception (Ashton, 2001; Green, 2003).  The acute 
effects of cannabis begin within a few minutes after smoking the drug, and usually 
diminish within four hours (Pacher et al., 2006).  
 
Functional and structural effects of cannabis 
Martin-Santos et al. (2010) conducted a review of the neuroimaging literature 
on the acute and chronic effects of cannabis on brain structure and function. The 41 
studies which met criteria for the review comprised 655 cannabis users and 402 
controls. Chronic cannabis users were defined as having used cannabis several times 
per week for a minimum of two years, and recreational users were defined as using 
up to four times per month. The control participants had less than 15 occasions of 
use in their lifetime. The most consistent results came from studies that examined the 
acute effects of experimental THC or marijuana cigarette administration on brain 
activity. Three PET studies reported global increases in regional cerebral blood slow 
(rCBF) for recreational and chronic cannabis users following smoking a marijuana 
cigarette (containing THC) compared with baseline or placebo conditions. Of the six 
studies that examined the effects of experimental administration of THC on resting 
state, all reported global increases in rCBF for cannabis users relative to controls, 
and some studies reported subjective levels of intoxication were positively correlated 
with increases in anterior and posterior rCBF (Matthew et al., 2002) and also with 
increases in the anterior cingulate cortex (Matthew et al., 1997) frontal cortex 
(Matthew et al., 1999) and in the cerebral cortex (Volkow et al., 1996). These results 
were consistent for recreational and chronic cannabis users following smoking a 
marijuana cigarette (Matthew et al., 1992; Matthew & Wilson, 1993). 
 
Studies that compared resting brain activity between chronic cannabis users 
and controls in the absence of THC administration reported resting global, prefrontal 
and anterior cingulate cortex blood flow was lower in cannabis users (maximum 
abstinence was two weeks) compared with controls (eg. Block et al., 2000; 
Lundqvist et al., 2001) although Sneider et al., (2008) examined changes in regional 
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cerebral blood volume (rCBV) between chronic cannabis users and controls and 
reported increased rCBV in the right frontal, temporal lobes (bilaterally) and the 
cerebellum at 6 hours, 36 hours and 7 days abstinence from cannabis. After 28 days 
of monitored abstinence, cannabis users continued to show this altered neural 
activity with the exception of the frontal region, where the activation was no longer 
different from controls, suggesting that the frontal cortex begins to normalise with 
continued cannabis abstinence.  
 
Structural differences between cannabis users and controls have been 
examined using various MRI techniques. One study used voxel-based morphemetry 
to examine possible brain structural differences in a group of 11 chronic cannabis 
users and 8 controls, and reported reduced grey matter volume in bilateral 
hippocampus (Matochik, Eldreth, Cadet & Bolla, 2005). Similarly, Yucel et al. 
(2008) reported bilateral reduction in the hippocampal and amygdala areas, with the 
hippocampal volume reduction being negatively related to cumulative exposure to 
cannabis over the preceding ten years. The participants in this study were carefully 
selected on the basis of prior exposure, all had been using daily for a minimum of ten 
years (mean = 19.7 years) and smoked a minimum of five marijuana cigarettes a day. 
Hermann et al. (2007) used MR spectroscopy to examine various brain regions in 
regular cannabis users and controls and reported diminished axonal integrity for 
cannabis users in the dorsolateral prefrontal cortex, however the cannabis users in 
this study were not required to undergo a required period of abstinence, thus these 
effects could be acute rather than residual.  
 
In an MRI which compared  hippocampal volumes between adolescents who 
used either alcohol and cannabis, alcohol only or who were drug free, only those 
with a history of alcohol use alone had smaller hippocampal volumes (Medina et al., 
2007).  Most MRI studies that have used region of interest analyses have failed to 
identify structural brain changes in regular cannabis users compared to controls 
(Block et al., 2000; DeLisi et al., 2006; Gruber & Yurgelun-Todd, 2005; Tzilos et 
al., 2005; Jager et al., 2007). Overall, the studies that have reported structural 
differences associated with cannabis use had small sample sizes, used very heavy, 
atypical cannabis users or had no required abstinence period, and as such more 
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research is required to investigate cannabis induced structural alterations in the 
human brain.  
 
Evidence for the effects of cannabis on human dopaminergic functioning 
Although animal studies have frequently reported increases in CNS 
dopamine release following cannabis consumption, dopaminergic fluctuations as a 
consequence of regular cannabis use in humans are reported inconsistently in the 
literature thus far. A few recent PET studies have used a selective dopamine D2/D3 
tracer to examine the effects of THC administration on dopamine receptor binding. 
Stokes, Mehta, Curran, Breen and Grasby (2009) reported an increase in psychosis-
like symptoms in participants with cannabis experience following experimental 
administration of THC at a dose equivalent to a standard marijuana cigarette, 
however compared to placebo there were no significant differences in dopamine 
receptor binding in the striatum. A SPECT study administered a relatively low dose 
of THC (2.5mg, compared with the usual 10mg) intravenously, and at this dose there 
was still an increase in positive type symptoms of schizophrenia, but no differences 
in receptor binding in the caudate or putamen relative to placebo (Barkus, et al., 
2010).  Sevy et al. (2008) examined differences in dopamine receptor availability 
between currently abstinent cannabis dependent persons (minimum of twelve weeks 
abstinence) and drug naïve controls. There were no differences in D2 and D3 receptor 
availability between groups, although the cannabis group did have lowered glucose 
metabolism in the orbitofrontal cortex and bilateral putamen. Bossong et al. (2009) 
however, examined the effects of THC inhalation on seven drug naïve participants 
and reported decreased D2 and D3 binding in the ventral striatum and dorsal 
putamen, indicating that an increase in dopamine release had occurred within these 
regions. Using PET with a specific dopamine transporter (DAT) radiogland, Leroy et 
al. (2011) assessed DAT activity in tobacco dependent and marijuana dependent 
participants in comparison with non-smokers. Region of interest analysis reported a 
20% decrease in DAT availability in the dorsal striatum in smokers compared with 
controls, and whole brain analysis showed lower DAT availability in the ventral 
striatum, midbrain and thalamus. Although DAT availability was lower in cannabis 
dependent compared with tobacco dependent persons, this difference did not reach 
statistical significance. Further,  DAT availability in the associative striatum has 
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been demonstrated to be related to earlier onset or longer duration of use in persons 
with mild to moderate cannabis dependence (Urban et al., 2012) , and this 
relationship has also been reported for the neurocognitive data also, with greater 
cognitive deficits associated with earlier onset of use (Pope et al., 2003). It therefore 
appears as though alterations to dopaminergic neurotransmission in cannabis users 
are mediated by age of onset.   
 
Ecstasy and cannabis are frequently used together, and their combined effects may 
be interactive rather than additive (Croft et al., 2001; Fisk, Montgomery, Wareing & 
Murphy, 2006; Parrot, Gouzouikis-Mayfrank, Riodgers & Solowij, 2004 ). It is 
therefore useful to consider the influence of cannabis when investigating the 
cognitive effects of ecstasy use. Cannabis receptors are distributed throughout the 
human brain, including the cerebral cortex and hippocampus.  Cannabis intoxication 
increases the release of dopamine from the nucleus accumbens and prefrontal cortex, 
however evidence that cannabis use is associated with alterations to DAT density 
and availability in the prefrontal cortex and hippocampus is limited at this time. 
Cannabis is a particularly useful drug to compare with ecstasy as each drug is 
associated with greater, though not exclusive, release of dopamine and serotonin 
respectively, and this difference means that the differential effects of each drug on 
the memory outcomes in the current thesis can be attributed with some degree of 
confidence to either the serotonergic or dopaminergic systems. Further, since there is 
still debate surrounding ecstasy specific, as opposed to poly-drug effects on verbal 
memory, including a Cannabis-only using group, and comparing their performance 
with an Ecstasy-only group and an Ecstasy-plus cannabis group can better address 
the role of poly-drug use in memory deficits for ecstasy users.  
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Chapter 3 
The Effects of Repeated MDMA Exposure on the Human Serotonergic System 
 
As discussed previously, typical recreational doses of MDMA releases up to 
80% of stored serotonin from presynaptic neurons in humans, increasing the 
extracellular concentration of serotonin in multiple brain regions (Green et al., 2004). 
Serotonin (5-HT) is a biogenic amine which acts as a neurotransmitter extensively 
throughout the central (CNS) and peripheral nervous systems. The 
neuropsychological and behavioural processes modulated by serotonin include 
mood, perception, appetite, sleep wake cycle, attention and memory (Berger, Gray, 
Bryan & Roth, 2009; Rubenstein, 1998). In rats, non-human primates and humans, 
the most notable alterations in MDMA induced neurotransmission involve the 
serotonergic system (Sarkar & Schmued, 2010). Because of these alterations to 
serotonergic functioning, the last two decades has seen an influx of reports claiming 
that ecstasy has the ability to produce neurotoxic effects in laboratory animals and 
humans. The meaning of the term neurotoxicity has received little attention in the 
literature until relatively recently, when the lack of consensus regarding its definition 
was raised by Biezonski and Meyer (2011) who suggested there has been a lack of 
differentiation between substances that cause a shortage of serotonin markers within 
intact neurons, and those that induce irreparable neurodegeneration. In the current 
thesis, the term neurotoxicity is reserved for when authors have specifically used this 
term to describe the effects of MDMA on the serotonergic system. Further, since 
neurotoxicity can be defined as an adverse change in brain structure or function 
which may be reversible or permanent, the term serotonergic alterations and 
synonyms are used to acknowledge the presence of serotonergic abnormalities in 
ecstasy users and also the current lack of understanding as to whether these are 
transient or permanent.  
 
Overview of the serotonergic system 
 The cell bodies of serotonin neurons are located in the raphe nuclei a 
collection of neurons localised along the rostrocaudal midline of the brain stem. The 
dorsal and median raphe nuclei contain approximately 85% of serotonin neurons 
found in the brain (Barnes & Sharpe, 1999; Berger et al., 2009; Hornung & 
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deTribolet, 1995).  Axons originating in the dorsal raphe nuclei project to the ventral 
hippocampus, amygdala, lateral septum, striatum and prefrontal and cerebral cortex. 
The dorsal hippocampus and cerebral cortex are also innervated by the median raphe 
nuclei (see Figure 1.2). The frontal cortex receives innervations that are twice as 
dense as those to the parietal and occipital lobes, with the dorsal frontal cortex 
containing the most serotonergic neurons (Barnes & Sharp, 1999; Hornung, 2003; 
Hoyer et al., 1994; Michelsen, Schmitz & Steinbusch, 2007).  
 
 
 
 
 
 
Figure 1.2. Serotonergic pathways (represented by arrows) in the human brain.  
 
 
Based on their morphology and origin, serotonergic axons differ in width and 
shape. Fine varicose axons originate from the dorsal raphe nuclei and are distributed 
through all cerebral cortical areas, but are more concentrated in layer IV of cortex 
and in primary sensory areas (Hornung, Fritschy & Tork, 1990; Wilson & Molliver, 
1991). The thicker axons stem from the medial raphe nuclei and are restricted to 
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layers of the hippocampus and the medial and frontal neocortex. In rats and non-
human primates, acute doses of MDMA preferentially affect the fine axons 
originating from the dorsal raphe nuclei, leaving the thicker axons intact 
(Mamounas, Mullen, O’Hearn & Molliver, 1991; O’Hearn, Battaglia, DeSouza, 
Kuhar & Molliver, 1988) although Gartside McQuade and Sharpe (1998) failed to 
observe differential reactions from dorsal and medial originating axons after an acute 
dose of MDMA in rats, concluding that MDMA affected the axons equally. MDMA 
also appears to differentially alter the neural plasticity of axons following MDMA 
exposure. The regeneration of serotonin axons after MDMA exposure may depend 
on their proximity to the raphe nuclei, with axon terminals in the frontal cerebral 
cortex showing lasting enervation, and those closer to the raphe nuclei showing 
greater re-innervation in squirrel monkeys (Fischer, Hatzidimitriou, Katz  & 
Ricaurte, 1995).  
 
Serotonin effects neural activity via excitation or inhibition of approximately 
14 different 5-HT receptor subtypes (Barnes & Sharp, 1999; Hoyer, Clarke et al., 
1994; Hoyer, Hannon & Martin, 2002). Some receptors, including 5-HT1a, 5-HT2a 
and 5-HT2c have been demonstrated to alter in sensitivity or number following 
exposure to treatment that increased serotonin release (Michelsen, Schmitz & 
Steinbusch, 2007) which is why these receptors have been the focus of PET studies 
when examining the effects of MDMA on serotonergic markers in human ecstasy 
users.  In addition to their sensitivity to serotonin agonists, 5-HT1, 5-HT2 and 5-HT4 
are potentially involved in memory functions, since these receptors are present in 
regions that are crucial to cognition, such as the hippocampus and frontal cortex 
(Berumen, Rodriguez, Miledi & Garcia-Alocer (2012- see Figures 1.3-1.4). 
Furthermore, SERT plays a key role in serotonergic transmission and serotonin has 
been posited to support plasticity in the brain generally, and also supports long term 
potentiation in hippocampus, which is pivotal to the formation of enduring memories 
(Buhot, Martin & Segu, 2000; Michelsen, Prickaerts & Steinbusch, 2008). 
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Figure 1.3 There are seven sub-types of 5-HT receptor and the 1A subtype is widely 
expressed throughout the brain. The highest levels of this sub-type are found in the 
hippocampus and medial temporal cortex, with slightly lower levels in the pre-
frontal cortex. Low levels of 5-HT1A are found in the basal ganglia.  
 
 
 
 
Figure 1.4. The 5-HT2 receptors (A, B and C subtypes) are widely distributed 
throughout the brain. These receptors can be found in the cerebral cortex, amygdala, 
hypothalamus, hippocampus, substantia nigra, choroid plexus, substantia innominata 
and some components of the basal ganglia. Images retrieved from: 
www.cnsforum.com/imagebank/section/Serotonergic/default.aspx 
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Studies on the long term effects of MDMA on serotonin in humans have used 
indirect measurement methods such as measurement of the serotonin metabolites, 
typically Positron Emission Tomography (PET) and Single Proton Emission 
Computed Tomography (SPECT). PET and SPECT require the administration of a 
compound that has been tagged with a radioactive isotope (referred to as a ligand) 
which allows the movement of the compound in the brain to be scanned and traced. 
The most common compound used in this research are [
123
I]β-CIT,  [11C] McN5652 
and [
11
C]DASB. These techniques have been validated for the measurement of 
MDMA- induced serotonergic abnormalities in humans (Kish, 2002; Reneman et al., 
2006). The PET radioligands (+)-[
11
C]McN-5652 and [
11
C]DASB have been found 
to selectively bind to serotonin transporters in the human brain (Frankle et al., 2004; 
Houle, Ginovart, Hussey, Meyer, & Wilson, 2000; Szabo et al., 1995 ). Other 
measures of the effects of MDMA in humans include Proton Magnetic Resonance 
Spectroscopy and the measurement of metabolites such as 5-Hydroxyindoleacetic 
acid (5-HIAA) in cerebrospinal fluid of ecstasy users. Research using these 
techniques will be reviewed below, followed by a review of PET and SPECT 
studies, which comprise the bulk of the neuroimaging literature thus far.  
 
Indirect measures of serotonergic alteration in ecstasy users; Cerbrospinal fluid 
measures and Proton MR Spectroscopy  
As serotonin levels cannot be measured directly in the human brain, some 
early research measured the concentration of the major metabolite of serotonin (5-
hydroxyindoleacetic acid; 5-HIAA) in the cerebrospinal fluid of ecstasy users as a 
substitute. One early study, with a small sample size of relatively novice ecstasy 
consumers (n = 5, lifetime dose ranging from 1-33 pills) reported no difference in 5-
HIAA concentrations between ecstasy users and controls (Peroutka, 1987). In 
contrast, in the CSF of approximately 30 ecstasy users who had used ecstasy on 
more than 25 occasions and had been abstinent for two to three weeks, the 
metabolite concentrations of 5-HIAA were significantly lower compared with the 
levels of control participants (McCann, Mertl, Eligulashvili, & Ricaurte, 1999; 
McCann et al., 1994; Ricaurte, Finnegan, Irwin & Langston, 1990). There was no 
difference in levels of 4-hydroxy-3-methoxyphenylacetic acid, homovanillic acid (a 
metabolite of dopamine) between the two groups, suggesting that ecstasy 
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preferentially affects the serotonin system (McCann, Mertl, Eligulashvili, & 
Ricaurte, 1999; McCann et al., 1994). Only one study however, (Bolla, McCann, & 
Ricaurte, 1998) showed a significant negative correlation (r = -0.52, p<.013) 
between average monthly dose and 5-HIAA concentration.      
Proton MR Spectroscopy (
1
H-MRS) is used to detect various metabolites in 
the brain, including N-acetylaspartate (NAA) and myo-inositol (MI) both of which 
have been investigated in ecstasy users. A reduction of NAA represents a reliable 
non-specific marker for neuronal loss or dysfunction (Reneman et al., 2006) and an 
increase in MI may reflect a glial response to MDMA- induced axon degeneration 
(Cowan, 2007). Chang, Ernst, Grob and Poland (1999) reported increased MI in the 
right parietal lobe of MDMA users compared with controls, however Cowan et al., 
(2007) and Reneman, Majoie, Flick and den Heeten, (2002) failed to detect 
differences in MI in the occipital lobe and parietal lobe between ecstasy users and 
controls. For NAA, no differences were observed for the hippocampus bilaterally 
(Obergriesser, Ende, Braus & Henn 2001) or in the in the left hippocampus, mid-
frontal grey matter or mid occipital grey matter of ecstasy users relative to controls 
(Daumann, Fischerman et al., 2004). Reneman, Schmand, and van den Heeten 
(2001) did report reduced NAA for ecstasy users in mid-frontal gray matter and also 
reported a significant correlation between impaired delayed recall scores on a word 
learning task and NAA concentration in the prefrontal cortex of ecstasy users. So far, 
H-MRS studies have lacked consistent results with regard to NAA and MI, although 
the sample sizes have been small (ranging from 5 to 21 for the ecstasy using group) 
and may have limited statistical power.  
 
Voxel-based morphometry (VBM) is a neuroimaging technique that allows 
investigation of differences in brain anatomy. The volume of the whole brain or 
specific regions of interest are measured by drawing on images from MRI and 
calculating the volume. The output from this method is a statistical parametric map 
which shows differences in grey matter concentration between groups (Ashburner & 
Friston, 2000). Cowan et al. (2003) used VBM to compare overall regional brain 
grey matter density between ecstasy-poly-drug controls and drug naive participants. 
Lifetime ecstasy use ranged from five to over 40 occasions of use, and urine screens 
confirmed that participants were abstinent at the time of testing.  Ecstasy users had 
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reduced grey-matter concentrations in various brain regions, particularly in the 
middle temporal gyrus, area V2 and bilateral parts of Broca’s Area. Following up on 
reports of two cases of “acute hippocampal toxicity” following chronic ecstasy use, 
den Hollander et al. (2011) selectively investigated the hippocampal volume of long 
term ecstasy users compared with poly-drug using controls. Ecstasy users were male; 
had a minimum lifetime dose of 50 tablets and were required to be at least two weeks 
abstinent at the time of testing (confirmed by urine analysis). Hippocampal volume 
was measured by manually outlining the hippocampus in volumetric MRI scans, 
which showed that ecstasy user’s hippocampal volume was, on average, 10.5% 
lower than poly-drug controls. VBM showed the proportion of overall grey-matter 
volume was on average, 4.6% lower in the ecstasy using group and there were no 
significant differences between total brain volume or left and right hippocampal 
volume. den Hollander et al. suggest that Cowan and colleagues did not find grey-
matter variations in the hippocampus as VBM analyses are less powerful at detecting 
differences than region of interest analyses due to correction for multiple 
comparisons.  
 
PET and SPECT neuroimaging studies investigating the effects of ecstasy on 
serotonin markers 
Much of the PET and SPECT literature on the effects of ecstasy on the 
human brain has focussed on indirect markers of serotonergic integrity, such as the 
SERT (serotonin reuptake transporter). SERT is responsible for the reuptake of 
serotonin from the synaptic cleft to the presynaptic neuron and is therefore a 
potential marker for serotonergic axons. SERT is found along the entire axon, rather 
than at the synaptic terminal alone and SERT density is highest in the raphe nuclei 
and subcortical structures and also in the hippocampus and prefrontal cortex 
(Gurevich & Joyce, 1996).There is currently limited agreement with regard to the 
underlying mechanisms that reduce SERT binding; it may loss of serotonergic axons 
(Reneman, Booij, Majoie, Van Den Brink, & Den Heeten, 2001) or axonal loss 
associated with subsequent formations of new serotonin projections (Erritzoe et al., 
2011) or a temporary down-regulation SERT to compensate for serotonin deficiency 
or excessive release (Kish, Fitzmaurice, Chang, Furukawa & Tong, 2010).  The 
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location and magnitude of decreased SERT binding have been inconsistent in the 
human literature, which is briefly reviewed below.  
 
Using PET in combination with a serotonin transporter ligand, several studies 
have reported lower SERT density for regular ecstasy users compared with controls, 
suggesting that MDMA use may induce neurotoxicity in humans (Buchert et al., 
2003; De Win et al., 2004; 2008; McCann, Szabo, Scheffel, Dannals & Ricaurte, 
1988; McCann et a., 2005; Reneman et al., 2001; Ricaurte, McCann, Szabo & 
Scheffel, 2000; Semple et al., 1999). In humans, some data indicates global SERT 
reductions (McCann et al,. 1988) some has revealed limited areas of SERT reduction 
(McCann et al., 2005; 2008) and yet others have reported reductions in striatal and 
cortical SERT (Buchert et al., 2007; Reneman et al., 2001) compared with no striatal 
or cortical SERT reductions (de Win et al., 2008; McCann et al., 2005).  A few 
studies have shown that SERT binding was only reduced for heavy female ecstasy 
users and not males, suggesting that females may be more susceptible to MDMA 
induced functional impairments (Buchert et al., 2004; Reneman et al., 2001; 
Thomasius et al., 2003). Importantly, some studies were able to show an association 
between the degree of MDMA exposure and reduction in SERT levels (Buchert et 
al., 2003; McCann et al., 2005; Thomasius et al., 2003).  
 
Two studies have compared markers for dopamine and serotonin functioning 
to investigate whether ecstasy selectively impairs serotonergic functioning. Semple 
et al. (1999) used SPECT and demonstrated reduced SERT density in the neocortex 
for ecstasy users (male only) compared with controls with no concurrent reduction in 
dopamine transporter density. The reduction in SERT density was positively 
correlated with abstinence from MDMA.  McCann, Szabo, Vranesic et al. (2008) 
recruited participants who had taken two to three sequential doses of ecstasy within a 
short period of time (between 3 and 12 hours) in an attempt to mimic the high 
MDMA plasma concentrations found in research rats. High plasma concentrations in 
rats have been associated with dopaminergic as well as serotonergic alterations. 
McCann et al. used PET with DAT and SERT ligands to ascertain if there were any 
differential effects of ecstasy use on these neurotransmitters. The results showed a 
significant reduction in SERT binding for ecstasy users compared with controls in 
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the dorsolateral prefrontal cortex, orbitofrontal and parietal cortical areas. There 
were no differences in dopamine transporter binding between ecstasy users and 
controls.  
Compared with SERT, less research has been conducted on 5-HT2a receptors 
to date. 5-HT2a receptors are distributed throughout the CNS, with dense 
concentrations in the neocortex(Capela, 2009). Located at the post-synapse of 5-HT 
neurons, they are therefore an indirect measure of synaptic serotonin release. The 5-
HT2a receptor has been shown to down-regulate with ongoing exposure to agonists 
and to up-regulate in their absence (Van Oekelen et al., 2003). Erritzoe et al. (2011) 
compared SERT and 5-HT2a levels between people who had used both ecstasy and 
hallucinogens (hallucinogens being a class of drugs that also rely on serotonin 
release for their acute effects), but who had consumed one significantly more than 
the other. They reported significantly reduced SERT binding for the ecstasy 
preferring group (mean lifetime dose = 1296 tablets) in the amygdala, neocortex and 
pallidostriatum compared with the hallucinogen preferring group (mean lifetime 
ecstasy dose = 60 tablets). The reductions in SERT were correlated negatively with 
lifetime ecstasy use for both groups. 5-HT2a receptor binding was slightly decreased 
for hallucinogen and ecstasy users relative to controls, although this effect was 
interpreted conservatively due to borderline statistical significance after removal of 
two potential outliers in the sample. Erritzoe and colleagues suggest that the lower 
binding of SERT may compensate for MDMA induced serotonin depletion, thus 
preventing post-synaptic receptors from up-regulating.  
 
Deficits in connecting multiple brain regions 
Recent research has suggested that the cognitive deficits associated with 
ecstasy use could be associated with compromised connections between different 
neural networks, possibly due to a reduction of serotonin in the thalamus. DeWin et 
al. (2008) used SPECT in combination the radioligand [
123
I]b-carbomethoxy- 3b-(4-
iodophenyl) tropane (CIT) and MRI to assess the functional and structural changes 
associated with ecstasy use. In this prospective cohort study, all participants were 
ecstasy naïve at baseline. At the 17 month follow up, 59 had taken Ecstasy (mean = 
6 tablets) and the remaining 56 matched controls remained ecstasy naïve. After 
statistical adjustment for various other illicit substances, De Win et al., reported 
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decreased cerebral blood volume in the globus pallidus and putamen, and decreased 
fractional anisotropy (a measure of axonal integrity) and increased apparent diffusion 
coefficient in the thalamus.  DeWin et al. suggest that these findings indicate 
ecstasy-induced damage to serotonergic axons caused by serotonin depletion.  As the 
thalamus provides multiple connections between cortical and subcortical areas and is 
important in memory and language, DeWin et al. speculate that serotonergic 
alterations in this area may partly explain the memory deficits often reported for 
ecstasy users.  
 
Due to the innervation of serotonin axons to the supplementary motor area, 
primary motor cortex and motor thalamus, and evidence suggesting that fluctuations 
in serotonin function may be associated with changes in functional connectivity 
within neural networks, recent research has examined the effect of ecstasy 
consumption on brain motor regions and the coordination of neural networks within 
this region (Karageorgiou et al., 2009, 2011). Using fMRI during performance of an 
event-related finger tapping task, Karageougiou (2009) reported no differences 
between ecstasy users and controls for finger tapping performance but greater event-
related activation and amplitude for the ecstasy using group. Re-analysis of the data 
to assess functional connectivity revealed disruptions in thalamic communications 
within the thalamo-cortical-striatal behavioural control triangle for ecstasy users 
compared with controls (Karageougiou, 2011). Thus, lifetime ecstasy exposure was 
significantly, negatively correlated with diminished connectivity between seven 
region pairs within the motor system and amplitude and activation was higher during 
the finger tapping task. The authors suggest that ecstasy use resulted in increased 
thalamic activity and decreased functional connectivity. Put simply, ecstasy users 
motor regions worked with less collaboration and required more neural activity to 
perform at the same level as controls.  
 
Serotonergic fluctuations may be transient 
Early non-human studies on the effects of MDMA on the serotonin system 
indicated that although MDMA caused long-term changes, they could be reversible. 
Fischer, Hatzidimitriou, Wlos, Katz and Ricaurte (1995) raised serious concerns 
about the potential for MDMA to be neurotoxic to humans. They examined 
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serotonergic innervations patterns in rats and monkeys lesioned with MDMA in the 
previous 12-18 months. Fischer et al. reported that two weeks after MDMA exposure 
there was significant denervation of serotonin axons in various brain regions, more 
so for primates than rats. Seventy-two weeks post exposure, Fischer et al. observed 
that for most of the monkeys, there was re-innervation of axons, although the pattern 
of re-enervation was unusual, with areas distal to the raphe nuclei remaining 
denervated and areas more proximal to the raphe being re-innervated or hyper-
enervated. Similalry, Hatzidimitriou, McCann and Ricaurte (1999) examined SERT 
densities in monkeys seven years after MDMA exposure and found long lasting 
reductions in SERT densities in the neo-cortex, hippocampus, cingulate cortex and 
amygdala, and recovered or hyper-enervation in the hypothalamus and globus 
pallidus respectively. There was no apparent loss of cell bodies in any brain region. 
These results suggested that although MDMA can cause structural alterations and 
denervation of serotonin axons, there is scope for regeneration in areas closer to the 
raphe nuclei. These patterns of serotonin axon alterations were consistent with 
Fischer et al. with regard to the distal and proximal nature of recovery.  
 
In human studies that have compared former ecstasy users with current 
ecstasy users, there is additional evidence that serotonergic alterations as a 
consequence of MDMA exposure may be transient. For example, Buchert et al. 
(2003, 2004) and Thomasius et al. (2003, 2006) recruited poly-drug users, current 
ecstasy users and former ecstasy users (abstinent for at least 5 months as confirmed 
by hair analysis) and compared SERT densities between groups. PET scans revealed 
significant reductions in SERT density in the mesencephalon of current users 
compared with the other groups, and reduced SERT density in the caudate nucleus 
compared to the poly-drug group only. The mesencephalon effects were best 
predicted by number of tablets taken within the preceding year (R2=0.12, p <.001) 
and number of occasions of ecstasy use was the best predictor for effects in the 
caudate nucleus (R2=0.07, p = 0.004). There were no significant differences between 
former ecstasy users and poly-drug users in SERT densities (Thomasius et al., 2003). 
Buchert et al. (2004) reported significant reduction in SERT density for current users 
compared with drug naive, poly drug and former ecstasy users in multiple brain 
areas, including the mesencephalon, thalamus, occipital cortex and hippocampus. 
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Consistent with Thomasius et al., (2003) there were no significant differences 
between poly-drug and drug naïve groups, suggesting these SERT effects may be 
reversible. There was also a significant correlation between SERT density and period 
of abstinence in the basal forebrain and brainstem regions of current ecstasy users. 
Using PET and the SERT ligand [
11
C]DASB, Selvaraj et al. (2009)  recruited former 
male ecstasy users and former male poly-drug users who had been abstinent for one 
year,  in an attempt to ascertain how long SERT reductions are present as a 
consequence of ecstasy use. There were no differences in SERT binding between 
former ecstasy users, former poly-drug users and drug naive controls and no 
significant correlations between pattern of ecstasy use and SERT binding. Selvaraj et 
al. suggest that a period of prolonged abstinence from ecstasy allows recovery of 
SERT availability. These studies suggest that MDMA may alter serotonin 
availability in the CNS but this alteration may be reversible after a period of 
abstinence from ecstasy.   
 
Kish et al (2010) used PET with the SERT ligand [
11
C]DASB and MRI with 
voxel-based analyses to assess SERT density in ecstasy users and controls. They 
reported no differences between ecstasy users (who typically used one to two tablets 
per session) and polydrug controls in various SERT dense areas, such as the 
thalamus and striatum, however SERT binding was significantly lower in the 
cerebral cortex (particularly the hippocampus and occipital cortex). The ecstasy 
group reported lower subjective mood relative to controls, and showed “modest” 
deficits on tests of executive function, attention and memory, the latter being 
associated with SERT decrements in the hippocampus. Importantly, the reduction in 
SERT binding was not related to structural changes or partial volume effect (which 
addressed potential bias arising from possible reduced brain volume in the ecstasy 
group) recent use of other stimulant drugs (confirmed by hair analysis) blood 
testosterone or oestradiol levels, major SERT gene promoter polymorphisms, 
gender, psychiatric status, or self-reported  hyperthermia or tolerance. Consistent 
with previous research (eg. Thomasius et al., 2003; Buchert et al., 2005, McCann et 
al., 2005) Kish et al. also reported that maximum single dose of ecstasy taken (F 
(2,44) = 9.57, p <.001) and  number of years of ecstasy use (F (1,41) = 4.91, p = 
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0.032) were the best predictors of SERT binding in all cortical areas and also in the 
caudate nucleus, respectively.   
 
Three case studies of ecstasy users have recently demonstrated ecstasy 
induced neurotoxicity to the human brain. The first two isolated cases followed 
ingestion of ecstasy (1-2 tablets) which resulted in the persons experiencing seizures. 
Forty-eight hours post seizure, MRI showed significant swelling and altered signal 
volume in the right hippocampus in both users (one male, one female). Three months 
post seizure, both ecstasy consumers denied having taken subsequent doses since the 
seizures and both had ongoing right hippocampal atrophy and ongoing high signal 
volume in the hippocampus. Although the authors could not rule out an infectious 
encephalitic cause or continued subclinical seizure activity, they suggested that in 
these cases, ecstasy ingestion caused an “acute toxic insult to the hippocampus” 
leading to MRI changes and seizures (Gardner, Lawn, Fatovich & Archer, 2009).  In 
addition to these cases, the first direct measurement of serotonin markers in a human 
(post mortem) brain of a heavy ecstasy user was reported on by Kish, Fitzmaurice, 
Chang, Furukawa and Tong (2010). The authors reported decreased levels of 
serotonin, as well as the related markers of 5-HIAA, protein concentrations of 
tryptophan hydroxylase and SERT, thus providing more direct evidence that 
serotonergic neurotransmission is altered by ecstasy use in humans. 
   
Overall, there appears to be adequate evidence that ecstasy use is associated 
with alterations to the human serotonergic system. Serotonin is associated with 
smooth synaptic transmission and is involved in long term potentiation in the 
hippocampus and serotonergic axons project to cortical and subcortical brain areas 
associated with cognition, including the frontal cortex and hippocampus, and both 
these regions also contain serotonin receptors 5-HT1 and 5-HT2 (Michelsen, 
Prickaerts & Steinbusch, 2008).  Reduced SERT densities in the prefrontal cortex, 
occipital lobe, thalamus, hippocampus and in cortical areas generally have been 
reported for ecstasy users relative to non-users (Erritzoe et al., 2011; Kish, 
Fitzmaurice, Chang, Furukawa & Tong, 2010; Reneman, Booij, Majoie, Van Den 
Brink, & Den Heeten, 2001) and this ecstasy related effect is specific to SERT rather 
than DAT, suggesting specific, longer term alterations to serotonergic rather than 
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dopaminergic transmission with regular ecstasy use (McCann et al., 2008). These 
effects may be temporary however, with lower SERT density reported for current 
users compare with former users (Buchert et al., 2005; Selvaraj et al., 2009).  
Reduced SERT density has been demonstrated to correlate with poor memory 
performance and measures of previous ecstasy exposure (Thomasius et al., 2003; 
Buchert et al., 2005, McCann et al., 2005) and emerging prospective cohort, 
neuroimaging studies indicate that even after relatively few lifetime occasions of use, 
axonal injury can occur (De Win et al., 2008).   
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Chapter 4. 
Components of Memory and Measures of Verbal Memory Relevant to the 
Present Thesis.  
 
The previous chapter reviewed the evidence for serotonergic irregularities 
associated with recreational ecstasy use, and found that these irregularities were 
sometimes correlated with poor memory performance. Verbal memory deficits have 
frequently been reported or regular ecstasy users (reviewed in detail in Chapter 6) 
and as the present thesis investigates components of verbal memory and learning that 
may be vulnerable to the effects of regular ecstasy use, this chapter reviews some of 
the cognitive processes inherent to verbal memory performance, and the ways in 
which these processes have been assessed using tests from neuropsychological 
practice.  
 
Learning is the process of acquiring new information which has the potential 
to alter behaviour. Memory includes the acquisition of new information and its 
subsequent storage and retrieval, as such it is intricately involved with learning 
(Lezak, Howieson, & Loring, 2004; Purdy, Markham, Schwartz, & Gordon, 2001). 
Memory may therefore be defined as a lasting, internal representation of a past event 
or experience (or an aspect of it) that is reflected in thought or behaviour 
(Moscovitch, 2007, p. 17). By analysing memory as a collection of heterogeneous 
hypothetical constructs, cognitive psychology has made significant contributions to 
our understanding of memorial processes. Although this fractionation of memory has 
led to some criticism that cognitive psychology relies too heavily on un-tested 
concepts and models, insights from research participants with brain lesions and from 
neuroimaging studies have begun to link these concepts with specific memory 
processes and brain regions, and these neural correlates have been incorporated into 
memory models (Moscovitch, 1992; Tranel & Damasio, 2002).  
 
Short term memory (also referred to as immediate or primary memory) is of 
short duration (about one minute) and has limited capacity. Short term memory is 
often tested by span tasks, such as Digit Span Forwards. This test involves the verbal 
presentation of a series of numbers, increasing in length from two to nine digits, and 
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requires the participant to repeat them back in the same order of presentation. Word 
span tasks are similar, and consist of the presentation of increasing strings of one 
syllable words. The number of digits or words recalled in the correct order is a 
measure of short term memory capacity. How much information can be stored in 
short term memory is debatable, although George Miller’s famous paper, The Magic 
Number 7±2 (Miller, 1956) indicated that between 5 and 9 items can be 
simultaneously held in STM, a range that is still reported in short term memory 
scores (Salmon & Squire, 2009).  Strategies such as chunking and rehearsal can be 
used to maximise short term memory performance (Purdy, Markham, Schwartz & 
Gordon, 2001). Short term memory is heavily dependent on the allocation of 
attention, if attention is directed elsewhere during span tasks, items in short term 
memory are likely to be lost (Woodard, 2006).   
 
Short term memory is used during recall of immediately presented 
information that is no longer physically present, and passively stores information for 
a limited time. This is in contrast to working memory, which refers to the ability to 
store a limited amount of information and also to manipulate that information 
(Baddely & Hitch, 1974; 1994). Working memory was termed by Atkinson and 
Shiffrin (1968) who suggested that information could be stored in working memory 
so other cognitive operations, such as re-ordering, could be performed on it. 
Working memory is often tested using the Digit Span Backwards task, which is 
identical to the Digit Span Forwards task except that the participant is instructed to 
recall the digit string in the reverse order to which it was presented, thus requiring 
mental manipulation of the numbers. The prevailing model of working memory has 
been Baddely and Hitch’s,(1974)  who have conceptualised working memory as an 
interaction between verbal short term memory (termed the phonological loop in 
order to express the sub vocal rehearsal required to prevent decay of information) the 
visiospatial sketchpad (responsible for storage and manipulation of non-verbal 
information), and the central executive (posited to selectively attend to certain task 
demands while suppressing irrelevant information, and regulating the operations of 
the short term systems). Later the episodic buffer was added to the model, which is a 
limited capacity store that binds or links information across different areas to form 
integrated episodes. This slave component is also under the intentional and 
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conscious control of the central executive (Baddeley, 2000). The premise of a system 
dedicated to cognitive control has been widely accepted in theories of cognition, and 
may include processes such as attentional control (Shallice, 1986) self-regulatory 
control (Barkley, 1997)  updating, inhibition, and shifting (Miyake et al., 2000) 
selective attention, decision making, response inhibition (Miller & Cohen, 2001) and 
planning and strategising goal directed behavior (Lezak, 2004). All of these skills are 
termed executive functions and results from cognitive studies of persons with frontal 
lobe lesions and neuroimaging research has identified them as being dependent on 
the integrity of the prefrontal cortex (eg. Alvaroy & Emory, 2006; Baldo & 
Shimamura, 2003; Lezak, 2004).  
 
Well-researched theories of memory have identified two types of long term 
memory, declarative (also referred to as explicit) memory and non-declarative (or 
implicit) memory. Declarative memory is the conscious and deliberate recollection 
of facts and events that can be “declared” and includes memory for the words on a 
recently presented list (also an example of episodic memory: memory for events) and 
knowledge that a dog is an animal (this is an example of semantic memory: memory 
for facts and meaning of words). This is in contrast to implicit, non-declarative 
memory because an implicit memory cannot be consciously recalled and stated. 
Implicit memory arises from priming, when participants perform better on tasks for 
which they have been unconsciously prepared for. Presenting a study list of words, 
followed by a word fragment completion task in which the study words appear with 
missing letters is an example of an implicit priming task. Procedural memory 
(memory for a series of actions, such as actions required to drive a car) is an example 
of implicit memory (Cohen & Squire, 1980; Tulving & Madigan, 1970; Tulving, 
1983; Otto & Eichenbaum, 1992). Declarative memory requires the storage and 
recollection of temporally dated events that depend upon temporal, or spatial 
contextual cues for accurate retrieval. Although it is not possible to map a memory 
task to a memory process on a one-to-one basis recalling a list of words presented 20 
minutes earlier is widely regarded as a test of verbal declarative memory (Tulving, 
2002). Source memory, which refers to the recollection of the context in which an 
item was encountered (eg. being able to recall whether a previously presented word 
was in written or spoken form) is also a type of episodic memory (Baddely, 
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Kopelman & Wilson, 2002; Salmon & Squire, 2009). The focus of the current 
research is on verbal declarative memory, which is defined as the conscious and 
deliberate recollection of words that were previously learnt or that participants have 
consciously tried to learn.    
 
Most memory theories are to some extent, mediationist; they adhere to the 
idea that to form a memory, three processes take place; acquisition (which is 
dependent on encoding and consolidation), storage and retrieval (Watkins, 1990). 
Encoding refers to the accurate perception of information, which is transformed into 
a perceptual or conceptual format so that it can be stored into long term memory. 
Encoding is thus the processing of information to be stored. The process of encoding 
causes a change in the central nervous system, such that the perception of a stimulus 
leads to a corresponding mental representation. This term is sometimes used 
interchangeably with memory trace, or engram, all of which are hypothetical 
constructs to describe how a representation of external stimuli is created in the brain. 
Thus, encoding is the process of transforming an external stimulus into a mental 
representation. This initial perception includes properties of the individual item, the 
familiarity of the item, and its relationship to the context in which it was presented.  
 
Encoding is the first process of learning, which Lezak (2004) defines as the 
acquisition of new information. Whether or not a person can learn something 
depends partly on how often the stimuli are repeated or rehearsed. Repetition of 
stimuli can strengthen the duration of a memory trace, thus fortifying encoding and 
speeding up the consolidation process. Repeated presentations of a word list for 
example, allow more items to be learnt, and thus participants can expand recall 
beyond short term memory span (Tulving & Madigan, 1970). With repeated 
exposure to stimuli, the signalling strength of neural circuits involved in processing 
is reinforced, ultimately becoming more automated and “hardwired.” This process is 
referred to as long term potentiation, and is believed to be the cellular mechanism 
underlying learning and memory (Bliss & Collingridge, 1993; Tranel & Damasio, 
2002).  The hippocampus is well positioned to host long term potentiation due to its 
high interconnectivity with the cerebral cortex and dense serotonin receptor sites 
(Molodstova, 2008). The hippocampus is also believed to support consolidation, 
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which refers to the memory trace becoming stronger after encoding, consequently 
becoming more durable over time (Squire, Stark & Clark, 2004; Wixted, 2005). 
Some theories postulate that consolidation can be disrupted, and hence recall 
impaired, when there has been a high degree of mental exertion during encoding 
(Wixted, 2004). Storage, sometimes referred to as retention, occurs when the 
memory trace becomes a permanent, stable record of information in the brain 
(Tulving & Madigan, 1970; Tulving & Thomson, 1973; Purdy et al., 2001). Storage 
is thus the consequence of the process of consolidation. Although the memory trace 
is consolidated in the medial temporal lobe, long term declarative memories are 
ultimately distributed throughout the cerebral cortex. This theory accounts for why 
new learning cannot take place when the hippocampus is severely damaged but 
previously stored information can be retrieved (Gabrieli, 1998; Squie & Zola-
Morgan, 1991; Squire et al., 2004).  In list learning tasks, the traditional measure of 
storage/retention is delayed Recognition performance, as this measure provides a 
word as a memory cue, thus eliminating the need for a retrieval search.    
 
Retrieval of information is an interactive process that involves search 
processes that identify the correct context in which an item was learnt (eg. recalling a 
time when a list of words was learnt) and from there, searching for the correct items 
and copying information from long term memory into short term memory. Evidence 
from Craik and Lockhart’s (1972) famous levels of processing paradigm, as well as 
evidence from list learning tasks that present categorical to-be-remembered items 
(Gershberg & Shimamura, 1995) indicate that the more an item can be related to pre-
existing knowledge or organised with others at encoding, the greater the likelihood 
of retrieval. Retrieval of information can be achieved via free recall, cued recall or 
recognition.  In list learning tasks, retrieval of presumably consolidated words is 
assessed by free recall after a delay. Retrieval demands greater cognitive processing 
as it requires temporarily copying stored information into consciousness, via short 
term or working memory, to be utilised for the current task demands (Watkins, 
1990). For example, free recall requires the retrieval of words from a list that was 
learnt 30 minutes previously. Recognition, on the other hand, only requires that one 
decides whether one of several items was encountered previously. Unlike 
recognition, free recall does not provide any cues, and as such is a more difficult task 
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(Tulving & Madigan, 1970).  Most memory researchers accepts the idea that 
recognition consists of dual processes and currently the most prominent theory 
distinguishes between recollection and familiarity (Curran & Hintzman, 1995; 
Yonelinas, 1998). Recollection is episodic as it includes information about the 
episode and context in which an item was encountered, whereas familiarity is a 
“knowing” that an item was encountered in the absence of contextual information. 
The theory assumes that stronger memories are subsumed by recollection, but when 
recollection fails, weaker memory relies on familiarity (Eichenbaum, Yonelinas & 
Ranganath, 2007). Evidence from fMRI data suggests that recollection is the 
function of the hippocampus, and familiarity is mediated by the adjacent areas of the 
medial temporal lobe (MTL, Brown & Aggleton, 2001; Eichenbaum et al., 2007; 
Rugg & Yonelinas, 2003) although Wais (2008) performed a meta-analysis on the 
recognition-based fMRI research and argued that fMRI evidence indicates there are 
different regions associated with strong (hippocampus) and weak (parahippocampal 
cortex) memory strengths. 
 
Neuroimaging memory processes 
The mediationist account of memorial processes has been influential in the 
development of neuropsychological tests that provide information on processes that 
are susceptible to neurological conditions, and this has resulted in a large catalogue 
of research comparing measures of list learning between persons with localised brain 
injuries. These studies have provided a wealth of data on how damage to certain 
regions impair memory scores, however a problem in the interpretation of both 
neuropsychological data and lesion studies is the inability to differentiate between 
the processing stages of memory. For example, hippocampal lesions impair free 
recall of newly learnt material, however it is not possible to determine whether this 
arises from a deficit in encoding or a deficit in retrieval.  Further, lesion studies 
potentially confound the effects of localised injury and disruption to a region with 
alterations in neurotransmitter regulation as a consequence of injury. Functional 
magnetic resonance imaging is able to address these shortcomings, particularly with 
the advent of event related fMRI (efMRI) which shows the neural activity associated 
with a specific stimulus (as opposed to previous block designs which were an 
average of activity over repeated stimuli presentations). This means that events (eg. 
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neural response to a word) can be categorised post hoc on the basis of a participant’s 
behaviour, such as whether the word was subsequently recalled correctly or 
forgotten. This subsequent memory paradigm is used in conjunction with efMRI to 
identify the neural correlates of encoding. This paradigm consists of a study phase 
(during which imaging takes place while a participant intentionally tries to encode 
words) and a recognition phase, when old items are interspersed with new items. The 
activity that is elicited by study items can be correlated with whether they were 
subsequently judged correctly as old. Such subsequent memory effects link encoding 
related-neural activity with a behavioural measure of memory (i.e remembering or 
forgetting). The neural correlates of retrieval can be assessed by imaging during the 
recognition phase, with activity associated with correct judgments being assumed to 
underlie retrieval regions (Henson, 2005). An overview of memory processes 
involved in verbal list learning and their neural correlates is presented below.  
 
Medial temporal lobe 
An extensive literature has identified the medial temporal lobes (MTL) as 
being critical for the encoding of verbal, episodic memories. Within the MTL, the 
hippocampus (including the dentate gyrus), the entorhinal and perirhinal cortices, 
and the parahippocampal gyrus are typically identified as key structures for encoding 
and consolidating verbal items. The benchmark finding from studies of MTL lesions 
in humans is profound forgetting of recently presented verbal and visual information 
when immediate memory is intact (for reviews see: Aggleton & Brown, 2006; 
Eichenbaum, 2000; Gray & McNaughton, 1983; Manns & Squire, 2002; 
McClelland, McNaughton, O’Reilly & Randall, 1995; Squire & Stuart, 1991; Squire, 
1992; Squire, Stark & Clark, 2004; Winocur & Moscovitch, 2011). Even for people 
with large MTL lesions, digit span is normal (Cave & Squire, 1992; Gagnon, Foster, 
Turcotte & Jongenelis, 2004).  
 
Early neuroimaging experiments of hippocampal activation during verbal 
memory tasks did not corroborate the lesion studies to the extent that was 
anticipated, however more recent meta-analyses have begun to consistently report 
activation of the hippocampus across studies (Henson, 2005). Studies have reported 
subsequent memory effects during verbal tasks for the hippocampus during encoding 
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(Cabeza & Nyberg, 1997; Daselaar, Veltman, Rombouts, Raaijmakers & Jonker, 
2003; Fletcher, Stephenson, Carpenter, Donovan, & Bullmore, 2003; Morcom, 
Good, Frackowiak, & Rugg, 2003; Otten, Henson, & Rugg, 2001) and during 
successful retrieval of verbal items (Cabeza, Dolcos, Graham & Nyberg, 2002; 
Cohn, Moscovitch, Lahat & McAndrews, 2009; Greicius et al., 2003; Jonides, 
Wager & Badre, 2002). Lapage, Habib and Tulving (1998) conducted a review of 52 
PET studies of episodic memory and reported changes in BOLD response associated 
with encoding and retrieval in the rostral and caudal portions of the hippocampus 
respectively. By designating sites as caudal or rostral based on their proximity to 
predetermined markers, the authors summarised that 83% of rostral sites were 
activated during encoding, and 94% of the caudal sites were occupied by the 
retrieval conditions. In a meta-analysis of 17 studies investigating the neural 
correlates of the dual process theories of recognition memory, Wais (2008) reported 
that the hippocampus was involved in recollection and the perihinal cortex subserved 
familiarity. Wais reinterpreted these results based on an alternative dual process 
model which posits that when the hippocampus is engaged, strong memory results 
and when the perihinal cortex is activated, weaker memory results.  In an attempt to 
quantify the existing efMRI studies of episodic encoding and recollection, Spaniol et 
al. (2009) conducted a meta-analysis to identify the significant concordances in brain 
activity patterns across independent studies using the Activation Likelihood Estimate 
(ALE) method. The meta-analysis consisted of 26 efMRI studies that used 
subsequent memory paradigms for either encoding or retrieval success. The meta-
analysis showed that activation of the MTL was reliably evident in efMRI studies of 
memory. Within the MTL, the left anterior hippocampus and right amygdala were 
more strongly associated with encoding than retrieval, and the left parahippocampal 
gyrus was more strongly activated during retrieval. A recent ALE based meta-
analysis which limited inclusion to studies that conducted whole brain analyses 
during encoding of visually presented words reported subsequent memory effects for 
the left anterior hippocampus (Kim, 2010). The findings from these later meta-
analyses indicated preferential involvement of anterior hippocampus during 
encoding and as such are consistent with the results from the early review of Lapage 
et al. (1998). Overall, the evidence indicates that the MTL and particularly the 
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hippocampus support the encoding and recall of previously experienced events, such 
as lists of words.  
 
Frontal cortex 
Although the importance of the medial temporal lobes to memory has been 
recognised for at least fifty years, the contribution of the frontal lobes has only been 
acknowledged in the last decade. Several neuroimaging studies have shown that the 
level of activity in the prefrontal cortex can predict whether an item will be 
subsequently recalled or forgotten. Early PET studies using verbal memory tasks 
reported subsequent memory effects for the left prefrontal cortex, activation of which 
was greater when participants engaged in semantic encoding strategies, such as 
deciding if a word is living or non-living (Kapur et al., 1994; 1996). Several fMRI 
studies later replicated these results, showing that prefrontal activation during 
encoding could predict accurate retrieval (Baker, Sanders, Maccotta & Buckner, 
2001; Buckner, Kelley & Petersen, 1999; Kirchoff & Wagner, 2000) and that greater 
activation was associated with semantic judgements about words compared with 
structural judgements (Daselaar, Veltman, Rombouts, Raaijmakers & Jonker, 2003; 
Demb et al., 1995; Wagner et al., 1998). In a review of thirty-seven studies that 
investigated the frontal neural correlates of long-term memory encoding, Blumenfeld 
and Ranganath (2007) identified that activation in the ventrolateral prefrontal cortex 
(VLPC) was associated with subsequent recollection of items that had been encoded 
under semantic processing instructions. Activation in the dorsolateral prefrontal 
cortex (DLPC) was more likely to occur during encoding where some form of 
organisation or manipulation of items had to occur, such as chunking or serial 
reordering. The authors concluded that the VLPC may contribute to long term 
memory by selecting relevant item information at encoding, whereas the DLPC may 
support long term memory during encoding by building associations between items. 
Further evidence for the role of VLPC and DLPC in episodic memory encoding 
came from Spaniol et al’s. (2009) meta-analysis, who reported similar activations of 
these regions across 26 efMRI studies of subsequent memory effects and activation 
of the left inferior frontal cortex and left anterior fusiform cortex were evident across 
31 fMRI studies involving encoding of visually presented words (Kim, 2010). It has 
been suggested that the prefrontal cortex contributes to verbal episodic memory by 
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selecting task relevant information to assist in encoding, such as implementing 
strategies to find associations between items to assist in encoding (Blumenfeld & 
Ranganath, 2008; Moscovitch, 1992; Shimamura, 2000) and to search for cues and 
implement strategies to assist with retrieval (Buckner et al., 1999; Rugg & Wilding, 
2000).    
 
The utility of eFMRI has been extensive in the memory literature however a 
brief consideration of the caveats to this method is warranted. Firstly, any kind of 
retrieval paradigm is not “process pure” (because retrieval is always preceded by 
encoding and consolidation, and recognition itself relies on multiple processes). 
Secondly, efMRI is not suited to study the neural correlates of free recall, as there is 
no clear interval or stimulus to lock imaging to, resulting in too much noise. Most 
noteworthy though, neuroimaging data is ultimately correlational, it can provide 
information on which regional activations are associated with subsequent memory 
effects, but it cannot identify whether or not this activation is necessary for memory 
processing. For this, lesion studies are more effective as they provide information on 
how damage to a specific region disrupts memory (Logothetis, 2008). Nevertheless, 
efMRI is currently the most effective means of examining memorial processes with 
neuroimaging (Rugg, 2002) and neuroimaging studies have revealed a number of 
neuronal circuits that are associated with memory processes, and recent meta-
analyses of this data have demonstrated consistent roles for the prefrontal and medial 
temporal structures in encoding and retrieval. 
 
To summarise, prefrontal areas, including the ventrolateral prefrontal cortex 
and dorsolateral prefrontal cortex contribute to the selection of task relevant 
information and semantic properties of verbal items to assist with encoding and 
consolidation in the hippocampus, and during retrieval the prefrontal cortex plays a 
role in memory search and selecting retrieval cues and strategies. The MTL and 
frontal cortex appear to be involved in transforming verbal stimuli into a mental 
representation, which can later be retrieved. Since episodic memory involves both 
the MTL and prefrontal cortex, several researchers have proposed that the formation 
of memory relies on an interaction between these regions (eg. Becker & Lim, 2003; 
Blumenfeld & Ranganath, 2008; Kelley et al., 1998; Kirchhoff, Wagner, Maril & 
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Stern, 2000; Moscovitch, 1992; Moscovitch & Winocur, 2002; Shimamura, 2000; 
Simons & Spiers, 2003; Tranel & Demasio, 2002). Moscovitch and Winocur (1992) 
used the term working with memory to describe the relative contributions of the 
frontal and medial-temporal systems to encode, store and retrieve memories.  
 
The Working with Memory Model 
In contrast to the purely cognitive models of memory, the Working with 
Memory model has a strong neuropsychological basis and its formulations were 
arrived at from integrating the neuropsychological literature from perception, 
attention, memory as well as lesion and fMRI studies of memory. Many of the 
model’s propositions, such as the idea that encoding and retrieval of memories 
depend on the interaction between prefrontal and MTL regions, have been become 
standard in the memory research field.  
 
The Working with Memory model has four components; the posterior 
neocortex, which mediates performance on implicit memory tests, the parietal 
cortex, which is responsible for directing attention to stimuli, the medial temporal 
lobes, which automatically stores information and mandatorily recovers information 
that is cue driven, and the frontal lobes, which work with the MTL by supporting 
strategic processes that are required for encoding and retrieval (Figure 4.1). When 
information is consciously apprehended, the hippocampal component mandatorily 
takes on that information and binds those neural elements from the neo-cortex that 
mediates the conscious experience of an event. The hippocampal component is 
therefore required to bind together information from the neo-cortex to maintain 
cohesion between the various neural activations that represent an event. This process 
is assumed to be subserved by reciprocal pathways connecting the hippocampus and 
neo-cortex via the entorhinal cortex. The episodic memory trace is thus a cohesion of 
neocortical and hippocampal neurons. The hippocampal contingent is a sparse neural 
network that represents the trace. This acts as an index which activates the neo-
cortical neurons comprising the content and the conscious experience of an event. 
Retrieval occurs when an internal or external cue triggers the hippocampal trace 
(index) which activates the neo-cortical ensemble bound with it. Retrieving episodic 
memories therefore entails retrieving the content and conscious experience of the 
 Chapter 4. Components and measures of verbal memory relevant to the current thesis  
 
 
  39 
 
event. This recovered consciousness is akin to recollection- which, as mentioned 
previously, has been demonstrated to be a process mediated by the hippocampus. 
According to the Moscovitch model, recollection is a two staged process. The first 
stage is an automatic, rapid process in which retrieval may be unconscious, as is the 
case for procedural memory. The second, slower stage involves the conscious 
apprehension of the memory trace, which is then used to direct further action, such 
as searching for other items associated with the memory trace. 
 
 
 
 
Figure 4.1. Flow diagram for interactions among medial temporal cortex and regions of the frontal 
cortex during retrieval of episodic memories. When presented with an indirect cue (such as recalling 
words from a previously encountered word list) the DLPFC supports retrieval strategies and the 
VLPFC fine specifies a cue. The frontal components work with the hippocampal complex to access 
recently consolidated  items. When the cue is direct (such as in recognition tasks) the strategic frontal 
component may not be required, as there is an automatic interaction between the cue and the MTL- 
referred to here as ecphory. Image from Moscovitch and Winocur (2002, p. 204).  
 
The hippocampal component is “stupid” in that it encodes without 
discernment, and it encodes at a shallow level. Memories have no semantic meaning 
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or organisational structure, they are simply stored “like beads in a jar” (Moscovitch, 
2008, p. 65) in the MTL and throughout the neo-cortex. The reason for this is that 
humans cannot anticipate when a particular piece of information will be required, so 
all is encoded, and what is retrieved is retrieved either automatically, in response to a 
cue (as in the case with tests of recognition) or deliberately, as a consequence of an 
internally generated cue- a process that is mediated by the frontal component. Thus, 
the frontal component works with the hippocampal component, it controls the 
information delivered to the MTL, initiates and guides retrieval and helps to interpret 
and organise the information to be encoded and retrieved. Selecting contextual 
information at encoding, and cue specification and memory search processes at 
retrieval have all been attributed to the pre-frontal cortex by various authors (eg. 
Blumenfeld & Ranganath, 2007; Shallice, 2002; Simons & Spiers, 2003). The frontal 
component is needed to “confer intelligence” on the hippocampal system, it is 
required “to string the hippocampal beads into different necklaces to be worn as 
befits the occasion” (Moscovitch, 2008, p. 65).   
 
 The hippocampal component includes the parahippocampal gyrus, the 
entorhinal and perihinal cortices. Amnesia in humans is associated with bilateral 
damage to any one of those structures, and they have been shown to be activated in 
fMRI studies of encoding and retrieval. Memory impairments associated with 
damage to the frontal lobes also exist, however these tend be associated with 
impaired strategy selection for encoding and organisation rather than a memory 
deficit per se (eg. Alexander, Stuss & Gillingham, 2008; Fletcher & Henson, 2001; 
Shimamura, Janowsky & Squire, 1990). As there are multiple, reciprocal pathways 
between the hippocampus and frontal cortex, and both regions are innervated by 
serotonergic neurons (Barnes & Sharp, 1999; Hornung, 2003; Hoyer et al., 1994; 
Michelsen, Schmitz & Steinbusch, 2007) the hippocampal and frontal components of 
this model provide a useful framework for understanding why deficits in verbal 
learning might occur in ecstasy users.  
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Chapter 5 
Assessing Verbal Memory Using List Learning Tasks 
 
Verbal declarative memory requires adequate encoding, consolidation and 
retrieval and these processes can be distinguished on standard tests of verbal 
learning. List learning tasks have a long history in neuropsychology and have 
become an invaluable tool for evaluating memory functioning. Since learning a list 
of items which later need to be recalled is a relatively common occurrence, list 
learning tasks also provide a degree of ecological validity. List learning tasks have 
also been developed in accordance with concepts from cognitive psychology, and 
attempt to assess the processes underlying verbal learning and memory, such as 
immediate memory span, rate of acquisition, long term memory storage and retrieval 
and encoding strategies. 
  
The Rey Auditory Verbal Learning Task (AVLT, Rey, 1958) is one of the 
most widely used tests both in clinical practice and research, and has been shown to 
effectively detect verbal memory deficits in a range of populations (Bigler, Rosa, 
Shultz, Hall, & Harris, 1989; Geffen, Butterworth, Forrester, & Geffen, 1994; 
Guilmette & Rasile, 1995; Janowsky, Shimamura, Kirtchevsky, & Squire, 1989; 
Lucas & Sonnenberg, 1996; Schmidt, 1996; Woodard, Dunlosky & Salthouse, 1999; 
Woodard, 2006). The AVLT has also been a very popular test of verbal memory in 
the ecstasy and memory research to date. The California Verbal Learning Test 
(CVLT, Delis Kramer, Kaplan & Ober, 1987) is also a widely administered test that 
has been shown to differentiate between healthy controls and persons with various 
neurological conditions (Baldo, Delis, Kramer, & Shimamura, 2002; Delis et al., 
2005; Donders & Nienhuis, 2007). 
 
The AVLT and CVLT are both multi-trial list learning tasks. They involve 
five presentations of a list of 16 semantically related (CVLT) or 15 unrelated 
(AVLT) words, which are read aloud to participants at a rate of one word per second. 
After each presentation, participants are asked to recall as many words as they can 
remember, in any order (free recall). This procedure is repeated five times, and 
allows an evaluation of the number of words recalled over the five trials. Delayed 
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recall is assessed after a 20-30 minute delay, after which a forced choice (yes or no) 
recognition test is administered, which consists of a longer list of words, half of 
which are from the original list and the remainder being distracters. 
 
The primary difference between the AVLT and the CVLT is that the latter 
consists of semantically related items. Words from the same category are never 
presented consecutively in the CVLT, allowing examinees to organise the verbal 
material in such a way that can maximise recall. Two forms of organisation are 
serial-order clustering and semantic clustering. Clustering words serially involves 
organising them on the basis of presentation order, which is a shallow level of 
processing. Serial order clustering also elicits primacy and recency effects, which is 
the tendency to recall the words at the beginning and end of the word list, at the 
expense of words from the middle of the list. Semantic clustering involves 
organising words based on simular semantic features. For the CVLT, this involves 
grouping items according to one of four categories (eg. fruits, spices, tools) which 
imposes greater meaning on to-be –remembered words and allows for a deeper level 
of processing and better long term retention (Craik & Lockhart, 1972; Delis et al., 
1987). Participants with lesions in the prefrontal cortex have been reported to have 
semantic clustering deficits on semantically related lists (eg. Alexander, Stuss & 
Fansabedian, 2003; Gershberg & Shimamura, 1995; Raz, 2000), frontal lesions 
impair semantic clustering more than serial clustering (Mangeles, 1997) and higher 
density of frontal lobe and not hippocampal volume has been shown to be associated 
higher semantic clustering on the CVLT (Kramer et al., 2005).  
 
Measures derived from list learning tasks used in ecstasy research 
  The AVLT and the CVLT are both considered to be test of verbal learning 
and memory (Spreen & Strauss, 1998) and these terms are sometimes used 
interchangeably within the ecstasy and memory literature (eg. Indlekofer et al., 2009; 
Kalechstein et al., 2007; Zakzanis ety al., 2007). Care needs to be taken however, to 
define which list measures assess memory, and which assess learning. In this thesis, 
the ability to immediately recall information based on a single presentation of 
material is operationalised as immediate memory. Although some authors refer to 
Trial 1 as a measure of immediate span (eg. (Lezak, 1995; Mitrushina, Boone & 
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D’Elia, 1999; Spreen & Strauss, 1998) the current thesis reserves the use of span for 
tasks such as digit or word span. Thus, Trial 1 assesses the acquisition of newly 
presented information, and is therefore a measure of initial encoding (Lezak, 2004). 
Consistent with Miller’s (1956 Magic Number 7±2 a reasonable score for Trial 1 is 
between 5 and 9 items for healthy control participants (Salmon & Squire, 2009; 
Woodard, 2006). Recall performance over the five trials of the AVLT and CVLT 
reflects the ability of the examinee to increase the number of words recalled beyond 
their immediate memory score.  This increase in performance reflects learning and 
the change of performance over the five trials is referred to as the learning curve. 
The learning curve reflects the rate of encoding and consolidation, and is quantified 
by Total Learning (the sum of words recalled across all five trials) and by Learning 
Over Trials (calculated as Total Learning – 5 * Trial 1). Total Learning has been 
demonstrated to show the best test-retest reliability of the summary scores, however 
Learning Over Trials corrects for baseline differences on Trial 1 and is more 
sensitive to variations in cognitive ability, therefore providing greater diagnostic 
utility (Tierney et al., 1994; Vakil, Blachstein & Sheinman 1998; Woodard, 2006). 
Although Total Learning is purported to measure rate of encoding and consolidation, 
the learning curve is affected by immediate memory, storage ability and retrieval 
efficiency and as such is a measure of multiple hypothetical memory components. 
When attempting to discriminate between components of memory using list learning 
tasks it is therefore necessary to consider the interdependence of each measure (for 
example, low recall scores for the learning rates might reflect an encoding deficit, or 
it might reflect poor retrieval ability). Rate of forgetting also impacts on the learning 
curve, and could be due to interference, inadequate retrieval cues resulting in 
retrieval failure or decay of the memory trace (poor consolidation). Forgetting is not 
reduced by the number of times a word is presented to be learned (Rubin & Wenzel, 
1996; Slamenka & McElree, 1983) however as the number of successful retrieval 
attempts increases, forgetting is less likely to occur (Karpicke & Roediger, 2008). 
Examining participant forgetting patterns can provide information about whether 
they are failing to recall words that had previously  been recalled once or twice 
(indicating the word has not been adequately consolidated) or whether they are 
failing to recall words that have previously been  recalled several times 
consecutively, indicating forgetting.  This is a purer measurement of forgetting, and 
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can help to differentiate between whether poor consolidation or higher incidence of 
forgetting is contributing to the overall learning curve (Lezak, 2004).  
  
Verbal declarative memory is not only dependent on how well information is 
encoded, but also on how durable the stored information is. The learning curve is 
comprised of inter-trial, short term consolidation in which participants build on the 
number of words recalled on the preceding trial. This is referred to as short term 
consolidation in the present thesis. The traditional storage concept refers to long term 
consolidation and retrieval processes, usually assessed via recognition or delayed 
free recall. The recognition test is commonly used to measure consolidation and 
storage, by counting the number of words that were correctly identified form the 
original list (hits). Recognition tests are useful as they assess whether words that 
were not available in the free recall test were stored. According to the Working with 
Memory model, simple recognition is the domain of the hippocampal component. 
Recognition is a cue dependent test, meaning that the cue (target word) should be 
sufficient for retrieval.  When an external cue interacts with the memory trace in the 
hippocampus, the trace is made conscious. For example, when asked “was this word 
(eg. umpire) on the original list?” the cue automatically elicits the trace, and a 
response  “yes” or “no” is relatively automatic in individuals with healthy memory 
function. Hippocampal volume has been shown to be related to recognition accuracy 
on the CVLT (Kramer et al., 2005), and as mentioned previously the MTL has been 
implicated in recognition performance in several lesion and fMRI studies.   
Delayed free recall measures consolidation, retention over time and retrieval, and 
can be assessed by the number of words recalled after the delay. A measure of 
retrieval efficiency can be derived by comparing the delayed recall score with the 
number of recognition hits, which indicates how many stored words could be 
retrieved without cuing. Retention and consolidation can be assessed by comparing 
the delayed recall score with the final learning trial (Trial 5) which provides the 
number of words that were forgotten during the delay (Lezak, 2004; Woodard, 
2006). In contrast to cue dependent tests such as recognition, free recall trials do not 
provide a cue that is sufficient for retrieval. The cue may provide a starting point for 
retrieval, for example, asking “tell me all the words you can remember from the list” 
provides a contextual cue, but the items need to be searched for in memory. 
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According to the Working with Memory model then, free recall involves both the 
frontal and hippocampal components for successful task performance. Consistent 
with this prediction by the model co-activation of the dorsolateral prefontal cortex 
and perihinal cortex (Staresina & Davachi, 2006) the prefrontal cortex and left MTL 
(Alkire, Haier, Fallon & Cahill, 1998; Johnson, Saykin, Flashman, McAllister & 
Sparling, 2001) and hippocampus and perihinal cortex (Strange, Otten, Josephs, 
Rugg & Dolan, 2002) have been significantly correlated with free recall 
performance.  
 
The test variables of the CVLT and AVLT have been demonstrated to 
reliably and accurately reflect different memory constructs. In a factor analysis study 
of AVLT scores, Vakil and Blachstein (1993) reported a three factor structure, 
comprised of Acquisition, Storage and Retrieval. As would be expected, Trial 1 
loaded on to the Acquisition factor, as did Learning rate (Trial 5 score minus Trial 
1). Recognition performance accounted for the majority of variance on the Storage 
factor and Delayed recall had the highest loading on the Retrieval factor. Thus, at 
least when considered with regard to the mediationsist account of memory stages, 
the RAVLT appears to have adequate construct validity.  
 
The Role of Serotonin in Memory- Evidence from Acute Tryptophan Depletion 
Studies 
The past two decades has produced numerous human experimental studies 
indicating that serotonin is involved in memory and learning. For example, reduced 
serotonergic functioning may be responsible for memory deficits found for depressed 
persons, people with Alzheimer’s disease, and normal cognitive decline for older 
adults (Hasselbalch et al., 2008;Lai et al., 2002; Newhouse, Tatro, Naylor, Quealey 
& Delgado, 2002; Porter, Lunn & O’Brien, 2003; Richter-Levin & Segal, 2003). In 
order to investigate the role of serotonin in cognitive processes of humans, several 
studies have used verbal list learning tasks similar to the RAVLT and the CVLT, in 
combination with a procedure called acute tryptophan depletion (ATD). ATD has 
been used to mimic the effects of reduced serotonin function in the brain. 
Tryptophan is an enzyme that is involved in serotonin synthesis in the brain, and is 
almost uniquely found in serotonin neuron terminals of the raphe system. The acute 
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tryptophan depletion (ATD) method is used to induce lowered serotonin 
neurotransmission in the brain. This method involves replacing normal dietary intake 
with a drink that contains no tryptophan, but several amino acids that compete with 
tryptophan for access through the blood brain barrier. This procedure typically 
reduces serotonin synthesis in the human brain by 60-80% within 4-7 hours after 
consumption of the drink (Booij, Van der Does & Riedel, 2003; Norra, 2007). CSF 
sampling in healthy volunteers have demonstrated an 80-90% reduction in 
tryptophan levels post drink (Carpenter, Anderson, Pelton et al. 1998; Williams, 
Shoaf et al. 1999)  and a PET study involving healthy female volunteers reported 
that 5-HT2 receptor binding showed a significant decrease following ATD (Yatham, 
Liddle et al., 2001). ATD challenge paradigms are used to examine cognitive 
performance following a reduction in serotonin release, and as such can be used to 
better understand the role of serotonin in memory. ATD produces an acute disruption 
to serotonin synthesis in the absence of neuronal damage (Riedel, 2004) and thus 
provides useful information on the effects of altered serotonergic functioning on 
cognition. Assuming that ecstasy use produces alterations to serotonin availability 
after the acute intoxication phase, ATD may also provide a model of serotonergic 
degeneration which may simulate the effects of ecstasy use.   
 
Linking serotonin with memory processes; acute tryptophan depletion studies and 
list learning tasks 
Several studies have investigated the effect of ATD on healthy participants 
using either auditory or “visual” verbal list learning, usually consisting of a list 
between 15 and 30 words.  For “visual” verbal learning tasks, the words are 
presented visually, on a computer screen, rather than being read aloud as is the 
standard RAVLT/CVLT procedure. These studies assessed Immediate recall, 
Delayed recall and Recognition performance and all reported a decrease in plasma 
tryptophan levels relative to the placebo condition. Schotissen et al. (2006) reported 
a trend towards impairment on Immediate recall for healthy older adults, however 
the majority of studies including healthy participants with mean ages ranging from 
21-41 found that ATD did not impair Immediate list recall (Evers et al., 2005;  
Harrison et al., 2004; Klaassen et al., 1999; Riedel et al., 1999; Sambeth et al., 2009 
and Scmitt et al., 2000). Similarly for the RAVLT or a 30 item auditory verbal 
 Chapter 5. Assessing verbal memory using list learning tasks 
 
 
  47 
 
learning test, no effect of ATD was found for Immediate recall (Haywood et al., 
2005; Hughes et al., 2003 and Shansis et al., 2000) although Porter et al. (2005) and 
Merens et al. (2008) reported lower Immediate recall for healthy older adults and 
remitted depressed persons respectively.  
 
With regard to Delayed recall, visually presented verbal learning studies have 
reported reasonably consistent deficits following ATD (Harrison et al., 2004; 
Klaassen et al., 1999; Riedel et al., 1999; Sambeth et al., 2009 and Scmitt et al., 
2000) although Evers et al. (2005) failed to find a deficit for this measure. For tests 
of auditory verbal learning, a Delayed recall deficit was only reported for healthy 
older adults (Porter et al., 2005). Only three of these studies reported impaired 
delayed Recognition performance (Schotissen et al., 2006; Riedel et al., 1999; Scmitt 
et al., 2000) and no effects of ATD for Recognition were reported for the auditory 
learning tasks.  The lack of consistency between visual and auditory list 
presentations may be due to a ceiling effect observed for 15 word lists (Uttl, 2005) or 
due to the auditory modality being differently affected by ATD (Mendelsohn, Riedel 
& Sambeth, 2009). 
 
In a meta-analysis of nine ATD studies which used the visual verbal learning 
test, performance was compared for Immediate recall, Delayed recall and 
Recognition on word lists consisting of 15 and 30 items. Effect sizes (f) were 
calculated as the standardised mean difference between tryptophan present and 
tryptophan depleted conditions. For 15 item lists, ATD impaired Immediate ( f = .13) 
Delayed (f =.31) and Recognition (f  = .18) performance, and this impairment 
increased for the 30 item list: Immediate (f = .32) Delayed (f = .48) Recognition (f = 
.32).  For both list lengths, ATD had a greater effect on Delayed recall compared 
with Immediate recall and Recognition, suggesting that long term consolidation and 
retrieval are most impaired by reduced serotonin availability. Overall, these ATD 
results are indicative of the effect of lowering of serotonin on encoding and 
consolidating processes in episodic memory (Sambeth, 2007).   
 
Harrison et al (2004) used the same group of participants to test the effects of 
ATD and acute tyrosine/phenylalanine (ATP- which has been shown to acutely 
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reduce dopaminergic function) on a visually presented verbal learning task and a 
working memory task.  ATD impaired delayed recall performance relative to both 
placebo and ATP, and ATP had no effect on any of the verbal learning measures, 
however impaired spatial working memory performance. These finding suggest that 
low brain serotonin impairs episodic memory performance, whereas lowered 
dopamine activity impaired working memory, and supports evidence that low 
serotonin and dopamine may have selective effects on memory due to their actions in 
temporal and frontal brain regions.  Van der Veen et al. (2006) provided further 
evidence for altered serotonergic functioning impacting on hippocampal processing. 
During ATD, van der Veen et al. used fMRI to examine changes in brain activation 
during the encoding and retrieval phase of a visually presented verbal episodic 
memory task. During the encoding phase, participants were asked to indicate 
whether the word gave them an emotionally positive or negative feeling. The 
retrieval phase consisted of a recognition task with distractors.  During the encoding 
phase, fMRI showed decreased activation of the right hippocampus during ATD, and 
no differences in brain activation during ATD in the retrieval phase. The authors 
suggested that reduced serotonin levels impaired activation of the hippocampus 
during the encoding phase, leading to impaired encoding and consolidation of verbal 
items.     
 
ATD, and therefore attenuated CNS serotonin synthesis, appears to 
selectively disrupt visual verbal learning. Several studies failed to find an effect of 
ATD on non-verbal learning tasks, such as the Rey Complex Figure Task (Hughes et 
al., 2003; Kulz et al., 2007) Rey Visual Design Learning (Porter et al., 2003; 2005; 
and a pattern recognition task (Booij et al., 2005; Evers et al., 2005; Park et al., 1994; 
Porter et al., 2003 and Roiser et al., 2007). For spatial memory, one study reported 
healthy controls needed more trials to learn spatial locations on a spatial recognition 
task (Park et al., 1994) and another reported improved scores on an object relocation 
task for the immediate task, and no differences between ATD and placebo on the 
delayed version (Sambeth et al., 2009). Other spatial memory studies failed to find 
any differences between ATD and placebo (eg. Amin et al., 2006; Hughes et al. 
2002; 2003) and short term memory, as assessed by Forward Digit Span has also 
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been shown to immune to effects of ATD (eg. Luciana et al., 2001; Porter et al., 
2003; Shansis et al., 2000; Stewart et a., 2002). 
 
The reported findings suggest that disruptions to the serotonergic system 
have a negative effect on the ability to recall verbal information. Specifically, the 
results show a limited effect of ATD on Immediate recall, however Delayed recall 
was often impaired following ATD, indicating a role of serotonin in the 
consolidation and retrieval of newly learnt verbal information. This type of 
impairment suggests that serotonin plays a key role in verbal episodic memory. 
Furthermore, as recreational use of ecstasy is sometimes associated with decreased 
SERT density and reduced activity in the hippocampal region of regular ecstasy 
users compared with non-users, and both serotonin and the hippocampus are 
believed to be crucial to the formation of new memoires, it might be expected that 
regular use of ecstasy may impair memory.  Chapter 6 provides a systematic review 
of the ecstasy and memory literature with a view to identifying which measure; 
Immediate, Delayed or Recognition performance, is most impaired in recreational 
consumers of ecstasy.   
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Chapter 6 
 
Study 1. A Quantitative Review of the Effects of Ecstasy use on Trial 1, Total 
and Delayed recall measures of Auditory Verbal Learning Tests. 
 
 
As will be reviewed below, the ecstasy and memory research to date is fraught 
with inconsistencies with regard to methodology and results, with several studies 
reporting an ecstasy related verbal memory deficit and several not. One possible 
explanation for this inconsistency is that the standard list learning tasks used in these 
studies obscure the specific processes that may contribute to verbal memory deficits. 
Single studies are often subject to low statistical power and mixed comparison groups 
which potentially mask or inflate true effects.  The present study aimed to overcome 
these limitations by providing both a qualitative and quantitative review of studies 
that have examined the effects of ecstasy on verbal memory using word list learning 
tasks. The chapter will describe the state of the ecstasy and memory literature to date 
and expand on this by reporting meta-analyses for three specific measures of verbal 
memory derived from standard neuropsychological tests of word-list learning; Trial 
1, Total recall and Delayed recall.  In the current study, Immediate Memory is 
operationalized as performance on Trial 1, consolidation and learning are assessed 
by Total recall and retention was defined as Delayed recall performance.   
 
Evidence for ecstasy related deficits on word list learning tasks 
 
The possibility that ecstasy use impedes memory ability has underpinned 
several studies attempting to identify neurocognitive consequences of ecstasy use. 
Several studies have recruited regular consumers of ecstasy and other illicit drugs 
and administered batteries of neuropsychological tests to identify whether cognitive 
deficits exist, and if so, their type and severity. The vast majority of this research has 
used standard neuropsychological measures of learning such as the Rey Auditory 
Verbal Learning Test (RAVLT) the California Verbal learning Tests (CVLT) and the 
Rivermead Behavioural Memory Test (RBMT) to examine differences in recall 
scores that may be associated with ecstasy use.  In an attempt to better link the 
association between ecstasy use and memory impairment, some authors have used 
regression analysis to investigate whether there is a dose dependent relationship 
between a measure of ecstasy use, such as estimated lifetime dose or number of 
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tablets taken in the preceding six months, and a list learning measure. An alternative 
to using regression analysis to look for dose related effects of ecstasy on verbal 
memory scores is to build dose effects into the design by comparing people with 
arbitrarily defined “high” and “low” lifetime consumption.  
 
Brown, McKone and Ward (2010) administered the CVLT and RAVLT to 
regular ecstasy users (estimated lifetime dose = 384) cannabis users and drug naïve 
controls. For the CVLT they reported a significant deficit for ecstasy users compared 
with the cannabis group and the non-drug using controls on Total words recalled and 
Delayed recall, and no significant differences between the cannabis group and the 
drug-free controls. For the RAVLT, there was no effect of ecstasy on Trial 1, and a 
small deficit on Total words recalled which failed to reach statistical significance 
after differences in estimated pre-morbid IQ were taken into account. There was no 
evidence of a dose related effect for the CVLT and RAVLT scores however. Brown 
et al. concluded that for relatively simple tasks such as free recall of unrelated words, 
ecstasy use has minimal impact on performance, but for more complicated tasks that 
require strategic organisation, such as the CVLT, ecstasy-related deficits are more 
apparent, possibly due to the requirement of engaging multiple brain regions, such as 
the hippocampus, frontal lobes and perceptual areas for successful performance. In 
contrast, Bedi & Redman (2008) also reported no significant differences in verbal 
memory performance for the RAVLT, however when the summary scores for the 
RAVLT (including Total recall, Delayed recall and recognition) were combined into 
a verbal memory factor, they found estimated lifetime ecstasy consumption predicted 
verbal memory, with higher use associated with lower RAVLT scores.    
 
Alternatively, Halpern et al. (2010) failed to find an ecstasy related deficit on 
the CVLT. They studied the effects of ecstasy on the neurocognitive functioning of 
52 regular ecstasy users (median occasions of use for ecstasy use = 43.5 and 
cannabis= 10) and 59 non-ecstasy using controls (median cannabis use = 1), all of 
whom had attended at least ten all-night dance parties and had experienced less than 
ten occasions of alcohol intoxication (defined as more than four standard drinks in 
four hours). Halpern et al. screened participants for surreptitious drug use, using hair, 
urine and breath samples at the time of testing.  Results indicated small impairments 
for ecstasy users compared with non-users on Wechsler Memory Scale-III spatial 
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span forwards and digit span backwards. Unlike Brown et al. Halpern et al. failed to 
identify verbal memory deficits on the CVLT, with ecstasy users and non-users 
performing equivalently on Trial 1 and Total recall (delayed recall results were not 
reported). Halpern et al. also compared “moderate” users (defined as those with 
fewer than 50 occasion of ecstasy use) with “heavy” users (greater than 50 
occasions) on CVLT measures and reported no differences between sub-groups, or 
between the entire ecstasy using sample (median use of ecstasy = 43, cannabis= 10) 
and 59 non-ecstasy using controls (median cannabis use = 1). Halpern et al., 
conclude that there were no marked cognitive deficits associated with ecstasy use 
and that ecstasy use does not appear to produce lasting neurotoxicity. Although these 
results seem to conflict with those reported by Brown et al. (2010), it is difficult to 
compare the studies directly due to the different characteristics of the ecstasy using 
sample.  As Halpern et al., note, their sample have a relatively low exposure to 
ecstasy (only 6 of the 22 “heavy” users had lifetime occasions of use greater than 
150) whereas the mean estimated lifetime dose in the Brown et al., study was 384. 
Further difficulty for comparisons arises from the differences in other illicit drug use 
between the studies, as the Halpern et al., cohort also had very few occasions of 
intoxication for cannabis and alcohol, something that is not typical for regular 
ecstasy consumers generally (Parrot, 2001).  
 
These disparate methods and results typify the current state of the ecstasy and 
memory research; studies have used a variety of different methodological 
approaches, and as such it is not surprising that conflicting results arise.  Some 
authors have argued that the memory deficits associated with ecstasy use are 
negligible once other drug use has been taken into account (eg. Bedi & Redman, 
2008; Halpern et al., 2011) while others suggest regular ecstasy use is associated 
with memory deficits, possibly via its impact on serotonergic system function (eg. 
Blagrove  et al., 2010; Indlekofer et al., 2009). When considering three measures of 
memory commonly derived from word lists; Trial 1 score, Total recall and Delayed 
recall, findings have generally been inconsistent. For example, an ecstasy related 
deficit relative to control participants has sometimes been reported for Trial 1 (Parrot 
& Lasky, 1998; Fox, Toplis, Turner & Parrott, 2001; Gouzoulis-Mayfrank et al., 
2000) while others have not identified an ecstasy related effect (Thomasius et al., 
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2003, 2006; Curran & Verheyden, 2003; McCardle, Luebbers, Carter, Croft & 
Stough, 2004; Bedi & Redman, 2008; Brown, McKone & Ward, 2009). Similarly, 
there is a combination of significant and non-significant results for Total recall 
scores, with several studies reporting an ecstasy related deficit on this measure 
(Bolla et al., 1998; Parrott & Lasky, 1998; Reneman et al., 2001b: Thomasius et al., 
2003; Quednow et al., 2006; Thomasius et al., 2006; Reneman et al., 2006; Lamers, 
Bechara, Rizzo & Ramaekers, 2006; Schilt et al., 2008; Schilt et al., 2010) although 
a few have not (Reneman, Booij, Scmand, van den Brink & Gunning, 1999; Croft, 
Mackay, Mills & Gruzelier, 2001;  Reneman, Majoi, Schmand, van den Brink & den 
Heeten, 2001; Simon & Mattick, 2002; Back-Madruga et al., 2003; Bedi & Redman, 
2008; Brown et al., 2009). Finally, the results for delayed recall have been equally 
inconsistent, with some studies reporting a delayed recall deficit associated with 
increased ecstasy consumption (Reneman, Booij, Scmand, van den Brink & 
Gunning, 1999; Reneman, Majoi, Schmand, van den Brink & den Heeten, 2001; 
Reneman et al., 2001b; Fox, Toplis, Turner & Parrott, 2001; Curran & Verheyden, 
2003; Thomasius et al., 2003; McCardle, Luebbers, Carter, Croft & Stough, 2004; 
Yip & Lee, 2005; Reneman et al., 2006; Thomasius et al., 2006; Schilt et al., 2010) 
and some not (Bolla et al., 1998; Gouzoulis-Mayfrank et al., 2000;  Croft, Mackay, 
Mills & Gruzelier, 2001; Simon & Mattick, 2002; Back-Madruga et al., 2003; 
Lamers, Bechara, Rizzo & Ramaekers, 2006; Bedi & Redman, 2008).  
 
Compared with research on unrelated word lists, the research on semantically 
related word lists is limited. With the exception of Fox, Parrott and Turner (2001), 
who reported no differences between ecstasy users and controls for immediate and 
delayed recall, all studies which have examined performance on semantically-related 
word lists have used the CVLT. For Trial 1 scores of CVLT, only three studies 
report results, all of which failed to identify an ecstasy related effect (de Sola et al., 
2008; Halpern et al., 2004; 2010). For Total recall, two studies report an ecstasy 
related deficit (Semple et al, 1999; Brown et al., 2009) and four do not (de Sola et 
al., 2008; Halpern et al., 2004; 2010; Medina, Shear & Corcoran, 2005). For Delayed 
recall, de Sola et al. (2008) failed to find an ecstasy related deficit, however Medina, 
Shear and Corcoran (2005) and Brown et al. (2009) reported that ecstasy consumers 
recalled significantly fewer words than control participants after a delay.    
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To investigate whether impairments change after a period of abstinence from 
ecstasy, Thomasius et al. (2003) compared former ecstasy users (minimum 20 weeks 
abstinence) with current users and poly-drug controls. In this study, males and 
females from both former and current ecstasy using groups had very similar levels of 
ecstasy consumption, and the poly-drug controls were well matched for other 
substance use. Current use and abstinence was tested with hair analysis and the 
concordance rate was 95%. Results showed that former, but not current, users 
performed significantly worse on Total and Delayed recall of the RAVLT. 
Regression analyses showed that typical number of tablets taken per session best 
predicted Trial 1 RAVLT scores, and estimated lifetime consumption best predicted 
Delayed recall.  Dose dependent effects for Delayed recall have also been reported 
by Fox, Toplis et al. (2001), Yip & Lee (2005). In addition Schilt et al. (2008) and de 
Sola et al. (2008) reported a dose related effect on CVLT recognition. Although 
Medina et al. (2005) and Bedi and Redman (2008) found the majority of ecstasy 
consumers scoring within the normal range for the CVLT and RAVLT respectively, 
both groups demonstrated that estimated  lifetime ecstasy consumption significantly 
predicted verbal memory performance.  For Total recall Reneman et al. (2006) 
reported that heavy ecstasy consumers (defined as more than 50 tablets prior to 
testing) scored significantly lower on RAVLT total and delayed recall compared 
with moderate users (less than 50 tablets prior to testing). Alternatively, de Sola et al. 
(2008) Brown et al. (2010) and Schilt et al. (2010) failed to find a dose related 
relationship between lifetime ecstasy consumption and verbal memory.  
 
To overcome the methodological limitations of small and heterogeneous drug 
using samples and the large amount of seemingly disparate results within the ecstasy 
and cognition literature, several meta-analyses have been conducted to assess the 
effects of ecstasy on cognitive functioning. Meta-analyses have the advantage of 
using data from several studies that have investigated the same task variables, and 
thus the significance and magnitude of the effect can be pooled to reveal a more 
consistent pattern of results. Dose related effects can also be investigated with a large 
sample size. The following section reviews the ecstasy and cognition meta-analyses 
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to date, focusing on the verbal learning and memory domain. A summary of these 
studies is presented in Table 6.1 below.  
 
 
Table 6.1 
Summary of Previous Ecstasy and Memory Meta-analyses  
 
Review Cognitive 
Domain 
Number of 
Studies 
Effect Size Dose 
Related 
Effect 
Short Term Memory     
Verbaten (2003) Short term 
memory 
10 -1.15ᵃ** ns 
Laws and Kokkalis 
(2007) 
Short term 
memory 
25 -0.63ᵇ*** ns 
Nulsen et al. (2010)
z
 
 
Verbal short 
term memory 
30 -0.40
c
    ns 
Working Memory     
Nulsen et al. (2010)
z
 
 
Verbal working 
memory 
22 -0.37
 c
 sig* 
Verbal Memory     
Laws and Kokkalis 
(2007) 
Verbal memory 22 -1.00ᵇ*** ns 
Rogers et al. (2009)
x
 Verbal memory- 
total recall 
35 -0.34ᵃ*** ns 
     
Kalechstein et al. 
(2007)
y
 
Verbal learning 
and memory  
 
23 
 
-0.73ᵇ*** 
 
na 
Zakzanis et al. (2007) Learning and 
memory 
21 -0.55ᵇ sig** 
Verbal Memory Delayed     
Rogers et al. (2009)
x
 Verbal memory- 
delayed recall 
27 -0.36ᵃ*** ns 
Verbaten (2003) Long term 
memory 
10 -1.36ᵃ** ns 
Laws and Kokkalis 
(2007) 
Long term 
memory 
 
19 -0.87ᵇ*** ns 
Notes: All studies corrected for random effects. a Mean Effect Size b Cohen’s d, c Hedges g, x compared with polydrug groups, y 
lenient analysis only, z  all studies included, *** p<.001, ** p<.01, * p <.05, na = not assessed, ns = not significant 
Verbaten (2003) Short Term Memory comprises: working memory and logical memory subtests of the Wechsler Memory Scale 
(WMS), prose recall test (immediate recall), Trial 1 recall for; Rivermead Behavioural Memory Test (RBMT), Verbal Learning 
Memory Test (VLMT), Coughlan list and design learning. 
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Table notes from previous page: Verbaten (2003) Long Term Memory comprises delayed word recall, delayed prose recall, 
delayed recall trial on; RAVLT, RBMT, Coughlan design and list learning, WMS logical memory 
Laws and Kokkalis (2007) Verbal Short Term Memory comprises digit span forwards, logical memory, verbal paired 
associates, Trial 1 of RBMT, RAVLT, Coughlan List and CVLT. 
Long term measures typically involved the delay trials of the tasks. 
 Kalechstein et al. (2007) did not include description of tasks included. 
 Nulsen et al. (2007) Verbal Short Term Memory comprises digit span forwards, immediate prose recall, paired word recall, 
letter span, match to sample and Trial 1 on verbal list learning tasks including;  RBMT, CVLT German and English RAVLT.  
Nulsen et al. (2007) Verbal Working Memory comprises digit span backward, Keep-track task, Verbal n-back task, 
Computation span, Letter-number sequence, mental counters, Reading span, Consonant updating. 
 
 
 
 
Verbaten (2003) provided the first meta-analysis investigating the effects of 
ecstasy use on different cognitive domains. This review included ten studies that 
provided measures of short term and long term verbal memory and attention. After 
controlling for lifetime exposure to ecstasy (number of tablets taken) and cannabis 
use, the mean effect size (MES) indicated that ecstasy users performed one standard 
deviation below non-ecstasy using controls on measures of short term memory (d = -
1.15, z = -4.52) . For long term memory, the mean effect size was also large (d = -
1.36, z = -3.65) and remained significant after taking into account previous cannabis 
use. The short term memory domain included prose recall, list learning (total words 
recalled and Trial 1 recall for the RAVLT) and as such included both measures of 
short term memory span and verbal learning in the one domain. The long term 
memory domain however was limited to delayed recall of words and prose. Verbaten 
concluded that, based on the limited studies available at that time, ecstasy use leads 
to a decline in short term memory functioning however may not be detrimental to 
long term memory, which might be more vulnerable to cannabis use.  
 
Laws and Kokkalis (2007) provided an extension to Verbaten’s 2003 review 
and examined the extent of the effects of ecstasy use on short and long term memory 
and verbal and visual memory. This yielded four composites; verbal memory, visual 
memory and short term memory and long term memory, the latter two comprising 
both verbal and visual memory scores. For short term memory, Laws and Kokkalis 
reported a moderate effect size (d = -0.63, 95% CI: -0.91, -0.41) and a larger effect 
for long term memory (d = -0.87, 95% CI: -1.38, -0.45), although the short term and 
long term effect sizes did not differ significantly from each other.  The effect size for 
verbal memory was very large (d = -1.00, 95% CI: -1.45, -0.59) and significantly 
larger than that obtained for visual memory (d = -0.27, 95% CI: -0.55, -0.03). 
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According to these results, ecstasy users performed an average of one standard 
deviation below non-ecstasy users on verbal memory tasks and also had poorer short 
and long term memory scores relative to controls, with long term memory producing 
the larger effect size. There was no significant dose related effect for cannabis or 
ecstasy. Laws and Kokkalis suggest that the non-significant effect of the extent of 
ecstasy use on memory performance may be attributable to the relationship being 
stepwise rather than linear, such that an initial (unknown) dose of ecstasy may have a 
large effect on memory and further consumption may be less important. 
Alternatively, the variability in estimations of consumption and pill content may also 
compromise the dose related analyses. Laws and Kokkalis’ effect sizes were 
considerably smaller than those reported by Verbaten, and the authors suggested this 
was because their sample contained more studies and therefore provided a more 
reliable estimate of effect size.  
 
To attempt to control for some of the methodological limitations of published 
cross-sectional ecstasy studies, Kalechstein et al. (2007) categorised 44 ecstasy and 
neurocognition studies as lenient or stringent based on their level of control for 
potential moderator variables such as premorbid IQ and education. Kalechstein et al. 
investigated five cognitive domains; attention, verbal learning and memory, non-
verbal learning and memory, motor/psychomotor speed and executive functioning, 
however the specific tasks included in the analyses were not detailed. Verbal 
learning and memory had the largest effect size for both the stringent (d = -0.85, 
95% CI: -0.32, -1.34) and lenient analyses (d = -0.73, 95% CI:  -0.44, -1.01), and 
attention/concentration had the smallest effect size across both analyses, although 
even for this domain ecstasy use was still associated with a performance deficit 
equivalent to one third of a standard deviation below controls. Comparisons of effect 
sizes between the lenient and stringent analyses showed no significant differences, 
suggesting that the ecstasy related impact on cognition is observable regardless of 
the level of control for potential confounds.  Based on these results Kalechstein et al. 
argued that the cognitive deficits associated with ecstasy use are not equal across 
different domains, with verbal learning and memory, information processing speed 
and executive functioning being most vulnerable to negative consequences of ecstasy 
use.  According to Kalechstein et al. this pattern of deficits is consistent with a 
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“frontal-subcortical” typology. In the Kalechstein et al study, dose-related effects 
were not examined, and it was unclear whether the control participants were poly-
drug users, drug naive or both, thus it is difficult to ascertain whether the effect sizes 
are attributable to ecstasy consumption.  
 
 Zakzanis, Campbell and Jovanovski (2007) performed meta-analyses to 
investigate the effects of ecstasy consumption across seven neuropsychological 
domains; learning and memory, verbal comprehension, processing speed, attention 
and concentration, executive function, perceptual organisation and motor skill. 
Zakzanis et al. included both poly-drug and drug naive controls, although if a study 
included both groups the former was given preference. Consistent with Kalechstein 
et al. (2007) the effect of ecstasy use was largest for learning and memory (d = -0.55, 
95% CI: -0.76, -0.33), followed by verbal comprehension (d = -0.36, 95% CI: -0.54, 
-0.17) and processing speed (d = -0.33, 95% CI: -0.57 – 0.09).  Unlike Verbaten 
(2003), and Laws and Kokkalis (2007) who failed to identify any dose related effects 
on memory performance, Zakzanis et al. reported a significant negative relationship 
between total lifetime ecstasy consumption and learning and memory scores.  
 
In an updated meta-analysis, Nulsen, Fox and Hammond (2010) aimed to 
determine whether the effects of ecstasy use differ for short term and working 
memory in the verbal and visual domains. The measures for verbal short term 
memory included digit span forward, letter span, immediate recall subtest of the 
Rivermeand Behavioural Memory Test (RBMT), Trial 1 and Total recall of the 
RAVLT and CVLT.  For verbal working memory, the tasks included digit span 
backwards, computation span, sentence span, n-back tasks and keep-track tasks. The 
magnitudes of the effect sizes for ecstasy users compared with poly-drug controls 
were largest for visuospatial working memory (g = -.60, 95% CI = -0.85, -0.36) and 
smallest for visuospatial short term memory (g = -0.25, CI: -0.49, -0.02). For verbal 
memory, the effect of ecstasy use was small for both short term (g = -0.40, 95% CI: -
0.59, -0.21) and working memory (g = -0.37, 95% CI: -0.51, -0.23). Although the 
effect sizes across the four domains did not differ significantly from one another, 
self-reported lifetime ecstasy consumption only significantly predicted the effect size 
for the working memory domains. These results suggest that it is not the verbal or 
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visual nature of information that is differentially effected by ecstasy use, but rather 
the nature of the information processing. Thus, short term retention in either the 
verbal or visual domains is negatively impacted by ecstasy use to a small extent, 
however retention of, and working memory type manipulation of information is most 
impaired by ecstasy use.  
 
In a comprehensive meta-analysis of published studies addressing ecstasy use 
and cognition, Rogers et al. (2009) reviewed studies that had included measures of 
Total recall and delayed verbal memory performance. The analysis included 46 
different outcome measures, the most common being the RBMT, followed by the 
RAVLT and digit span backwards. The effect measures were expressed as 
standardised mean difference scores, and for verbal memory (d = -0.33, 95% CI: -
0.47, -0.22) indicated that on average ecstasy users’ memory performance was one 
third of a standard deviation worse than poly-drug controls. When compared with 
drug naive individuals, the magnitude of the effect increased to -0.85 (95% CI: -1.03, 
-0.67) indicating that immediate verbal memory performance among ecstasy users is 
almost one standard deviation below that of drug free controls. For Delayed recall 
measures, results showed that long term memory scores for ecstasy users were also 
one third of a standard deviation lower than poly-drug controls (d = -0.36, 95% CI: -
0.49, -0.22) . When compared with drug naive controls, the effect increased to over 
one standard deviation of difference between scores (d = -1.11, 95% CI: -1.99, -
0.23). Yip and Lee’s (2005) unique study comparing 100 ecstasy-only users 
(reported to have no exposure to other illicit drugs and minimal exposure to alcohol 
and tobacco) with 100 drug naïve controls was an outlier in the meta-analysis, 
however when it was removed from the analysis the ecstasy effect was still large (-
0.72, 95% CI: -0.91, -0.52). Rogers et al. failed to identify a dose related effect for 
ecstasy however.  
 
Summary 
In contrast to the individual studies of ecstasy related memory deficits, for 
which inconsistencies are the norm, all the meta-analytic reviews to date have 
reported significant verbal memory performance decrements for ecstasy users 
relative to polydrug and/or drug naive controls. The magnitude of the effect sizes 
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differs considerably across analyses however, and not all have identified dose related 
effects. Verbaten (2003), Laws and Kokkalis (2007) and Zakzanis et al. (2007) all 
reported verbal learning and memory as being the cognitive domain most impaired 
by ecstasy use.  Alternatively, Nulsen, Fox and Hammond (2010) suggest that it is 
not a specific domain that is impaired by ecstasy consumption, but rather, more 
complicated cognitive processes such as mental manipulation of information that are 
compromised by ecstasy consumption. These analyses have the advantage of 
including a large number of studies and participants to evaluate the effects of ecstasy 
on memory, and have shown clear verbal memory deficits for ecstasy users.  
 
A limitation of the meta-analyses reported is that they are unable to 
determine which specific memory processes are being impaired by ecstasy use. List 
learning tasks for example, comprise several memory processes, such as encoding, 
consolidation, retrieval, strategising and rehearsal. Many meta-analyses have 
combined Trial 1 recall with Total recall as a measure of verbal learning, therefore 
combining scores for immediate memory with learning over multiple trials. Factor 
analysis has shown that recall on Trial 1 is statistically different from recall based on 
Total RAVLT scores (Johnstone, Vieth, Johnson & Shaw, 2000; Vakil & Blachstein, 
1993) and that Trial 1, but not subsequent trials, positively correlates with self-
reported memory problems (Krch, Sumowski, DeLuca & Chiaravalloti, 2011) 
suggesting that these variables should be treated  separately in meta-analyses. 
Similarly, several meta-analyses included prose recall, such as the Rivermead 
Behavioural Memory Test and list learning in the same measure. This is not a useful 
approach as a story allows for greater depth of processing (Craik & Lockhart, 1972) 
more scope for visualisation and contains more recall cues to recall items than a list 
of unrelated words, and as such the two tasks require different cognitive strategies 
for successful performance. Thus, because combining task variables in this manner 
makes the meaning of a “verbal learning and memory” impairment difficult to 
interpret, studies using the RBMT as the memory measure were excluded from the 
meta analysis.  
 
Although the existing literature provides no clear pattern for which specific 
measures of list learning are more likely to be affected by ecstasy use, further 
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investigation of the outcome measures using meta-analysis can provide a more 
meaningful summary of ecstasy related deficits.  With this in mind, Rogers et al. 
(2009) performed a meta-analysis with 8 studies that included data for Total recall 
and 7 for Delayed recall of the RAVLT. For Total recall, ecstasy users recalled an 
average of four words less than poly-drug controls (d = -3.9, 95% CI: -7.12,  - 0.70) 
and performed at an average of half a standard deviation below the normative 
population aged between 20 and 29. For Delayed recall ecstasy users recalled an 
average of one word less than polydrug controls (d = -1.04, 95% CI: -1.6, -0.48 and 
again performed at one standard deviation below the normative population for this 
measure. There was no evidence for a dose dependent effect, although Rogers et al. 
noted there was a trend for worse performance on Total recall to be associated with 
longer duration of use.  
 
The present study aimed to provide a quantitative review of studies that have 
examined the effects of ecstasy on verbal memory using word list learning tasks. 
Importantly, it separates the domain of verbal memory into three dependent variables 
that are commonly reported in the literature; Trial 1, Total recall and Delayed recall. 
This procedure allows possible differences in the ecstasy related effects to be 
observed, which can in turn inform about which memorial processes are impaired or 
spared following ecstasy use.  The current meta-analysis expands on Rogers et al. 
(2009) meta-analysis, by including studies of verbal learning that reported Trial 1, 
Total recall and Delayed recall outcome measures. Of the thirteen studies that 
reported results for Trial 1 of the RAVLT, only three identified an ecstasy-related 
deficit. Trial 1 limits the use of extra cognitive processes such as imagery and 
strategic organisation to assist with encoding and retrieval and is therefore a more 
pure measure of immediate memory. Thus, performance on Trial 1 is a useful 
addition to a meta-analysis as it can inform as to whether ecstasy related memory 
deficits are in part mediated by limited memory span for words. 
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Method 
 
The electronic database Psych. Info was searched using the terms ecstasy OR 
MDMA and cognition to identify publications up until June, 2013 (see Figure 6.1). 
Publications other than peer reviewed scholarly articles were excluded and the 
search was also restricted to English language publications with a human population. 
The search term memory was then used to search within these publications. The 
remaining abstracts were scanned and publications that focused solely on executive 
functions, working memory, visuospatial memory, prospective memory and studies 
that examined the acute effects of ecstasy were also excluded. The method sections 
of the remaining studies were scanned and only included if means and standard 
deviations for ecstasy users and non-users on a word list learning task that was 
comparable to the RAVLT were reported. This meant that studies that used the 
Rivermead Behavioural Memory Test, paired associated tasks and later trials of 
selective reminding tasks as tests of verbal episodic memory were excluded. Of the 
remaining 23 studies that were included in the analysis, the tasks were; the RAVLT 
(or a non-English equivalent: 18 studies), CVLT (four studies) one novel word list 
learning task consisting of non-semantically related words,  and Trial 1 of the 
Bushke Selective Reminding Test (BSRT, one study). Trial 1 of the BSRT consists 
of free recall of 12 non-semantically related words. A summary of the included 
studies is presented in Table 6.3 at the end of this chapter.   
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342 
Records identified from database 
searching (PsychInfo) 
 
108 
Records excluded based on 
methodology and memory search 
226 
Studies identified for further 
examination against 
inclusion/exclusion criteria 
23 
Studies were identified for inclusion 
in the meta-analysis 
116 
Records excluded due to non-
English language or non-human 
populations 
62 
Publications excluded based on 
non-verbal memory tasks   
56 
Studies identified for examination of 
methods section 
118  
Studies identified for further 
examination against 
inclusion/exclusion criteria 
Figure 6.1. Flow diagram of the literature search process.  
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In studies where ecstasy consumers were categorised into light, moderate and 
heavy users, the categories were combined. In one study (Fox, Parrott & Turner, 
2001) ecstasy consumers were classified based on whether they had reported 
significant problems related to their ecstasy use, such as experiencing affective 
distress or cognitive problems. In this instance, a conservative approach was taken 
and only the non-problem group was included to prevent the possible impact of 
prescribed psychotropic medications or low task motivation on the results. Because 
this study investigates the effects of current ecstasy use on memory performance, 
groups of ex-ecstasy users were also excluded from the analysis. 
Numerous studies included control participants who had no or very little 
exposure to illicit drugs, and as such could be classified as drug naive. As ecstasy 
users typically use other illicit drugs such as amphetamines, cocaine or cannabis, 
comparing ecstasy users with drug naive persons is not ideal, as it allows differences 
in memory scores to be attributable to substances other than ecstasy (Verdejo-Garcia, 
Lopez-Torrecillas, Gimenez & Perez-Garcia, 2004).  Comparing with other drug 
using individuals also means there is some level of control for the potentially 
confounding effect of other drug use. Therefore, two sets of analyses were 
undertaken, one analysis which included drug naive participants, and one that 
excluded them.  
 
Effect sizes were calculated to identify the degree of ecstasy related 
impairment relative to controls on Trial 1, Total recall and Delayed recall measures.  
Analysing these measures separately avoids the problem where data that is indicative 
of different processes is combined to produce a summary main effect of ambiguous 
meaning (Lipsey & Wilson, 2001; Borenstein et al., 2009). For example, combining 
scores on Trial 1 and Total recall is questionable because these measures are thought 
to underlie different memory processes. The current meta-analysis therefore aimed to 
identify the specific measure of verbal learning most affected by ecstasy use. 
 
Analyses 
 
Meta-analyses were performed using the means, standard deviations, and 
group sizes (n) for scores on Trial 1, Total recall and Delayed recall. The measure of 
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effect size chosen was Hedges’ g, as this corrects for problems arising from small 
sample sizes. Due to the heterogeneous nature of drug research participants, and as 
recommended for current meta-analytic studies, a random effects model was chosen 
a-priori (Borenstein et al., 2009). Publication bias, whereby peer-reviewed journals 
tend to publish more studies with statistically significant results, can prevent a true 
effect from being identified due to a number of unknown results being excluded 
from analyses. This was addressed by reporting Rosenthal’s fail-safe N (NFS) for 
each analysis. This statistic provides an estimate of the number of studies required to 
render a result non-significant. A true effect, rather than a result due to publication 
bias is more likely to be found with a higher NFS (Laws & Kokkalis, 2007; Nulsen, 
Fox & Hammond, 2010). Effect sizes were classified according to Cohen’s (1969) 
recommendation; g = 0.20 – 0.49 is a small effect, g = 0.50 – 0.79 is a medium effect 
and g > 0.80 is a large effect. In addition to effect sizes, meta-regression was 
performed using estimated lifetime ecstasy consumption (number of tablets) as a 
predictor of effect sizes where this data was available. Meta-analyses were 
conducted using Comprehensive Meta-Analysis (CMA 2.0) software. 
 
 
Results 
Effect sizes and 95% confidence intervals for the effect of ecstasy use on 
Trial 1, Total recall and Delayed recall for all studies are presented in Figures 6.2, 
6.3 and 6.4 respectively. There was a small effect of ecstasy use for Trial 1 recall 
scores compared with drug naive and poly-drug controls.  The ecstasy related 
deficits for Total and Delayed recall were moderate, with ecstasy associated with a 
performance decrement of over half a standard deviation relative to controls. All 
effect sizes were significant (p < 0.01).  
 
Table 6.2 summarises the results for the analyses that included and excluded 
drug naive participants. As can be seen, removing drug naive participants from the 
analysis made little difference to the magnitude of the effect sizes, with the exception 
of Trial 1. The small effect for Trial 1 decreased further, indicating that the effect of 
ecstasy use on short term memory span is negligible. This was confirmed by the very 
low NFS value, which indicates only 9 studies would be required to produce a non-
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significant ecstasy related effect for Trial 1. Using estimates of mean lifetime ecstasy 
consumption (reported in Table 6.3 when available) meta-regression failed to 
identify any significant relationship between ecstasy consumption and effect size for 
Trial 1(β = .00019, SE = .00060, z = .32, p = .75).  
 
For Total recall, the removal of drug naive participants had very minimal 
effect on the magnitude of the ecstasy effect, with the effect size remaining in the 
moderate range for this measure, and although the NFS decreased, it was still high 
relative to the number of studies included (Table 6.3). Meta-regression identified the 
relationship between effect size and ecstasy consumption to be non-significant (β = 
.00041, SE = .00069, z =.96, p = .33).  
 
For Delayed recall, as can be seen in Figure 6.4, the Yip and Lee (2005) 
study is anomalous compared with the other studies and consequentially this study 
was removed from the meta-analysis. Removal of this study reduced the magnitude 
of the effect from g = -.98 to g = -.67 however removal of the other studies that 
included a drug naïve comparison (Bedi & Redman, 2008; Reneman, Booij et al., 
1999; Schilt et al., 2010) made little difference to the effect size (g = .60).  Yip and 
Lee reported that participants in their study had no exposure to illicit drugs other 
than ecstasy and minimal exposure to tobacco and alcohol. Nearly two-thirds of 
potential participants were excluded from this study, leaving only relatively new 
users in the sample. This pattern of use is thus quite different from many studies, 
who typically recruit regular, as opposed to novice, ecstasy users. Although it is 
unclear why this exclusion appears to have inflated the effect size, this study is not 
representative of ecstasy studies generally (Rogers et al., 2009).  There was evidence 
of a dose related effect for Delayed recall, with meta-regression including estimates 
of lifetime ecstasy consumption from seven studies showing a significant linear 
relationship between ecstasy consumption and effect size (β = .0008, SE = .00036, z 
= 2.38, p = .02).  
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Figure 6.2. Effect sizes and confidence intervals for all Studies included in Trial 1 analysis 
Figure note: Positive (+) values indicate an ecstasy related deficit.  
 
Study name Subgroup within study Comparison Outcome Statistics for each study Hedges's g and 95%  CI
Hedges's Standard Lower Upper 
g error Variance limit limit Z-Value p-Value
Gouzoulis-Mayfrank 2000 Ecstasy-polydrug Cannabis VLMT Trial 1 0.443 0.267 0.071 -0.080 0.966 1.660 0.097
Halpern et al. 2010 Ecstasy-polydrug Polydrug-no ecstasy CVLT trial 1 -0.039 0.189 0.036 -0.409 0.331 -0.206 0.836
McCardle et al. 2004 Ecstasy-polydrug Polydrug-no ecstasy RAVLT trial 1 0.278 0.347 0.120 -0.402 0.958 0.801 0.423
Curran et al 2003 Ecstasy-current users Polydrug-no ecstasy Bushke trial 1 0.147 0.247 0.061 -0.338 0.631 0.593 0.553
Halpern et al. 2004 Ecstasy-only Drug naive CVLT trial 1 0.211 0.320 0.102 -0.416 0.838 0.660 0.509
Brown et al. 2010 Ecstasy-polydrug Drug naive RAVLT trial 1 2.242 0.317 0.101 1.621 2.864 7.073 0.000
Thomasius et al. 2006 Ecstasy-current Drug naive RAVLT trial 1 0.401 0.388 0.151 -0.361 1.162 1.032 0.302
de Sola Llopis et al. 2008 Ecstasy-polydrug Cannabis CVLT trial 1 0.241 0.263 0.069 -0.274 0.757 0.918 0.359
Fox, Parrot & Turner, 2001 Ecstasy-polydrug Polydrug- no ecstasy Trial 1 -0.215 0.311 0.097 -0.824 0.394 -0.691 0.489
Golding, Groome et al. 2007Ecstasy-polydrug Polydrug-no ecstasy RAVLT Trial 1 0.142 0.310 0.096 -0.466 0.751 0.459 0.646
Wagner et al., 2012 Ecstasy-polydrug Polydrug-no ecstasy RAVLT Trial 1-follow up 0.237 0.256 0.066 -0.265 0.739 0.926 0.355
0.359 0.180 0.032 0.007 0.712 1.997 0.046
-4.00 -2.00 0.00 2.00 4.00
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Figure 6.3. Effect sizes and confidence intervals for all Studies included in Total recall analysis 
Figure note: Positive (+) values indicate an ecstasy related deficit.  
Study name Subgroup within study Comparison Outcome Statistics for each study Hedges's g and 95%  CI
Hedges's Standard Lower Upper 
g error Variance limit limit Z-Value p-Value
Schilt, deWin 2007 Ecstasy-polydrug Polydrug (<10 ecstasy) RAVLT total 0.737 0.250 0.063 0.247 1.228 2.945 0.003
Halpern et al. 2010 Ecstasy-polydrug Polydrug-no ecstasy CVLT total 0.107 0.189 0.036 -0.264 0.477 0.566 0.572
Quednow et al 2006 Ecstasy-polydrug Cannabis RAVLT total 1.161 0.344 0.119 0.486 1.836 3.371 0.001
Croft et al. 2001 Ecstasy and cannabis Cannabis RAVLT total -0.088 0.372 0.139 -0.818 0.641 -0.237 0.813
Halpern et al. 2004 Ecstasy-only Drug naive CVLT total 0.206 0.320 0.102 -0.421 0.833 0.644 0.520
Medina et al. 2005 Ecstasy-polydrug Cannabis CVLT total 0.653 0.285 0.081 0.095 1.211 2.294 0.022
Schilt et al. 2010 Ecstasy-old Drug naive RAVLT total 1.161 0.350 0.122 0.476 1.847 3.319 0.001
deSola et al. 2008 Ecstasy-polydrug Cannabis RAVLT total 0.059 0.374 0.140 -0.673 0.791 0.158 0.874
Brown et al. 2010 Ecstasy-polydrug Cannabis CVLT total 2.340 0.320 0.102 1.713 2.966 7.319 0.000
Lamers et al. 2006 Ecstasy and cannabis Cannabis RAVLT total 0.106 0.385 0.148 -0.648 0.860 0.275 0.783
Thomasius et al. 2006 Ecstasy-current Drug naive RAVLT total 0.812 0.401 0.160 0.027 1.597 2.028 0.043
Reneman, Schilt et al. 2006Ecstasy-high Polydrug-no ecstasy RAVLT total 1.589 0.391 0.153 0.823 2.356 4.064 0.000
Reneman, Schilt et al. 2006Ecstasy-moderate Polydrug-no ecstasy RAVLT total 1.092 0.396 0.157 0.317 1.868 2.760 0.006
Reneman, Majoi et al. 2001 Ecstasy-polydrug Polydrug-no ecstasy RAVLT total 0.922 0.515 0.266 -0.088 1.932 1.789 0.074
de Sola Llopis et al. 2008 Ecstasy-polydrug Cannabis CVLT total 0.518 0.266 0.071 -0.004 1.040 1.946 0.052
Hanson & Luciana, 2010 Ecstasy-polydrug Drug naive RAVLT Total 0.320 0.231 0.053 -0.133 0.772 1.384 0.166
0.714 0.159 0.025 0.402 1.027 4.479 0.000
-4.00 -2.00 0.00 2.00 4.00
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Figure 6.4. Effect sizes and confidence intervals for all Studies included in Delayed recall analysis 
Figure note: Positive (+) values indicate an ecstasy related deficit
Study name Subgroup within study Comparison Outcome Statistics for each study Hedges's g and 95%  CI
Hedges's Standard Lower Upper 
g error Variance limit limit Z-Value p-Value
Gouzoulis-Mayfrank 2000 Ecstasy-polydrug Cannabis VLMT delay 0.435 0.267 0.071 -0.088 0.958 1.631 0.103
Schilt, deWin 2007 Ecstasy-polydrug Polydrug (<10 ecstasy) RAVLT delay 0.913 0.255 0.065 0.414 1.413 3.586 0.000
McCardle et al. 2004 Ecstasy-polydrug Polydrug-no ecstasy RAVLT delay 0.389 0.349 0.122 -0.294 1.072 1.115 0.265
Croft et al. 2001 Ecstasy and cannabis Cannabis RAVLT delay -0.088 0.372 0.139 -0.818 0.641 -0.237 0.813
Reneman, Booij et al. 2000 Ecstasy-polydrug Drug naive RAVLTdelay 2.255 0.674 0.454 0.934 3.576 3.345 0.001
Yip & Lee 2005 Ecstasy-only Drug naive AVLT delay 5.767 0.321 0.103 5.138 6.396 17.970 0.000
Schilt et al. 2010 Ecstasy-old Drug naive RAVLT delay 1.138 0.349 0.122 0.455 1.822 3.264 0.001
Bedi & Redman 2008 Ecstasy-polydrug Drug naive RAVLT delay 0.038 0.215 0.046 -0.384 0.460 0.176 0.860
Brown et al. 2010 Ecstasy-polydrug Cannabis CVLT delay 3.268 0.377 0.142 2.529 4.007 8.665 0.000
Lamers et al. 2006 Ecstasy and cannabis Cannabis RAVLT delay -0.270 0.386 0.149 -1.027 0.487 -0.699 0.484
Thomasius et al. 2006 Ecstasy-current Drug naive RAVLT delay 0.764 0.399 0.159 -0.018 1.545 1.915 0.055
Reneman, Schilt et al. 2006 Ecstasy-high Polydrug-no ecstasy RAVLT delay 1.223 0.372 0.138 0.494 1.951 3.289 0.001
Reneman, Schilt et al. 2006 Ecstasy-moderate Polydrug-no ecstasy RAVLT delay 0.848 0.385 0.148 0.094 1.603 2.203 0.028
Reneman, Majoi et al. 2001 Ecstasy-polydrug Polydrug-no ecstasy RAVLT delay 1.059 0.524 0.275 0.032 2.087 2.021 0.043
de Sola Llopis et al. 2008 Ecstasy-polydrug Cannabis CVLT delay 0.353 0.264 0.070 -0.165 0.870 1.336 0.182
Fox, Parrot & Turner, 2001 Ecstasy-polydrug Polydrug- no ecstasy Delayed recall -0.247 0.311 0.097 -0.857 0.363 -0.794 0.427
Golding, Groome et al. 2007 Ecstasy-polydrug Polydrug-no ecstasy RAVLT delay 0.157 0.310 0.096 -0.452 0.765 0.505 0.613
Hanson & Luciana, 2010 Ecstasy-polydrug Drug naive RAVLT Delay -0.129 0.230 0.053 -0.579 0.322 -0.560 0.576
0.979 0.347 0.120 0.300 1.658 2.824 0.005
-8.00 -4.00 0.00 4.00 8.00
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Table 6.2 
Summary Statistics for Trial 1, Total and Delayed Recall Meta-analyses 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Ecstasy users n = 723, Control n = 699. 
+
 Ecstasy users n = 514, Control n = 498.
 
 
Hedges’ g 
(SE) 
95 % 
confidence 
Interval 
Z Zp Q Qp NFS 
All studies (N = 1422*)        
Trial 1 -.36 (.47) .007 - .72 1.99 .046 44.68 <.001 35 
Total recall -.71 (.16) .42 - 1.03 4.48 001 60.70 <.001 297 
Delayed recall -.98 (.35) .30 – 1.66 2.82 .005 353.64 <.001 601 
Delayed recall
- 
Yip and 
Lee (2005) excluded  
-.67 (.19) .27 – 1.04 3.34 .001 98.81 <.001 230 
Without Drug Naïve (N = 
1012) 
       
Trial 1 -.15 (.09) .03 - .33 1.67 .094 4.35 .82 9 
Total recall -.71 (.18) .35 – 1.06 3.89 <.001 56.79 <.001 212 
Delayed recall -.60 (.20) .21 - .99 3.01 .003 79.24 <.001 168 
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Discussion 
 
This meta-analysis has investigated three measures of verbal list learning in 
an attempt to identify which aspect of the task is most affected by ecstasy use. This 
was only achievable when studies reported group performance for each dependent 
variable rather than combining scores from multiple aspects of performance into a 
single overall score. This allows for a clear interpretation of the effect ecstasy use 
has on Trial1, Total and Delayed recall scores. The effect size measures showed that 
ecstasy users performed more poorly than non-ecstasy users on each list learning 
measure, and the magnitude of the effect was largest for Total recall, moderate for 
Delayed recall and small for Trial 1. Removal of the drug naïve comparisons so that 
studies comparing ecstasy users with poly-drug controls were only included made 
little difference to the magnitudes for the effect of ecstasy use on Total and Delayed 
recall. Given the current concerns raised in the literature regarding whether it is 
ecstasy or poly-drug use that is contributing to memory deficits frequently reported 
for ecstasy users, the comparison of ecstasy users with poly-drug consumers only is 
an important one as it provides support for an ecstasy specific deficit on the three 
measures of verbal memory that are most commonly reported in the ecstasy and 
cognition literature. Nulsen, Fox and Hammond (2010) and Rodgers (2009) also 
compared ecstasy users with poly-drug using controls in their meta-analyses and also 
reported small to moderate effects of ecstasy on global measures of verbal memory 
performance. Since comparisons between ecstasy and poly-drug users have been 
demonstrated to reduce estimates of effect sizes relative to ecstasy and drug naïve 
comparisons (Taylor, Greene, Morgan & Munafò, 2011) the finding that the 
magnitudes for Total and Delayed recall remained moderate in the current and 
previous studies suggests these effects are robust. A novel finding from the current 
study however, is the lack of ecstasy related effect for Trial 1 recall. This finding can 
provide greater clarity regarding the components of verbal memory that are spared 
by regular ecstasy use and can also better inform about the memory processes that 
are associated with an ecstasy related deficit.  
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Weak effects of ecstasy use on Trial 1 of verbal list learning tasks 
Of the three measures examined in the current study, Trial 1 had the smallest 
effect size and the NFS of 9 indicates that only nine additional studies included in the 
analysis would be required to render the effect statistically non-significant. It is 
therefore possible that the effect for Trial 1 is a result of publication bias rather a true 
effect, and in either case the magnitude of a Trial 1 effect appears minimal in 
magnitude. Previous meta-analyses have not assessed the effect of Ecstasy on Trial 
1, and individual studies have reported inconsistent results, with some earlier studies  
reporting a Trial 1 decrement (Parrot & Lasky, 1998; Fox, Toplis, Turner & Parrott, 
2001; Gouzoulis-Mayfrank et al., 2000)  and later studies finding no ecstasy related 
deficit (Thomasius et al., 2003, 2006; Curran & Verheyden, 2003; McCardle, 
Luebbers, Carter, Croft & Stough, 2004; Bedi & Redman, 2008; Brown, McKone & 
Ward, 2010). The low magnitude effect for ecstasy on Trial 1 in the current study is 
consistent with the later, but not earlier studies for this measure.  The discrepancy in 
findings between earlier and later studies has recently been investigated by Taylor, 
Greene, Morgan and Munafò (2011). These authors used linear regression to 
ascertain the relationship between various study characteristics and estimates of 
effect sizes and found a significant relationship between increased year of 
publication and reduced effect size in the ecstasy and cognition literature (B = .04, 
95% CI: .01 - .07, p = .024). They suggested there may have been an improvement in 
study quality over time, such as better control over the influence of drugs other than 
ecstasy that has reduced the likelihood of observing inflated effect sizes.  
 
There is little consensus in the memory literature with regard to the 
component of memory that Trial 1 actually measures, with  initial acquisition 
(Blachstein, 1993) simple attention span (Woodard, 2006) and immediate memory 
(Lezak, 2004) all being assessed by single trial word list recall. In contrast to Total 
and Delayed recall scores, which are derived after multiple list presentations and 
measure multiple processes, including inter-trial consolidation, storage and learning , 
Trial 1 performance assesses the capacity to acquire and retrieve information from a 
single trial and is thus more dependent on sub-vocal rehearsal of the items and 
maintaining them in short term memory for a brief amount of time. The trivial 
ecstasy effect for Trial 1 suggests that the phonological loop and initial encoding, or  
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processing of information to be stored, is largely un-impeded by regular ecstasy use. 
Further, the magnitude for Trial 1 means that initial acquisition of words is relatively 
equal between ecstasy users and non-users and is therefore not having a substantial 
impact on Total recall scores. 
 
The effect of Ecstasy use on Total recall 
 
Total recall measures the number of words recalled over multiple trials, and 
was the most commonly reported measure within the individual ecstasy and list 
learning studies, with several studies reporting an ecstasy related deficit for this 
measure (Bolla et al., 1998; Parrott & Lasky, 1998; Reneman et al., 2001b: 
Thomasius et al., 2003; Quednow et al., 2006; Thomasius et al., 2006; Reneman et 
al., 2006; Lamers, Bechara, Rizzo & Ramaekers, 2006; Schilt et al., 2008; Schilt et 
al., 2010) although the ecstasy group-means vary considerably. Based on 16 studies 
that included Total recall as a dependent variable, the current meta-analysis found a 
moderate effect of ecstasy on Total recall (g =-.71) in both the combined and the 
drug naïve excluded analyses.  
 
Compared to Trial 1 findings, for which the effect of ecstasy use was weak, 
the ecstasy related effect was much larger as a consequence of the addition of 
multiple learning trials. Unlike Trial 1, which provides little scope for strategically 
organising input, multiple list presentations allow participants to build on the number 
of words initially encoded in Trial 1 and to engage in learning strategies that can 
facilitate consolidation and retrieval. Thus, the lack of a substantial Trial 1 deficit, 
coupled with the moderate ecstasy impairment for total words recalled informs us 
that for ecstasy users, it is not the initial acquisition of words that is impaired so 
much as the ability to build on the initial level of word acquisition efficiently, 
suggesting there is a verbal learning, rather than immediate memory deficit. Total 
recall is comprised of multiple cognitive components, and previous deficits for 
ecstasy users on this measure have been attributed to encoding problems (Ward et 
al., 2006) working memory or executive dysfunction (Gouzoulis-Mayfrank, 2000; 
Verbaten, 2010, Zakzanis et al., 2007) and retrieval and temporal lobe deficits 
(Daumann et al., 2005; Fox et al., 2002). Thus, Total recall relies on encoding, 
consolidation and retrieval processes, as well as organisational or semantic strategies  
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that enhance encoding and consolidation, and as such this measure provides limited 
insight into the specific cognitive processes that cause impairment.  
 
The effect of ecstasy use on Delayed recall 
The ecstasy related effect for Delayed recall was moderate (g = -.67) and this 
reduced slightly for the drug naive excluded analysis (g = -.60). This result is 
consistent with previous research identifying an ecstasy related effect on this 
measure (Reneman, Booij, Scmand, van den Brink & Gunning, 1999; Reneman, 
Majoi, Schmand, van den Brink & den Heeten, 2001; Reneman et al., 2001b; Fox, 
Toplis, Turner & Parrott, 2001; Curran & Verheyden, 2003; Thomasius et al., 2003; 
McCardle, Luebbers, Carter, Croft & Stough, 2004; Yip & Lee, 2005; Reneman et 
al., 2006; Thomasius et al., 2006; Schilt et al., 2010). This Delayed recall 
impairment may indicate that ecstasy users are either failing to retain previously 
learnt words (that is, they have forgotten more words than non-ecstasy users) or they 
have stored the words, but are unable to retrieve them. Due to the marked 
impairment on Total recall, it not possible to ascertain whether the Delayed recall 
deficit is associated with higher rates of forgetting for ecstasy users during the delay 
or whether it is consequence of their already low memory scores as identified on 
Total recall, which has impacted on the Delayed recall scores. A finer examination 
of the learning curve and recall consistency over the five trials of the RAVLT or 
CVLT could address this question directly.  
 
The relationship between lifetime ecstasy consumption and measures of verbal 
memory 
Although the current meta-analysis found minimal difference in magnitudes 
between the combined and drug naïve excluded analyses for Total recall, which 
supports the view that the observed effects are not due to poly-drug use, it is 
noteworthy that meta-regression examining the relationship between estimated 
lifetime consumption of ecstasy and Total recall scores failed to show a significant 
linear relationship between these variables. As the broad domain of verbal memory 
was compartmentalised into three measures in the current study, this reduced the 
number of studies available that had reported estimated lifetime consumption to 
seven for Total and Delayed recall and five for Trial 1. It is therefore possible that  
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the non-significant relationship between estimated ecstasy usage and Total recall 
scores reflects lack of adequate power for a meta-regression analysis (Borenstein et 
al., 2009). Nevertheless, the lack of dose dependence is broadly consistent with 
previous meta-analyses that have not found a significant relationship between 
ecstasy consumption and effect size for visual and verbal short and long term 
memory (eg. Laws and Kokkalis, 2007; Nulsen et al., 2010; Rogers et al., 2009 
Verbaten, 2003). Nulsen et al. did find dose related effects for the working memory 
category of studies however, and there was significant dose related effect for the 
broad category of verbal learning and memory as reported by Zakzanis et al. (2007).  
Consistent with Rogers et al., the current meta-analysis found no relationship 
between ecstasy consumption and Total recall, however the present study did report 
a significant dose related effect for Delayed recall, where Rogers et al. did not.  
 
Methodological considerations for ecstasy and memory research 
It is difficult to draw comparisons between current and previous meta-
analyses however, as the literature is fraught with inconsistencies in how ecstasy 
consumption is measured and reported. Most, but not all, of the cited research reports 
estimated lifetime dose (number of tablets) however there is a great deal of 
variability in how ecstasy use is quantified (eg. total occasions of use versus number 
of units used, number of pills consumed in the preceding six months, estimated 
lifetime dose, age of onset, usual number of tablets per session, maximum number of 
tablets taken per session). This array of potential dose-related predictors may make it 
difficult for a consistent dose related effect to emerge between studies. The 
characteristics and variability in patterns of drug use (cumulative and acute dosage, 
concomitant drug use, frequency of use) could have contributed to the variability in 
dose related findings also, particularly if bingeing or recency of use has a greater 
impact on cognitive performance than long term, occasional use (Fox, Parrott & 
Turner, 2001; Gouzoulis-Mayfrank & Daumann, 2006; Parrott, 2005). Other 
potentially important non-drug factors that can contribute to different cognitive 
outcomes include potential neuro-protection from concomitant cannabis use 
(Dumont et al., 2009), environmental factors (ambient temperature, noise, physical 
activity and dehydration) premorbid vulnerability (Parrott, 2006) and variations of 
the 5-HTT gene in the cognitive sequelae of ecstasy use (Fagundo et al., 2010;  
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Roiser, Rogers, Cook & Sahakian, 2006). Reliance on accuracy of participant’s self-
reports is also often cited as an unreliable estimate of use. Despite some misgivings 
however, procedures such as the Lifetime Drug-Use Interview (Czermak et al., 2005) 
have been shown to have adequate validity, reliability and test-retest reliability for 
research purposes (Czermak et al.; Darke, 1998; Harrison, Martin, Enev, & 
Harrington, 2007; Morgan, 2000).   
 
Aside from differences in reporting conventions, establishing dose related 
effects is problematic due to the variability of MDMA content in pills sold as 
ecstasy, with some purity studies identifying consistent levels of MDMA in police 
seizure samples (eg. Cole et al., 2002; Simonsen et al. 2003; Parrott 2004; Giraudon 
and Bello 2007; Vogels et al. 2009) and others not (eg. Cheng et al., 2003). Many 
studies report fluctuating pill purity over time and identify several illicit substances 
other than MDMA in pills sold as ecstasy (Baggot et al., 2000; Morefield et al., 
2011; Parrott, 2004; Tanner-Smith, 2006; Vogels et al. 2009), thus making it very 
difficult to establish whether neurocognitive effects are a result of MDMA use.  
Even when estimated ecstasy dose in ‘numbers of pills’ is recorded accurately, the 
discrepancies in pill constitution may mean that each unit of measurement fluctuates 
for each participant. Although establishing the exact pill content in retrospective 
ecstasy research is not possible, the majority of ecstasy users attempt to find out 
about pill content prior to ingestion (Johnston et al., 2006) and use physiological 
indicators such as nausea and teeth grinding to estimate the strength and purity of 
ecstasy tablets (Parrott, 2004). Participants’ subjective ratings of MDMA-
intoxication have been shown to be significantly correlated with MDMA plasma 
levels (Kolbrich et al., 2008) and higher MDMA pill content (Brunt, Koeter, 
Niesink, van den Brink, 2012).  Overall, differences in drug consumption patterns, 
pill constitution, premorbid vulnerability and non-drug factors likely modulate the 
degree of memory impairment that can be attributed to dose-related ecstasy use.  
 
Methodological problems associated with retrospective, cross sectional 
designs have been frequently discussed in the ecstasy (and other illicit drug) 
literature. Cross sectional designs possess several potential confounds that may not 
be distributed equally between ecstasy users and non-users, such as intelligence,  
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education and poly-drug use. Poly-drug use can be addressed in cross sectional 
designs by including participants with minimal exposure to other illicit drugs, 
however the majority of ecstasy users consume other substances and excluding other 
drug use can make the results less ecologically valid and make study sizes too small. 
Thus, including poly drug users, whether compared to drug naïve or ecstasy-only 
users, can undermine the confidence with which memory related effects can be 
attributed to ecstasy use alone. Moreover, poly-drug users or ecstasy-only users may 
have more occasional patterns of use than poly-drug ecstasy users (Degenhardt & 
Hall, 2010), which creates large discrepancies in lifetime drug use. Indeed, there was 
a degree of variability in poly-drug use within individual studies in the present meta-
analysis. For example, Schilt et al. (2010) recruited ecstasy users with a mean 
lifetime use of 318 (SD = 511) grams of amphetamines, compared with 287 (799) 
grams for their poly-substance group. Alternatively, the ecstasy using group in Bedi 
and Redman’s (2008) study used an average of 23.5 grams of amphetamines (SD= 
68.4) compared with just 0.3 grams (22) for their poly-substance group. Bedi and 
Redman’s groups were well matched for cannabis use however, with the ecstasy 
group using an average of 355.6 (SD = 616.9) joints in their lifetime, compared with 
360.4 (634.2) for the poly-substance group.  Despite the shortcomings of 
retrospective studies, the present and previous meta-analyses have the advantage of 
estimating effect sizes from a large population of ecstasy users and have shown 
moderate magnitude ecstasy related verbal memory deficits which remain moderate 
even after the removal of drug naïve controls.  
 
Conclusion  
Overall, this meta-analysis has found limited evidence of an ecstasy related 
effect for immediate memory, and moderate, robust effects of ecstasy on Total and 
Delayed recall. Previous research that has identified reduced Total and Delayed 
recall scores for ecstasy users have suggested these may be indicative of temporal 
lobe, and in particular hippocampal dysfunction (Fox et al., 2002; Gouzouilis-
Mayfrank et al., 2003). More recent research has attempted to unravel the drivers of 
deficits on Total recall scores by including more specific list learning measures such 
as semantic clustering and recall consistency and have suggested that ecstasy related 
deficits may be due to combination of episodic memory and executive processes that 
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are supported by the medial temporal lobes and the prefrontal cortex respectively 
(Brown, McKone & Ward, 2010; Quednow et al., 2006). Thus, although the current 
meta-analysis has clearly identified that immediate memory and therefore initial 
encoding (Trial 1) is less impaired than verbal learning and consolidation processes 
(Total and Delayed recall) the difficulty with interpreting studies that use these 
standard measures of memory and learning is that Total and Delayed recall are 
outcome measures of multiple memorial processes. Although these summary 
measures have been used in the ecstasy and verbal memory literature to date, and are 
routinely calculated when using verbal list learning tasks for research or clinical  
practice, they do not adequately capture the more specific trial to trial differences  
that comprise the overall learning curve.  The following chapter reports on ecstasy 
users’ data from two list learning tasks similar to the CVLT and RAVLT, and 
includes a detailed deconstruction of trial by trial performance as well as the 
summary measures to better elucidate the effect of ecstasy consumption on memory 
processes.  
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Table 6.3 
All Studies Included in the Meta-Analysis 
Author & Location 
of Study 
Measure    Ecstasy using group Controls 
  
N 
Mean (SD) 
estimated 
lifetime use 
Bedi & Redman 
(2008) 
Australia 
RAVLT Trial 1 
RAVLT Delay 
45 77.8 (89.1) 48 cannabis 
& polydrug 
users 
40 alcohol 
users 
Brown, et al. (2010) 
Australia – Sample 
2 
RAVLT Trial 1 
RAVLT Total 
30 394.5 (123.0) 
 
34 drug naïve 
Brown, et al. (2010);  
Australia – Sample 
3 
CVLT Total 
CVLT Delay 
 
33 384 (109.0) 32 drug naïve 
32 cannabis 
users 
Curran & 
Verheyden (2003) 
UK 
Buschke Trial 1 
Buschke Delay 
 
32 
NA 
 
 
 
32 polydrug 
Halpern et al. (2004) 
USA 
CVLT Trial 1 
CVLT Total 
CVLT Delay 
23 Median = 60 16 
Halpern et al. (2010) 
USA 
CVLT Trial 1 
CVLT Total 
 
52 Median = 
43.5 
59 
Golding et al.(2007) 
UK 
RAVLT Trial 1 
 
RAVLT Delay 
 
20 55.05 (56.0) 20 Ecstasy 
naive 
Gouzoulis-Mayfrank 
et al. (2000) 
Germany 
 
 
 
German AVLT 
Trial 1 
German AVLT 
Delay 
28 
NA 
 
 
 
 
28 drug naïve 
28 cannabis 
users 
Lamers et al. (2006) 
USA 
RAVLT Total 
RAVLT Delay 
 
11 ecstasy + 
cannabis 
37.6 (33.6) 15 cannabis 
users 
15 drug naïve 
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McCardle et al. 
(2004) 
Australia 
RAVLT Trial 1 
RAVLT Total 
RAVLT Delay 
 
17 NA 15 
Medina et al. (2005) 
USA 
CVLT- Total 
 
48 267 (482) 17 cannabis 
users 
Parrot & Lasky 
(1998) 
UK 
Auditory recall 
test – Single 
trial 
15 regular 
users 
15 novice 
users 
NA 
 
 
 
 
15 
Reneman, Majoie et 
al. (2001) 
Netherlands 
RAVLT Total 
RAVLT Delay 
 
8 902 (801.2) 7 drug naïve 
Reneman, Lavalaye 
et al. (2001) 
Netherlands 
 
RAVLT Total 
RAVLT Delay 
 
22 
485.5 (598.0) 
13 
Schilt et al. (2008) 
Netherlands 
RAVLT Total 
RAVLT Delay 
31 327.8 (364) 38 polydrug 
users 
 
Schilt et al. (2010) 
Netherlands 
RAVLT Total 
RAVLT Delay 
17 888.7 (678) 16 polydrug 
users 
[lifetime 
ecstasy <15] 
20 drug naïve 
Smith et al. (2006) 
USA 
CVLT Trial 1 
CVLT Total 
CVLT Delay 
 
13 42.8 (57.8) 13 drug naïve 
Thomasius et al.  
(2003) 
Germany 
 
AVLT Trial 1 
AVLT Total 
AVLT Delay 
30 
NA 
 
29 polydrug 
users 
30 drug naïve 
controls 
Thomasius et al. 
(2006) 
Germany 
 
AVLT Trial 1 
AVLT Total 
 
 
 
 
11 798.23 
(609.29) 
11 polydrug 
users 
15 drug naïve 
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AVLT Delay  
Wagner et al. (2012) 
Germany 
RAVLT Total 23 33.6 (7.2) 43 abstinent 
new ecstasy 
users  
Yip & Lee (2005) 
Hong Kong 
  
Chinese 
RAVLT Total 
Chinese 
RAVLT Delay 
 
100 35.84 (13.21) 100 drug 
naïve 
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Chapter 7 
 
Study 2: An Investigation of the Cognitive Processes in Multi-trial Word Recall 
Tasks that are impaired by Ecstasy and Poly-drug use 
 
Previous studies that have used neuropsychological clinical tests of word list 
learning such as the AVLT and CVLT have obtained mixed results, although meta-
analyses have identified verbal learning and memory to be the cognitive domain 
most affected by regular ecstasy use (Kalechstein et al., 2007; Laws & Kokkalis, 
2007; Zakzanis et al., 2007; Rogers et al., 2009). The meta-analysis in the previous 
chapter aimed to specify which measures in word list learning are most impaired by 
ecstasy use, and identified a small effect of ecstasy use for Trial 1 and moderate 
effects of ecstasy use for Total and Delayed recall. These results suggest that regular 
ecstasy use may induce alterations to neural networks responsible for consolidation 
and retrieval processes. However, these measures are not independent of one 
another; Delayed recall scores are dependent on how many words were recalled 
during the learning trials, therefore Delayed recall is not just a measure of storage 
and retrieval, but consolidation as well. Thus, scores on these measures are limited in 
the extent to which they can inform about the specific cognitive processes inherent to 
list learning tasks that are most impaired by regular ecstasy use. The purpose of the 
present study was to extend and clarify the findings of the previous ecstasy and 
verbal memory literature. This was achieved using two different list learning tasks 
and by calculating memory measures in addition to Trial 1, Total and Delayed recall. 
These alternative memory measures are often reported in the memory and cognition 
literature and were developed to provide more detailed information on the processes 
used in list learning. The list learning tasks and measures are outlined in the 
following section, with particular emphasis on the memory processes and neural 
correlates they assess.  
 
Verbal memory deficits for ecstasy users may be attributed to altered functioning of 
the medial temporal lobe.  
The frequently reported verbal memory deficits for ecstasy users have usually 
been interpreted as evidence that ecstasy users have deficits in the storage and/or 
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retrieval of verbal information, probably arising from impaired medial-temporal 
functioning (Fox, Toplis, Turner & Parrott, 2001; Fox et al., 2002; Gouzoulis-
Mayfrank, Thrimm, Rezk, Hensen & Daumann, 2003; Wagner, Becker, Koester, 
Gouzoulis-Mayfrank & Daumann (2011) and fMRI conducted during working 
memory tasks have demonstrated differences in hippocampal activation between 
ecstasy users and controls (Becker et al., 2012; Daumann et al., 2005; Jacobsen, 
Mencl, Pugh, Skudlarski & Krystal, 2004; Moeller et al., 2004). The hippocampus is 
innervated by serotonergic axons originating from the medial and dorsal raphe nuclei 
and serotonin is believed to be a key neurotransmitter involved in learning and 
memory (Hornung, 2003). Verbal memory has also been assessed during acute 
tryptophan depletion (ATD; a dietary manipulation which temporarily lowers 
serotonin levels). These studies have frequently reported fewer words recalled during 
ATD compared to placebo (Harrison et al., 2004; Klaassen et al., 1999; Riedel et al., 
1999; Sambeth et al., 2009 and Schmitt et al., 2000) and in an fMRI study of verbal 
episodic memory, van der Veen and colleagues (2006) found that ATD reduced 
activity in the right hippocampus during encoding, but not the retrieval phase of the 
task. In rats, the hippocampus has displayed considerable serotonin receptor 
denervation after exposure to MDMA (Fischer et al., 1995; Hatzidimitriou et al., 
1999) and regular ecstasy users have displayed alterations to central serotonergic 
markers (eg. Kish, Fitzmaurice, Chang, Furukawa & Tong, 2010; McCann et al., 
2008; Reneman et al., 2001). Recently a prospective study of novice ecstasy users 
(less than 5 occasions of use) used fMRI and an associative memory task (matching 
a face with a profession) and reported that participants who had continued to use 
ecstasy one year from baseline testing showed decreased activation in the 
parahippocampal-gyrus compared to those who did not continue to use ecstasy, and 
this decreased activation showed a dose-response relationship with ecstasy, and not 
amphetamine or cannabis use, indicating an ecstasy-specific effect (Becker et al., 
2013). This combination of reduced verbal memory scores, alterations in 
biochemical markers of serotonin for ecstasy users, coupled with impaired verbal 
memory performance under conditions of reduced serotonin availability and 
observed hippocampal differences for ecstasy users compared to non-users has 
supported the view that regular ecstasy use impairs verbal memory via alterations to 
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two important neural correlates of memory; serotonin receptors and neural networks 
within the hippocampus.   
 
As discussed previously, the hippocampus, although a key structure in 
episodic memory, does not operate in isolation, with many memory models now 
incorporating a role for the prefrontal cortex in memory encoding and retrieval. The 
Working with Memory model (Moscovitch & Winocur, 1992) consists of two 
components. The hippocampal/MTL component is posited as a memory module that 
functions to form a long-term memory trace for attended information. This 
component is passive as it relies on associations and simple proximity between 
memory traces, rather than actively engaging in strategic encoding of stimuli. In 
contrast, the frontal/strategic component serves to implement strategies that organise 
input and output from the hippocampal module, monitoring memory traces for 
temporal and spatial context and using this information to strengthen encoding and 
guide retrieval. This component therefore works with the hippocampus to transform 
a passive process into a reflexive, goal directed activity. This model, and others like 
it  are consistent with the neuroimaging memory literature which indicates prefrontal 
areas, including the ventral lateral prefrontal cortex and dorsolateral prefrontal cortex 
contribute to the selection of task relevant information and semantic properties of 
verbal items. These areas assist with encoding and consolidation in the hippocampus, 
and during retrieval the prefrontal cortex plays a role in memory search and selecting 
retrieval cues and strategies (Becker & Lim, 2003; Blumenfeld & Ranganath, 2008; 
Moscovitch & Winocur, 2002; Rugg & Wilding, 2000; Shimamura, 2000; Simons & 
Spiers, 2003; Tranel & Demasio, 2002).  
 
The frontal component and verbal memory deficits for ecstasy consumers 
Although the MTL has been the focus of ecstasy and memory research to 
date, there is some evidence that the frontal, strategic component is impaired by 
regular ecstasy use. The ability to organise to-be-remembered items requires intact 
executive functions such as forming associations between remote list items and 
planning and implementing goal directed strategies (Gershberg & Shimamura, 1995; 
Rocchetta & Milner, 1993). Ecstasy users’ performance on the CVLT can indicate an 
important role for strategic processes in ecstasy related memory deficits because it is 
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comprised of words from four different categories, so participants can benefit from 
this embedded organisational strategy to facilitate recall. Medina, Shear and 
Corcoran (2005) administered the CVLT to a group of ecstasy users and a cannabis-
only control group and reported that ecstasy users recalled fewer words on the short 
and long delay free recall measures, however when the demands on executive 
functions were reduced by providing a category cue at recall, the ecstasy group’s 
memory performance did not differ significantly from the cannabis control group. 
Although the authors interpreted the reduced recall performance as indicative of a 
verbal memory deficit, it is equally possible that the lower scores in the free recall 
compared to the cued recall condition indicates that the ecstasy users’ memory 
impairments may be secondary consequences of impaired use of strategies to 
optimise memory performance. Quednow and colleagues (2006) investigated this 
possibility and used the RAVLT to assess memory dysfunction in regular ecstasy 
users, cannabis users and drug naïve controls. They included two measures of the 
RAVLT that have been shown to be associated with frontal lobe functions; Recall 
Consistency and Retroactive Interference. Low recall consistency refers to recalling 
a word in an early trial and failing to recall the word on a subsequent trial. 
Retroactive interference is the detrimental effect of subsequent learning on the recall 
of previously learned target material (Woodard, 2006).  The ecstasy users showed 
significantly poorer scores for Total recall, Recall Consistency, Retroactive 
Interference and Forgetting Rate (number of words lost between the final learning 
trial and the long delay) compared with cannabis users and controls. There was also 
a trend for ecstasy users to recall fewer words than drug naïve controls on Trial 1 (p 
= 0.10, d = -.65). From these results it was concluded that in addition to having 
impaired encoding, consolidation and retrieval, the low Recall Consistency and high 
Retroactive Interference indicated that ecstasy users were less likely to successfully 
organise target items to assist in recall and were less able to overcome interference, 
both skills inherent to executive functioning. Turning again to ecstasy users’ 
performance on the CVLT, Brown, McKone and Ward (2010) found that ecstasy 
users were significantly impaired on Total free recall, Short and Long Delayed recall 
trials compared with cannabis users and drug naïve controls. Consistent with the 
results from Medina et al. (2005), when participants were provided with the category 
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name, in the cued recall condition, the ecstasy related recall deficit was again 
ameliorated.  
 
Brown and colleagues’ (2011) study is the only study thus far to specifically 
assess for strategic organisation during list learning by assessing the degree to which 
participants recalled words from the same semantic category consecutively. These 
semantic clustering scores showed ecstasy users engaged in spontaneous semantic 
organisation of material significantly less than the other groups. It is therefore 
apparent that the ecstasy group were less able to effectively self-initiate strategic 
organisation of the target items, thus producing lower recall and lower semantic 
clustering, which is consistent with a deficit in the frontal component of the Working 
with Memory model. Conversely, in the cued recall condition, a task that is classified 
as dependent more on the hippocampal component of the Working with Memory 
model, the ecstasy group were able to perform at an equivalent level to the control 
groups. These results therefore suggest frontally mediated strategic processes are 
contributing to the verbal memory deficits for ecstasy users, that have so often been 
attributed to impaired MTL functioning. Furthermore, the RAVLT results from 
Quednow et al., (2006) suggest this ecstasy related strategic impairment appears to 
be operating regardless of whether the list is semantically related or not, suggesting 
that other organisational strategies other than semantic clustering are impaired for 
ecstasy users. One such organisational strategy that is investigated in the current 
study is subjective organisation, which refers to the degree to which participants 
recall the same words together across multiple study-test trials.  
 
Uncovering the processes contributing to low verbal memory scores for ecstasy 
users-the current study 
To date, the majority of studies concerning ecstasy use and verbal memory 
have relied on the AVLT and CVLT to assess memory performance. These tests are 
quick to administer and provide information on new learning, immediate memory 
span, susceptibility to interference, semantic clustering and recognition performance 
(Spreen, Sherman & Strauss, 2006). They were designed to assess verbal memory 
performance in clinical, rather than research settings and are typically administered 
to people with self-reported memory deficits. As such, they may lack the sensitivity 
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to detect the more subtle memory deficits associated with recreational drug use 
(Fisk, Murphy, Montgomery & Waring, 2011). Furthermore, both tests have been 
shown to have severe ceiling effects for healthy controls (Davis et al., 2003; Uttl, 
2005).  Ceiling effects are problematic as they prevent participants from 
demonstrating the true extent of their abilities, thus compressing the range of scores 
and limiting the test’s ability to detect the full range of individual differences.  As 
illicit drug research often recruits university students who are matched on several 
demographic variables, including level of education and IQ, it is important that the 
tests administered are best placed to detect possibly small differences in verbal 
memory. As increasing the list length to between 18 and 24 words has been 
demonstrated to ameliorate ceiling effects (Davis et al., 2003; Uttl, 2005) the current 
study will has include two word lists, each comprised of twenty words. The word 
lists are based on the AVLT and the CVLT; one is comprised of semantically related 
items and is therefore categorical and the other is comprised of non-related items.  
The difficulty with interpreting studies that use standard measures of memory 
and learning however is that Total and Delayed recall are outcome measures of 
multiple memorial processes. Although these summary measures have been used in 
the ecstasy and verbal memory literature to date, and are routinely calculated when 
using verbal list learning tasks for research or clinical practice, they are limited with 
regard to how much they can inform about the reasons for lower recall scores for 
ecstasy users. The Total recall score for example, is comprised of immediate 
memory span (Trial 1 performance) actively processing (encoding) the target items 
as they are presented, which then facilitates consolidation and storage. Total recall is 
also dependent on how well participants can retrieve the stored information during 
the recall test at the end of each learning trial. Furthermore, Delayed recall is not 
only assessing retention over time, but it is also dependent on Total recall scores, 
since the number of words consolidated during the learning trials is going to be 
reflected in how many words are recalled after the delay. Thus, there are many 
component cognitive processes that may underlie gross verbal learning and memory 
deficits for ecstasy users. The working with memory model provides a useful 
framework of the processes involved in verbal memory. The hippocampal/MTL 
component is modular and cue-dependent; its primary role is to automatically store 
consciously apprehended information, whereas the frontal/strategic component is 
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responsible for organising the information in a manner that will facilitate 
consolidation to, and retrieval from the hippocampal component. The Working with 
Memory posits that Trial 1 and Recognition performance are within the domain of 
the hippocampal component. As there is limited opportunity to engage in strategic 
elaboration on a single learning trial, and because Recognition is a cued recall test, 
both these measures reduce the need of the frontal component to strategise at 
encoding and guide retrieval. However Total and Delayed recall are comprised of 
processes that are supported by both the prefrontal cortex and medial temporal lobes, 
and as such it is useful to deconstruct performance on multi-trial tasks into 
acquisition, forgetting and strategic components. 
 
Acquisition and forgetting during performance on multi-trial verbal learning tasks 
Although standard summary measures of list learning have been used in the 
ecstasy and verbal memory literature to date, and are routinely calculated when using 
verbal list learning tasks for research or clinical practice, they do not adequately 
capture the more specific trial to trial differences that comprise the Total recall score. 
Performance within discrete trials or pairs of trials may include deficits in encoding 
and retrieval, but these components are not easily identified in the traditional global 
list learning measures. Although much of the ecstasy related verbal memory research 
has used list learning tasks, as yet little is known about how encoding, consolidation 
and rapid forgetting combine to produce the often reported memory deficits.  Two 
measures that can assist in identifying the processes affecting list learning 
performance are Gained and Lost Access (Davis et al., 2003; Dunlosky and 
Salthouse, 1996) and Levels of Forgetting (Fisk & Warr, 1998; Montgomery et al., 
2005).Trial by trial performance can be deconstructed into a measure that identifies 
words that were not recalled on the preceding trial (gained access) and a measure of 
losses in access from trial to trial (lost access). Standard list learning measures, such 
as Total recall, which has been the most frequently reported measure assessing 
ecstasy related deficits, cannot inform on the gain of items that happens at the 
expense of other items. For example, a participant may recall “leather”, “cotton”, 
“spider”, “moth” on trial 3 and “leather,” “cotton,” “ant,” “butterfly” on trial 4. In 
both trials, the recall score is 4, but a measure of gained and lost access informs that 
there is low recall not due to poor encoding/acquisition (since two new words were 
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recalled) but because acquisition appears to only occur via forgetting previously 
recalled items. In comparison, another participant may consistently recall the same 
words, indicating that consolidation is intact, but there is no new encoding or 
acquisition. Thus, gained access is a measure of inter-trial encoding and acquisition, 
and lost access measures inter-trial consolidation failure, which is in contrast to the 
longer term consolidation processes long assessed by Delayed recall and 
Recognition.  
Another useful approach to examining verbal learning for ecstasy users is to 
study participant forgetting patterns using a Levels of Forgetting paradigm.  A level 
is defined by how many times a word is consistently recalled over trials. For 
example, if a word is consecutively recalled twice, this would be referred to as level 
2 learning, and thus if a word was consistently recalled twice, and then forgotten on 
the next trial, this would be referred to as level 2 forgetting. This paradigm provides 
information about whether participants are failing to recall words that were only 
previously recalled once (indicating the word has not been adequately encoded) or 
whether they are failing to recall words that they have previously recalled multiple 
times (in which case the words have probably been consolidated, but then forgotten). 
As participants proceed through the learning trials, recalling the same word should 
increase the strength of the memory trace and thus assist consolidation. If the word is 
successfully recalled four times, and then forgotten, this is referred to as level four 
forgetting and is likely a retrieval deficit. If the word is only recalled once, and then 
forgotten, this is referred to as forgetting at level one and is probably due to the word 
not yet being adequately encoded or consolidated (Salthouse, 1994; Montgomery, 
Fisk & Newcombe, 2005).  This approach therefore allows forgetting to be assessed 
at different levels of learning, rather than just between two pairs of adjacent trials, as 
is the case for gains and losses.  
 
 Evaluating the strategic component using measures of subjective and semantic 
clustering 
Performance on multi-trial list learning tasks also depends heavily on the use 
of memory strategies, and by including both a semantically-related word list and a 
non-related word list semantic and subjective organisation strategies can be assessed 
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for regular ecstasy users. The one ecstasy and memory study that has calculated the 
semantic clustering index for the CVLT reported poorer clustering for ecstasy users 
compared to cannabis and drug naïve controls (Brown, McKone & Ward, 2010).  
Subjective organisation has not been examined for ecstasy users as yet, however 
Quednow et al. (2006) inferred from ecstasy users’ lower Recall Consistency scores 
that these were possibly the result of ecstasy users’ not engaging in subjective 
clustering of items on the RAVLT. Unlike semantic clustering, which is assessed for 
categorical lists in which the organisational strategy is embedded, subjective 
organisation is dependent on participants forming their own associations between 
words, based on their prior knowledge of the words. By calculating both semantic 
and subjective clustering, the current study can better inform as to whether strategic 
processes associated with frontal functioning are contributing to the reported poor 
verbal memory scores for ecstasy consumers.   
In addition to acquisition, forgetting and organisational strategies, processing 
speed and short term storage capacity are processes that can influence a variety of 
memory tasks (eg. Conway et al., 2002; Salthouse & Babcock, 1991; Unsworth & 
Engle, 2005) and it is possible that ecstasy related verbal memory deficits could be 
accounted for by differences within these domains. The current study includes a 
processing speed and word span task to assess whether these processes are 
contributing to verbal memory deficits for ecstasy users.  
 
Residual cognitive effects of cannabis 
Regular consumers of ecstasy usually report using other psychoactive 
substances, most commonly alcohol, cannabis and amphetamines (Gouzoulis-
Mayfrank & Daumann, 2006) thus in early studies that compared the cognitive 
performance of ecstasy users with drug naïve controls, it was difficult to attribute 
differences in performance solely to the use of ecstasy. When poly-substance use 
was taken into account statistically, some early studies found that memory deficits 
among poly-drug users were more related to the amount of cannabis, rather than 
ecstasy that they had consumed (Croft, Mackay, Mills & Gruzelier, 2001; Dafters, 
Hoshi & Talbot, 2004; Rogers, 2001; Simon & Mattick, 2001). Amongst frequent (at 
least monthly) ecstasy users in Australia in 2011, 31% had also used cannabis in the 
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previous month, and 85% had used cannabis in the preceding 6 months (Sindicich & 
Burns, 2011). A high percentage (49%) of these ‘regular’ ecstasy users used 
cannabis and ecstasy concomitantly, and 58% reported using cannabis when coming 
down from a heavy session of ecstasy. These high rates of concomitant ecstasy and 
cannabis use are not always adequately controlled for in the ecstasy literature 
(Curran, 2000; Parrot, 2006).  These findings indicate that a consideration of the 
potentially confounding effect of cannabis is warranted when testing an ecstasy 
using population.  
Under acute conditions, cannabis use has been shown to impair performance 
across various cognitive domains (Crean, Crane & Mason, 2011; Martin-Santos et 
al., 2010; Ranganathan & DeSouza, 2006; Solowij et al., 2008). The more pertinent 
questions for researchers examining the long term cognitive effects associated with 
either cannabis or ecstasy use are; do residual cognitive deficits associated with 
cannabis use exist, and how long do these last?  Pope et al. (2001) addressed these 
questions by recruiting participants who had smoked cannabis a minimum of 5000 
times in their lifetime and who currently smoked daily (n = 63), a group who had 
previously smoked at least 5000 times but whom had smoked less than twelve times 
in the preceding three months (n = 45) and a group of control participants who had 
lifetime use of less than 50 occasions (n = 72). All participants completed a 28 day 
“washout” from cannabis use which was confirmed by urine analysis.  A 
neuropsychological test battery was administered on days 0, 1, 7 and 28 to assess 
general intellectual function, abstraction ability, sustained attention, verbal fluency 
and verbal and visuospatial learning. The Bushke Selective Reminding Test provided 
the verbal learning measure. This is a multi-trial list learning task similar to the 
RAVLT, however after Trial 1, only the words that were not previously recalled by 
the participant are presented.  The Bushke measures rate of learning across trials and 
also purports to differentiate between short and long term memory processes by 
measuring recall of items that were not presented on a given trial (Strauss, Sherman 
& Spreen, 2006). For verbal learning, current cannabis users recalled significantly 
fewer words in total and after a 30 minute delay than former users and controls on 
days 0, 1 and 7 and the size of these deficits were associated with higher urinary 
concentrations of THC at study entry. On day 28 however, there were no significant 
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differences in verbal learning between groups once differences in Verbal IQ were 
controlled for.  
 
Pope and colleagues (2003) later reanalysed the data by investigating the 
relationship between age of onset of cannabis use and neuropsychological 
performance. The sample was divided into three groups; an early onset group 
(people who began using cannabis prior to age 17) a late onset group (people who 
began to use at age 17 or later) and a control group. There were no significant 
differences between late onset users and controls on the Total and Delayed recall 
measures of the Bushke, however the early onset group performed significantly 
worse on these measures, although this effect ceased to be significant once 
differences in Verbal IQ were controlled for.   
 
Grant et al. (2003) conducted a meta-analysis comprising 15 studies that 
examined the non-acute (residual) effects of cannabis on cognition. There were a 
total of 1188 participants in the study, 704 of who were regular cannabis users, 484 
cannabis free controls. Participants’ history of cannabis use generally involved 
smoking cannabis multiple times per week for a duration of use ranging from two 
years to decades. The average length of abstinence prior to cognitive testing ranged 
between 24 hours to several months. The meta-analysis obtained effect sizes between 
cannabis users and controls across eight cognitive domains; reaction time, attention, 
verbal/language, abstraction/executive, perceptual/motor, motor, verbal learning, and 
forgetting. A global neuro-cognitve effect size was also calculated. The largest effect 
sizes were obtained for verbal learning (d = 0.21, 99% CI: -0.39, 0.02) and forgetting 
(d = 0.27, 99% CI: 0.49, 0.04). The effect size remained at a small magnitude when 
all 15 studies were used to calculate the global effect size (d = 0.16, 99% CI: 0.29, 
0.03). These results are largely consistent with Pope et al., (2001) and may be due in 
part to symptoms of cannabis withdrawal (Haney, Ward, Comer, Foltin & Fischman, 
1999; Kouri & Pope, 2000). Given the small magnitude of the effects for verbal 
learning and forgetting (failure to recall or recognise verbal items from list learning 
tasks) Grant et al. concluded that the residual impact on daily functioning for 
cannabis users was probably minimal, particularly since many of the participants 
were long term, relatively heavy users and therefore demonstrated larger deficits 
than might be apparent in moderate users.  
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Several studies have used verbal learning tasks to assess verbal episodic 
memory performance in cannabis users (Bolla, Brown, Eldreth, Tate & Cadet., 2002; 
Block, O’Leary & Hichwa, 2002; Croft, Mackay, Mills & Gruzelier, 2001; Fletcher, 
Page & Francis, 1996; Harvey, Sellman, Porter & Frampton, 2007; Medina et al., 
2007; Pope and Yurgelun-Todd, 1996; Pope et al., 2001; Pope et al., 2002; Quednow 
et al., 2006; Simon & Mattick, 2002; Solowij, Stephans & Rothman, 2002; 
Wadsworth et al., 2006; Wagner, Becker, Gouzoulis-Mayfrank & Daumann, 2010).  
Deficits for cannabis users compared with drug naïve controls have been reported for 
Trial 1 (Medina et al., 2007), Total recall (Croft et al., 2001; Battisti et al., 2010; 
Solowij et al., 2002; Wagner et al., 2010), and Delayed recall (Wadsworth et al., 
2006) of verbal list learning tasks, although these results have not been consistent 
across all studies, with several reports of no significant differences between cannabis 
users and controls (Medina et al., 2007; Simon & Mattick, 2002; Pope & Yurgelum-
Todd, 1996; Quednow et al., 2006) . Solowij and Battisti (2008) suggest that the 
inconsistent findings are due to variations in age of cannabis use onset and frequency 
and duration of use, the latter of which has recently been identified as being most 
predictive of lower total recall scores for cannabis users (Wagner et al., 2010). 
Nevertheless, there is sufficient evidence to indicate that cannabis related deficits on 
verbal list learning tasks persist after the period of acute intoxication, although the 
magnitude of these effects are considerably smaller than those reported for ecstasy 
use.  
 
The interactive effects of THC and MDMA 
Ecstasy and cannabis are frequently used together, and their combined effects 
may be interactive rather than additive (Croft et al., 2001; Fisk, Montgomery, 
Wareing & Murphy, 2006; Parrot, Gouzouikis-Mayfrank, Riodgers & Solowij, 2004 
). Furthermore, their acute effects have opposing effect on oxidative stress. In 
contrast to MDMA, which has been shown to produce a hyperthermic response in 
humans (Ciohen & Cocolres, 1997; Freedman et al., 2005; Kolbrich et al., 2008; 
Vollenweider et al., 1998) THC has hypothermic properties in rats (Morley, 2004; 
Hampson et al., 1998; Sarne & Mechoulam, 2005) and monkeys (Taffe, 2012). The 
co-administration of MDMA with THC has been shown to prevent MDMA induced 
hyperthermia in rats and monkeys, and to partially prevent the reduction of 
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serotenergic markers in the rat brain (Morley, 2004). These findings have 
contributed to the theory that cannabis may offer some neuro-protective effect in 
recreational ecstasy users (Parrot, 2006). In human participants, co-administration of 
THC and MDMA delayed the onset of MDMA- induced increase in body 
temperature, however it also prolonged the duration of elevated temperature 
(Dumont et al., 2009). Acute co-administration of THC and MDMA has also been 
demonstrated to reduce the lower 2 alpha band of EEG oscillations, which is 
believed to reflect general attentional processes (Lansbergen et al., 2011).  With 
regard to verbal learning and memory, Fisk, Montgomery, Wareing and Murphy 
(2006) investigated the interactive effects of cannabis and ecstasy use using a paired 
associates task. They compared ecstasy users who usually consumed ecstasy and 
cannabis concomitantly with ecstasy-only users and drug naïve controls, and 
reported no significant differences between the ecstasy-plus-cannabis and ecstasy 
only users on any measures of verbal paired associates, and a tendency for the 
ecstasy-plus-cannabis users to perform worse than non-users on initial learning and 
rate of forgetting. At present then, there is little evidence to support the view that 
concomitant cannabis use may protect against cognitive deficits associated with 
ecstasy use, however to date, published studies involving the co-administration of 
cannabis and MDMA in human participants are scarce, leaving the neuro-protective 
hypothesis under-investigated at this time. In summary, when taking into account the 
high proportion of ecstasy users who also smoke cannabis, combined with the 
individual effects of cannabis and ecstasy on verbal memory outcomes and the 
possibility that cannabis has neuro-protective properties, cannabis use will be 
controlled for in the present study by including it as an independent variable.   
 
Examining the effects of poly-substance use on verbal memory 
There has been much conjecture in the ecstasy and memory literature about 
whether ecstasy use is responsible for the observed cognitive deficits in regular 
users, or whether it is the effects of poly-substance use that is impairing cognition.  
Much of this conjecture was based on the methodological difficulties associated with 
cross sectional designs, including pre-morbid differences in estimated IQ, education, 
and most importantly, poly-substance use. This debate was revisited after Halpern 
and colleagues (2010) conducted a study of the cognitive effects of ecstasy use by 
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recruiting participants who had either used or not used ecstasy and who all had very 
minimal exposure to other illicit drugs and alcohol. They used the CVLT to assess 
verbal memory performance, and reported no significant differences between the 
poly-drug –plus- ecstasy group and the poly-drug only group on Immediate (g = -
.04) and Total recall (g = -.12) measures of the CVLT.  Halpern and colleagues 
concluded that by rigorously controlling for the potentially confounding effects of 
other drug use in their sample they failed to demonstrate marked residual cognitive 
deficits in ecstasy users and this might indicate that ecstasy use by itself does not 
produce lasting residual neurotoxicity. To specifically investigate the possibility that 
poly-drug-plus-ecstasy use can account for verbal memory deficits on a list learning 
task, the current study includes four groups; participants who use ecstasy with very 
minimal exposure to other illicit drugs, participants who use ecstasy and cannabis 
with very limited exposure to other illicit drugs, participants who use cannabis only 
and a drug naïve control group. Controlling for poly-substance use in the design of 
the study will therefore allow the effects of poly-substance use on verbal memory to 
be adequately assessed.  
 
Aims of the present study  
To summarise, the present study aims to investigate the underlying multiple 
cognitive processes inherent to performance on list learning tasks that may account 
for verbal memory deficits associated with ecstasy use. To achieve this, 
organisational strategies, encoding, consolidation and retrieval and inter-trial 
forgetting patterns will be examined, and the choice of these measures were 
informed by the Working with Memory model to elucidate the respective roles of the 
prefrontal and medial temporal cortices in list learning performance for ecstasy 
users. In light of recent evidence that suggests it may be poly-substance rather than 
ecstasy use that is responsible for cognitive deficits reported for ecstasy users, the 
present study will specifically investigate this by comparing an Ecstasy-only and 
Ecstasy-plus cannabis (poly-substance group) with a Cannabis-only and a Drug 
naïve group, thus extricating the contributions each drug makes to cognitive 
functioning, as well as their interactive effects. 
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Based on the results of the previous meta-analysis, it was expected that 
people who had used ecstasy would demonstrate poorer performance on Trial 1, 
Total and Delayed recall of both the related and unrelated word list tasks. 
Alternatively, if an Ecstasy x Cannabis interaction is observed, this will be examined 
to ascertain whether poly-substance use is impacting on the memory measures. If 
ecstasy users display lower levels of semantic or subjective organisation relative to 
cannabis users and controls, this would indicate that poor memory scores are partly 
due to impaired frontal functioning.  Alternatively, if ecstasy users have poorer recall 
but are comparable to non-ecstasy users on the organisational measures, this would 
suggest the memory deficits are more associated with memory-pure processes, such 
as encoding, consolidation and retrieval deficits.  Further, if ecstasy users do differ 
from non-ecstasy users on Total and Delayed recall, consideration of gained and lost 
access and levels of forgetting can inform as to whether this is likely due to poor 
encoding/acquisition (low gained access) or consolidation (high lost access) or a 
combination of both.  
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Method 
Participants  
Participants were recruited through advertisements distributed throughout the 
University of Tasmania and through peer-referral. Prospective participants were 
asked to contact the researcher via telephone, and were screened for eligibility. 
Seventy-nine people were recruited for the study and allocated to one of four groups 
based on their drug-use history: an ecstasy-only group (minimum of 10 occasions of 
ecstasy use; at least six in the past six months, minimal use of other illicit drugs), a 
cannabis-only group (minimum of 10 occasions of cannabis use; at least six in the 
past six months, minimal use of other illicit drugs), an ecstasy-plus-cannabis group 
(as for the ecstasy-only and cannabis-only groups), or a drug-naive control group (a 
maximum of five lifetime occasions of illicit drug use; none in the last six months). 
Subsequent examination of demographic and drug-use information resulted in ten 
participants being excluded. Eligible participants were over 18 years of age, of 
normal or corrected-to normal vision, spoke English as their first language, were free 
of pre-existing neurological or psychological disorders, had no psychotropic 
medication use in the month prior to testing, and no other notable history of other 
illicit drug use (exceeding five lifetime doses). 
 
Participants were asked to abstain from ecstasy or cannabis use for three days  
prior to their testing session in order to avoid the residual acute or sub-acute effects 
of these substances. The sub-acute effects of ecstasy intoxication include low mood 
and/or poor concentration and are believed to subside within 72 hours (Parrot & 
Lasky, 1998). The acute psychotropic effects of cannabis are suggested to abate after 
three hours (Grothenhermen, 2003). Additional exclusion criteria therefore included 
reported ecstasy use in the seven days prior to testing, and reported cannabis use in 
the 24 hours prior to testing. 
 
Materials 
A demographic questionnaire was included to ensure equality between the 
groups. Assessment included sex, age, education level, recent caffeine and nicotine 
intake, general medical information (neurological and psychiatric conditions and any 
prescribed medications), and the Karolinska Sleepiness Scale (Guilleminault & 
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Brooks, 2001) to assess current level of fatigue. The Kessler Psychological Distress 
Scale (K10; Kessler & Mroczek, 1992, 1994) was administered to assess levels of 
non-specific psychological distress, and has been demonstrated to possess adequate 
reliability and validity (Andrews & Slade, 2001). The Alcohol Use Disorders 
Identification Test (AUDIT; Saunders, Aasland, Babor, de la Fuente, & Grant, 
1993), which has been shown to be a reliable and valid instrument for assessing 
harmful alcohol consumption (Dawe, Loxton, Hides, Kavanagh, & Mattick, 2002) 
was included to assess problematic alcohol use in the preceding 12 months.  
Lifetime Drug-use Interview procedures (LDU; Czermak et al., 2005) were 
employed to assess the extent of participants’ lifetime drug exposure. Although it 
would have been preferable to have conducted urinary tests to verify self- reported 
drug use, the self-report method of obtaining drug use history for research purposes 
has been shown to have sufficient reliability and validity (Darke, 1998; Harrison, 
Martin, Enev, & Harrington, 2007), and the LDU has been demonstrated to have 
high test-retest reliability (Czermak et al.). Additionally, the Q-score index (Q= 
amount consumed on last two occasions/days since two most recent occasions of 
use) from the Opiate Treatment Index (OTI; Darke, Ward, Hall, Heather, & Wodak, 
1991) was measured to determine a measure of recent ecstasy and cannabis use that 
reflects dose and frequency. The OTI has been demonstrated to be a reliable and 
valid assessment tool (Darke, Ward, Hall, Heather, & Wodak, 1991.).  
 
The WTAR (Wechsler, 2001) is a reading recognition test comprised of 50 
words with irregular pronunciation (e.g. gnome). It has high validity and reliability 
(Ginsberg, Risser, Purisch, Hamilton, & Burns, 2003), and is a strong predictor of 
general intelligence (Green et al., 2008). It was administered to assess between group 
differences in general intellectual functioning, with raw scores converted to age-
normed United Kingdom standard scores. 
 
Non-related list stimuli  
A list of 40 words selected from the Medical Research Council 
Psycholinguistic Database, version 2.0 (Colthart, 1981, available online at 
http://www.psy.uwa.edu.au/mrcdatabase/uwa_mrc.htm) comprised the non-related list 
and Recognition task stimuli. Like the CVLT and RAVLT, all words were concrete 
nouns, with a mean concreteness rating of 569 (range: 471-634). The words had a 
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mean word frequency of 7 per million (range: 1-19 million) according to the Kucera 
and Francis norms (1967). The low level of word frequency was chosen to increase 
the difficulty of recall, as free recall is generally found to be poorer for low 
frequency words (Balota & Chumbley, 1984; Jescheniak & Levelt, 1994). Due to the 
tendency for shorter words to be more easily recalled than longer words (eg. 
Baddely, Thomson & Buchanan, 1975) all words were between 5 and 8 letters long 
(mode: 6). Of these words, twenty were randomly selected as the list stimuli and 
twenty comprised part of the Recognition test.  The list learning tasks were created 
and run in Inquisit (Version 2.0 ). Stimuli are presented in Appendix A. 
 
Related list stimuli 
The related list consisted of 20 concrete nouns, comprising four words from 
each of five semantic categories; geographical features, insects, types of fabric, 
musical instruments, vegetables. The categories and exemplars were chosen from an 
updated version (Van Overschelde, Rawson & Dunlosky, 2004) of the Battig and 
Montague (1969) norms. The words had a mean word frequency of 5 per million 
(range: 1-12 million) and a mean concreteness rating of 599 (range: 574-633). All 
words were between 6 and 9 letters long (mode: 6). Stimuli are presented in 
Appendix A.  
 
List learning and recall procedure 
Task administration was computerised, using an IBM compatible computer 
with a 40 centimetre screen. Before the learning phase of the task, participants were 
informed they were going to be presented with a list of words, and that the aim of the 
task was to try and remember all the words. Following instruction, words were 
presented one at a time, in lowercase, black, Arial, 36 point font in the middle of the 
screen against a white background. Each word remained on the screen for a duration 
of 2000 milliseconds, with an inter-stimulus interval of 250 milliseconds. The order 
of presentation was randomised across each learning trial. At the end of the learning 
phase, the recall phase began, in which participants were asked to recall all the words 
they could remember, in any order they wished. For the unrelated list, this procedure 
was repeated for eight learning and recall phases and for the related list there were 
only five learning and recall phases. Reducing the number of trials for the related list 
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was based on the pilot study in which participants often reached asymptote at Trial 5, 
and due to reports that the overall testing session was fatiguing. Due to the long and 
effortful nature of the task, after the sixth presentation of the unrelated list, 
participants were informed they had two more learning trials until completion.  
 
Delayed recall and Recognition procedure 
Delayed recall and recognition were conducted for the unrelated list only. 
Thirty minutes after the unrelated list task, during which participants performed a 
visual tracking task for a separate study and a letter comparison task (described 
below) participants were reminded of the list of words they had learnt and were 
asked to recall all the words from that list that they could remember. Following 
Delayed recall, the Recognition task commenced. This consisted of the twenty words 
from the non-related list and twenty additional items. Words were presented one at a 
time on the screen, in a randomised order for each participant. Participants were 
informed they were going to be presented with another list of words, and that some 
were from the original list, and some were not. They were instructed to respond YES 
if the word was on the original list and NO if it was not, by pressing the 
corresponding keys on computer the keyboard. Words remained onscreen until the 
participant had responded, after which it was replaced by the next word. Recognition 
accuracy was recorded by the program.  
 
Letter comparison task stimuli and procedure 
The letter comparison task was based on Salthouse’s (1994) version. Stimuli 
for the letter comparison task consisted of 90 pairs of letter strings consisting of 
three, six or nine letters. There were 30 pairs for each string length. Letters were 
presented in black, 26 point, Arial font in the middle of a white screen. One half of 
the pairs were different because of a change in the position or identity of one of the 
letters in one member of the pair.  
Participants were instructed to decide if the two rows of letters were the same 
or different, as quickly and as accurately as possible. The pairs of letter strings were 
presented in 3 blocks of 30, and each block contained strings of the same length. The 
first block consisted of pairs of three letters, the next six and the final consisted of 
nine. Trials within each block were randomised for each participant. Participant 
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responses were made by pressing the corresponding button on the computer 
keyboard and accuracy and reaction times were recorded by the Inquisit program.  
 
Word span task stimuli and procedure 
The word span task (Salthouse & Babcock, 1991) stimuli consisted of 105 
mono-syllabic nouns, all 4-5 letters in length. For the study phase, participants were 
instructed that the aim of the task was to remember the words in the same order as 
they were presented. Words were presented one at a time in black, 36 point Arial 
font in the middle of the screen, for a duration of 1000 milliseconds, with an inter-
stimulus interval of 250 milliseconds. The number of words per trial varied from 2 to 
8, and trial length started at 2 and increased by one word every three trials, thus there 
were three trials of the same length per block. At the end of each trial, participants 
were asked to recall the words in the same order of presentation. The task ceased 
when a participant failed to correctly recall all three trials. Word span was defined as 
the highest series length recalled in the correct order.  
 
Design and data analysis 
A 2 [Ecstasy use: present, absent] × 2 [Cannabis use: present, absent]  
factorial design was used, with ecstasy and cannabis use as the between subjects 
factors and various measures of memory as the dependent variables. The standard 
memory measures are summarised in Table 7.1 below.  For the inter-trial measures, 
the gained access score was defined as the number of words recalled on trial n + 1 
that were not recalled on n, and lost access was defined as the total specific words 
recalled on trial n that were not recalled on trial n + 1. For levels of forgetting, the 
incidence of forgetting was measured at different levels of learning (a level is 
defined as the number of times a specific word had been consecutively recalled.) For 
example, forgetting a word that had been previously recalled once would indicate 
forgetting at level 1, forgetting a word that was recalled twice would be forgetting at 
level 2, and so on.  The frequency of forgetting at each level was summed over all 
trials which provided 7 possible levels of forgetting.  
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Table 7.1 
Descriptions and calculations for Main Memory Measures for List Learning Tasks 
 
Dependent Variable 
 
Calculation Description 
 
Immediate memory 
 
Trial 1 
 
 
Number of words recalled 
after first list presentation 
 
Short term memory for a 
single trial 
Trials 1…8 Number of words recalled on 
each learning trial 
Learning- provides measure 
of the extent to which recall 
improves as the number of 
learning trials increase  
 
Total recalled 
 
 
Sum of all words recalled 
from trials 1 – 8 
 
 
Consolidation, learning and 
retrieval 
Learning over Trials Sum of words remembered 
across trials 1 – 8, corrected 
for immediate word span 
(Total recall – 8 x Trial 1 
score). 
Measure of learning, 
corrected for differences on 
immediate memory span  
Measures of organisation   
 
Bidirectional paired 
frequency+ (Tulving, 1962) 
 
PF =  O(IRT2) – E(IRT2) = 
O(IRT2) – 2c (c - 1) /hk 
 
 
The extent to which a 
subjective organizational 
strategy is used to assist 
recall on a learning trial 
 
 
List based clustering index
#
 
(Stricker, Brown, Wixted, 
Baldo & Delis, 2002) 
 
Measures after delay
^
 
     
            
    
 
 
 
 
 
 
 
The extent to which a 
semantic clustering strategy 
is used to assist word recall 
on a learning trial 
 
Delay 
 
 
Number of words recalled 
after 30 minute delay 
 
 
Long term consolidation and 
retrieval 
 
 
Forgetting rate Number of words recalled at 
Trial 8 minus number of 
words recalled delay 
Number of items forgotten 
during delay, strength of 
consolidation, retrieval 
 
Recognition 
 
 
 
 
 
Number of correctly 
identified targets on 40 item 
recognition  task 
 
Long term memory 
retention/storage. 
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Table notes from previous page:
 +
 Bi-directional pair frequency scores refers to the number of times a 
pair of words appear together over two consecutive trials, regardless of their order of output. O(ITR2) 
represents the number of pairs of items recalled on Trials t and t+1 in adjacent output positions in 
either of two possible orders, E(IRT2) represents the expected number of pairs of items, where c is the 
number of common items recalled on both Trials t and t+1, h is the number of items recalled on Trial 
t, and k is the number of items recalled on Trial t+1 (Tulving, 1962). 
# 
Related list only, where OBS = the number of observed clusters on a trial (a cluster is defined as two 
words from the same category being consecutively recalled). r = the number of correctly words on a 
trial, m = number of semantic categories and NL = number of words on the list (Stricker, Brown, 
Wixted, Baldo & Delis, 2002). 
 
^ 
Unrelated list only.  
 
 
Analyses were conducted using IBM SPSS 20. Demographic and drug use 
history variables were analysed using one-way ANOVAs and chi-square approaches, 
with significant main effects followed up with Tukey post-hoc tests.  Memory 
related measures were analysed using between groups or mixed ANOVA. Where 
repeated measures ANOVAs were used Greenhouse-Geisser adjustments were 
applied to correct for violations of assumptions of sphericity. Planned one-way 
ANOVAs were performed and Bonferoni adjusted as required and significant main 
effects were followed up with Bonferoni adjusted pairwise comparisons. Effect size 
measures (Hedge’s g) were calculated for drug related main effects and were 
classified according to Cohen’s (1969) recommendation; g= 0.20 – 0.49; a small 
effect, g = 0.50 – 0.79; medium effect and g > 0.80; large effect. Dose dependence 
was ascertained using bivariate correlations between the memory variables of 
interest and drug use measures. If dose dependence was found for drugs other than 
ecstasy ANCOVA was conducted to determine whether the ecstasy-related effects 
remained after the influence of other drug use was taken into account. Where the 
other drugs were not a significant covariate the unadjusted analyses are retained.  
 
 
 
Results 
 
Demographic  variables 
To reduce the possibility of confounds to the memory analyses, groups were 
compared on a number of demographic variables (Table 7.2). The groups did not differ 
significantly on the demographic variables of sex, age, level of psychological distress 
as measured by the K10, fatigue at time of testing as measured by the Karolinska 
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Sleepiness Scale, caffeine and nicotine intake on the day of testing, and general 
intellectual functioning as measured by the WTAR. Groups did significantly differ on 
commencement of tertiary study, the ecstasy plus cannabis group had fewer 
participants who had commenced tertiary education compared with the ecstasy only, 
cannabis only and drug naïve groups, although the ecstasy only and cannabis only 
groups had more participants who had commenced tertiary education compared with 
the drug naïve group. In summary, with the exception of commencement of tertiary 
education, the groups did not differ on any demographic variables, indicating that any 
differences between groups on memory performance would not be due to age, sex, 
mental health status, fatigue, acute effects of caffeine and nicotine or general 
intellectual functioning.   
 
Drug-use variables 
The experimental groups were compared on days of use in the past six months 
and total occasions of use for various illicit drugs. For ecstasy use, additional 
comparisons for the most pills used on one occasion and estimated lifetime total dose 
was also assessed to ascertain if a dose-response relationship may be present (Bolla, 
McCann, & Ricaurte, 1998). For ecstasy and cannabis use, a measure of recent 
consumption (frequency and amount used on the last three occasions, measured using 
the OTI Q-score method: dividing the amount consumed on the previous two 
occasions by the time period between them) was also obtained (see Tables 7.2 – 7.8).   
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Table 7.2  
Group Percentages, Means, Standard Deviations and ANOVA Results for Demographic Variables 
Control variable Drug naïve 
control (n=20) 
Cannabis-only 
(n=15)  
Ecstasy-only 
 (n=16) 
Ecstasy-plus-
cannabis 
 (n=17) 
 
F p 
Sex (% female) 
 
52.4% 40% 56.3% 47.1% χ² = 0.94 .81 
Level of Education  (% 
commenced tertiary) 
 
57.1 66.7 68.8 47.1 χ² = 25.29 .001 
Age (years) 
 
25.3(7.9) 24.2 (5.2) 22.9 (2.2) 21.2 (2.3) 2.1 .11 
Level of Psychological 
Distress (K10) 
 
19.2 (5.6) 17.1 (5.7) 17.8 (5.6) 19.8 (7.1) 0.6 .56 
Fatigue (Karolinska 
Sleepiness Scale) 
 
4.00 (1.4) 3.6 (1.50) 3.75 (1.39) 4.6 (1.7) 1.3 .27 
Caffeine Intake  
 
1.07 (1.4) 0.6 (0.6 0.81 (1.2) 0.4 (0.7) 1.2 .31 
Nicotine Intake 
 
0.14 (0.4) 0.6 (1.7) 0.73 (1.5) 0.4 (1.0) 0.8 .49 
General  Intellectual 
Functioning (WTAR) 
 
109.6 (11.1) 112.8 (11.2) 109.5 (8.7) 107.6 (12.3) 0.6 .59 
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Table 7.3 
Group Means, (Standard Deviations) and ANOVA Results for Ecstasy 
Drug  
 
Drug naïve 
control 
 (n=20) 
Cannabis-only 
(n=15)  
Ecstasy-only 
 (n=16) 
Ecstasy-plus-
cannabis 
 (n=17) 
 
F p 
Ecstasy 
 
n
+
 = 0 n
+
 = 8 n
+
 = 16 n
+
 = 17   
Days used in past 6 
months  
0.00 0.00 13.69 (7.09) 16.12 (11.42)   
Period of abstinence 
(days) 
 
 
 
n/a 1124.9 (1623.0) 25.44 (21.65) 16.06 (12.24)   
Number of pills used 
per session 
 
n/a n/a   1.75 (0.68) 2.76 (1.97)   
Total occasions of use  
 
n/a 1.47 (2.03) 68.38 (60.98) 64.65 (39.18)   
Lifetime total 
 dose  
 
n/a 1.86 (3.22) 130 (164.12) 162.41 (153.08   
Extent of recent use 
(OTI Ecstasy) 
 
n/a   n/a   0.19 (0.18) 0.26 (0.40)   
Note: + number within group with lifetime use in the particular drug class (however total n was used in the generation of means and SDs). F and p values refer to one-way ANOVAs 
comparing the 4 groups 
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Table 7.4 
Group Means, (Standard Deviations) and ANOVA Results for Cannabis 
Drug  
 
Drug naïve 
control 
 (n=20) 
Cannabis-only 
(n=15)  
Ecstasy-only 
(n=16) 
Ecstasy-plus-
cannabis 
 (n=17) 
 
F p 
Cannabis 
 
n
+
 = 8 n
+
 =  15 n
+
 = 14 n
+
 = 17   
Days used in past 6 
months 
 
 
0.00 39.07 (34.78) 0.38 (.71) 49.76 (36.79)   
Period of abstinence 
(days) 
 
 
2247.78 (1598.71) 11.67 (16.35) 460.43 (451) 6.71 (4.98) 25.92 <.001 
EC, C, E < N 
Total occasions of use 
 
1.43 (2.08) 1372.07 (1723.28) 144.06 (406.73) 648.29 (1282.09) 5.85 .001  
C, EC, > E, N 
Extent of recent use  
(OTI Cannabis) 
 
n/a 1.80 (2.06) n/a 1.27 (1.63)   
CUDIT  
 
n/a 21.20 (11.87) n/a 25.29 (18.35)   
Usually use cannabis 
with ecstasy
Ө
 (% yes) 
 
n/a 0% 0% 82.4%   
Note: 
+
 number within group with lifetime use in the particular drug class (however total n was used in the generation of means and SDs). F and p values refer to one-way ANOVAs 
comparing the 4 groups 
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Table 7.5 
Group Means, Standard Deviations and ANOVA Results for Stimulants 
Drug Drug naïve 
control 
 (n=20) 
Cannabis-only 
(n=15)  
Ecstasy-only 
(n=16) 
Ecstasy-plus-
cannabis  
(n=17) 
 
F p 
Amphetamines
 
 
n
+
 = 1 n
+
 = 4 n
+
 = 14 n
+
 = 14   
Days used in past 6 
months 
 
 
0.00 0.00 0.69 (0.87) 1.12 (1.40)   
Total occasions of use 
 
0.14 0.60 (1.35) 5.06 (6.19) 4.71 (5.56) 7.03 <.001 
E, EC > C, N 
Pharmaceutical 
Stimulants 
 
n
+
 = 0 n
+
 = 2 n
+
 = 3 n
+
 = 6   
Days used in past 6 
months 
 
 
0.00 0.13 (0.51) 0.00 .35 (0.99)   
Total occasions of use 
 
0.00 0.67 (2.09) 2.56 (7.72) 3.65 (9.76) 1.33 .271 
Cocaine 
 
n
+
 = 0 n
+
 = 6 n
+
 = 9 n
+
 = 7   
Days used in past 6 
months 
 
 
0.00 0.27 0.50 (0.89) 0.29 (0.58) 1.56 .206 
Total occasions of use 
 
0.00 3.20 (10.41) 3.38 (5.26) 2.65 (6.29) 1.22 .308 
Note: 
+
 number within group with lifetime use in the particular drug class (however total n was used in the generation of means and SDs). F and p values refer to one-way ANOVAs 
comparing the 4 groups 
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Table 7.6 
Group Means, Standard Deviations and ANOVA Results for Inhalants, LSD, Mushrooms and Ketamine.  
Drug Drug naïve 
control 
 (n=20) 
Cannabis-only  
(n=15)  
Ecstasy-only  
(n=16) 
Ecstasy-plus-
cannabis  
(n=17) 
 
F p 
Inhalants  
 
n
+
 = 1 n
+
 = 5 n
+
 = 8 n
+
 = 14   
Days used in past 6 
months 
 
 
0.00 0.00 1.38 (4.99) 5.24 (7.86)   
Total occasions of use 
 
0.05 (0.21) 3.40 (7.99) 5.25 (10.71) 32.06 (71.45) 2.92 .041 
EC > N 
LSD  
 
n
+
 = 0 n
+
 = 6 n
+
 = 6 n
+
 = 11   
Days used in past 6 
months 
 
 
0.00 0.40 (1.54) 0.81 (2.10) 1.59 (1.77)   
Total occasions of use 
 
0.0 4.07 (7.32) 2.25 (4.55) 3.35 (5.25)   
Mushrooms 
 
n
+
 = 3 n
+
 = 9 n
+
 = 6 n
+
 = 9   
Days used in past 6 
months 
 
 
0.00 0.40 (0.82) 0.25 (0.77) 1.94 (4.16)   
Total occasions of use 
 
0.14 (0.35) 2.67 (5.08) 1.25 (2.04) 7.24 (11.99) 4.13 .010 
EC > C, E, N 
Ketamine 
 
n
+
 = 0 n
+
 = 0 n
+
 = 3 n
+
 = 3   
Total occasions of use 
 
0.00 0.00 0.56 (1.75) 0.41 (1.22)   
Notes: 
+
 number within group with lifetime use in the particular drug class (however total n was used in the generation of means and SDs). No ketamine use in previous 6 months 
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Table 7.7 
Group Means, Standard Deviations and ANOVA Results for Tobacco and Alcohol 
Drug Drug naïve 
control 
 (n=20) 
Cannabis-only 
(n=15)  
Ecstasy-only 
(n=16) 
Ecstasy-plus-
cannabis  
(n=17) 
 
F p 
Tobacco 
 
n
+
 = 10 n
+
 = 11 n
+
 = 14 n
+
 = 13   
Days used in past 6 
months 
 
 
20.67 (54.11) 61.93 (77.88) 48.88 (69.80) 76.35 (81.76) 2.14 .104 
Total occasions of use 
 
311.76 (699.53) 1023 (1714) 777.13 (1119.35) 641.35 (976.29) 1.20 .313 
Alcohol 
 
n
+
 = 20 n
+
 = 15 n
+
 = 16 n
+
 = 17   
Days used in past 6 
months 
 
 
32.14 (33.14) 50.40 (35.15) 34.94 (26.34) 46.47 (28.64) 1.39 .253 
 
Total occasions of use 
 
611.48 (690.60) 1150.27 (1743.38) 612.56 (444.12) 560.18 (523.54) 1.32 .273 
Problematic Alcohol 
Use (AUDIT) 
 
5.24 (4.34) 11.93 (5.66) 11.13 (7.37) 15.75 (6.48) 9.93 .001 
E, EC, C > N 
Note: 
+
 number within group with lifetime use in the particular drug class (however total n was used in the generation of means and SDs). F and p values refer to one-way ANOVAs 
comparing the 4 groups 
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Table 7.8 
Group Means, (Standard Deviations) and ANOVA Results for Antidepressants, Benzodiazepines and Other Opiates 
Drug Drug naïve 
control 
 (n=20) 
Cannabis-only 
(n=15)  
Ecstasy-only 
 (n=16) 
Ecstasy-plus-
cannabis  
(n=17) 
 
F p 
Antidepressants 
 
n
+
 = 1 n
+
 = 1 n
+
 = 4 n
+
 = 1   
Days used in past 6 
months 
Δ 
 
0.0 0.0 2.5 (0.10) 0.0   
Total occasions of use 
 
2.8 (13.09) 12.1 (46.99) 36.8 (98.74) 0.1 (0.24) 1.68 .179 
Benzodiazepines 
 
n
+
 = 5 n
+
 = 3 n
+
 = 9 n
+
 = 10   
Days used in past 6 
months 
Δ 
 
0.0 0.4 (1.55) 0.5 (0.96) 1.6 (2.80)   
Total occasions of use 
 
3.0 (13.05 3.3 (10.30) 9.1 (27.11) 2.1 (2.92) 0.66 .575 
Other Opiates 
 
n
+
 = 0 n
+
 = 4 n
+
 = 0 n
+
 = 5   
Total occasions of use 
 
0.0 0.5 (1.55) 0.0 0.3 (.84) 1.26 .291 
Note: 
+
 number within group with lifetime use in the particular drug class (however total n was used in the generation of means and SDs). No opiate use in previous 6 months. 
F and p values refer to one-way ANOVAs comparing the 4 groups 
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Consistent with selection criteria for group allocation, there were significant 
differences between groups in their ecstasy and cannabis use. For ecstasy use, the 
Ecstasy-only and Ecstasy-plus cannabis groups did not differ significantly on the 
number of days they had used in the last 6 months, number of days since last used, 
extent of recent use, total occasions used and lifetime dose, and both the ecstasy 
groups were significantly higher on these variables compared with the Cannabis-only 
and drug naïve control groups. For cannabis use, the Cannabis-only and Ecstasy-plus 
cannabis groups did not significantly differ on number of days used in the past 6 
months and total occasions of use, and both groups reported significantly higher 
frequency of use compared with the Ecstasy-only and drug naive groups. The 
Cannabis-only and Ecstasy-plus cannabis groups were also well matched on CUDIT 
and OTI scores for cannabis use.   
 
For cocaine, pharmaceutical stimulant, ketamine, tobacco, antidepressant, 
alcohol and opiate use the differences between groups were non-significant. There 
were also no differences between groups for total occasions of LSD and 
benzodiazepine use. For problematic alcohol use, Tukey post hoc testing showed the 
ecstasy, Cannabis and Ecstasy-plus cannabis groups all scored significantly higher 
than the drug naïve controls. 
  
The Ecstasy-only, Cannabis-only and Drug naïve groups were well matched 
for the number of days they had used amphetamines, LSD, mushrooms, inhalants and 
benzodiazepines in the last 6 months and for total occasions of inhalant, mushroom 
and amphetamine use. The Ecstasy-plus cannabis, Ecstasy-only and Cannabis-only 
groups did not significantly differ on past 6 month use of LSD, benzodiazepines and 
mushrooms, however the Ecstasy-plus cannabis group reported more use of these 
drugs in the past 6 months compared with the Drug naïve controls. This poly-drug 
group had also used more inhalants in the last six months (an average of five 
occasions) compared with the Cannabis-only and Drug naïve groups who reported no 
inhalant use in the preceding 6 months.  
 
Mushroom use was low for all groups; the Ecstasy-plus cannabis group 
reported an average of 7 occasions of lifetime use compared with an average of 1 
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occasion of use for the Ecstasy-only group. The total occasions of amphetamine use 
was also higher for the ecstasy and Ecstasy-plus cannabis groups relative to the 
Cannabis and Drug naïve groups, although again, overall use of amphetamines was 
quite low, both the Ecstasy-only and Ecstasy-plus cannabis groups had used 
amphetamines an average of 5 times in their lifetime.  Overall, due to the low 
frequency of drug use other than ecstasy or cannabis in this group of participants, 
particularly within the preceding six months, these differences are minimal. 
 
 
List learning analyses- between lists 
To investigate the effects of ecstasy consumption on verbal memory across 
the two different list types, a 2 (Ecstasy; present, absent)  2 (Cannabis; present, 
absent)  2 (List; non-related, related)  5 [Trial; 1-5] mixed ANOVA was 
performed. As expected, the effect of List type was significant, F(1, 64) = 122.25, p 
<.001, g = 1.52, with participants recalling significantly more words per trial on the 
related list (M = 14.44, SD = 1.70) compared with the unrelated list (M = 11.81, SD 
= 1.70). Similarly, the effect of Trial was significant, with participants recalling 
significantly more words as the number of learning trials increased, F(4, 256) = 
390.72, p < .001. 
 
There was a significant and large magnitude main effect of Ecstasy, F(1, 64) = 19.8, 
p <.001, g = -1.07, with ecstasy users recalling significantly fewer words than non-
ecstasy users across both lists. There was no significant interaction between Ecstasy 
and Cannabis (F (1, 64) = 1.26, p = .26). The List  Ecstasy interaction was also 
non-significant, F(1, 64) = 1.53, p = .22, indicating that the lower recall scores for 
ecstasy consumers were consistent for the two list types. Figure 7.1 shows the mean 
number of words recalled per trial for ecstasy users compared to non-ecstasy users 
across both lists. 
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Figure 7.1 Mean number of words recalled per trial between the related and 
unrelated lists for ecstasy and non-ecstasy users (error bars represent standard 
errors.)  
  
In contrast, the lower recall scores for ecstasy users were not consistent 
across all learning trials as evidenced from the significant Trial  Ecstasy 
interaction, F(1, 256) = 2.93, p = .04.  To ascertain the nature of this interaction, a 
series of one way Bonferroni-adjusted ANOVAs compared the mean trial recall 
scores (averaged between lists) for Ecstasy-present and Ecstasy-absent groups at 
each trial. As shown in Figure 7.2, ecstasy users had significantly lower recall scores 
across all learning trials with the exception of Trial 1. Ecstasy use was not involved 
in any other higher order interactions, with Ecstasy   Cannabis  List   Trial, 
F(4, 256) = 0.15, p= .95,  Ecstasy  Cannabis  List, F(1, 64) = 0.46, p = .50, 
Ecstasy  Cannabis  Trial (F (1, 64) = 0.43, p = .70), Ecstasy List Trial, F(4, 
256) = 0.16, p = .95, all failing to reach statistical significance.
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Figure 7.2. Mean number of words recalled between the unrelated and the related list 
for each trial as a function of the presence and absence of ecstasy use (error bars 
represent standard errors.)  
  
 
The main effect of Cannabis was not significant, F(1, 64) = .48, p = .49, g = -
.17, and power analysis revealed that 1090 participants would have been required to 
reliably (Power = .8) identify an effect of this magnitude as significant. The 
Cannabis List, F(1,64) =.09, p=.76, Cannabis Trial, F(4,256) = .42 p=.71, and 
Cannabis List Trial interactions, F(4, 256) = .68, p =.59, were also non-
significant.  
 
Summary 
Overall, as would be anticipated, more words were correctly recalled on the 
semantically related compared with the unrelated list and more words were recalled 
as the number of learning trials increased. Importantly, ecstasy users recalled fewer 
words than non-ecstasy users across all bar the first trial, in which all participants 
recalled a similar number of items. These ecstasy related differences occurred 
regardless of the comorbid presence or absence of cannabis use. List type was not 
involved in any drug related interactions, indicating that ecstasy users performed 
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more poorly regardless of whether the list possessed categorical properties that could 
assist with recall. Given the lack of list-related interactions, the unrelated and related 
lists were each analysed separately to investigate several dependent variables, some 
of which are specific to each list type. Treating the lists separately also allows finer 
grained, trial by trial analyses to be conducted, to examine whether words were lost 
or gained from one trial to the next.  
 
 
Unrelated list, traditional measures: The effects of ecstasy use on memory for 
unrelated words, using a list learning paradigm.  
 
To examine the learning curve for each of the groups, the number of words 
recalled on the unrelated list task was first analysed using a 2 (Ecstasy; present, 
absent)  2 (Cannabis; present, absent)  8 [Trial; 1-8] mixed ANOVA. As 
predicted, the within subjects effect of Trial was significant, F(7,64) = 230.62, p  
<.001 and Bonferroni-adjusted pairwise comparisons showed the number of words 
correctly recalled by participants overall significantly increased between trials 1 to 4, 
did not differ significantly between trials 4 and 5, 5 and 6, and 6 and 7, and increased 
significantly between trials 7 and 8. 
 
The main effect of Ecstasy was significant and large in magnitude, F(1, 64) = 
14.87, p = <.001, g = .92, with ecstasy users recalling significantly less words 
averaged across trials (M = 12.45, SD = 2.18), than non-ecstasy users (M = 14.51, SD 
= 2.21). This effect was independent from the effects of Cannabis as evidenced by 
the non-significant Ecstasy  Cannabis interaction, (F (1, 64) = 2.01, p = .16. There 
was no significant Ecstasy x Trial interaction (F (4, 64) = 1.47, p = .20) which 
indicates that ecstasy users recalled fewer words than non-users on each learning 
trial. As can be seen in Figure 7.3, the profiles for the ecstasy users and non-users are 
similar, with the only difference between the learning curves being the number of 
words correctly recalled for each trial. 
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Figure 7.3. Mean number of words recalled on each trial of the unrelated list based 
as a function of status of ecstasy use (error bars represent standard errors.)  
 
 
There was no effect of Cannabis on number of words recalled overall across 
trials, F(1, 64) = .33, p = .56, g = .14, and power analysis revealed that 1604 
participants would have been required to reliably (Power = .8) identify an effect of 
this magnitude as statistically significant. The Cannabis  Trial, F (4, 64) = .52, p = 
.75, and Trial  Cannabis  Ecstasy, F (4, 64) = .20, p = .96, interactions were all 
non-significant.  
 
Immediate memory and learning measures for the unrelated list 
To further investigate immediate memory, learning variables and delayed 
recall, a series of 2 (Ecstasy; present, absent)  2 (Cannabis; present, absent) 
ANOVAs were performed with Cannabis (present, absent) and Ecstasy (present, 
absent) as the between subjects factors and the memory measure as the dependent 
variable. The results from the univariate analyses for the unrelated list are 
summarized in Table 7.9 below. As can be seen, there were no significant Cannabis 
main effects or Ecstasy   Cannabis interactions. However four significant effects of 
Ecstasy were found.  
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As shown in Table 7.9, there was no significant main effect of Ecstasy for 
Trial 1, although there was some indication of a small magnitude effect, g = -.36, 
with ecstasy users (M = 6.18, SD = 2.54) to perform more poorly than non-users (M 
= 7.12, SD = 2.57). As shown in Figure 7.4, for Total Recall across all learning trials, 
the Ecstasy users recalled significantly fewer words (M = 99.61, SD = 17.46) 
compared with the non-ecstasy users (M = 116.05, SD = 17.62), a large magnitude 
effect, g = -.92. The Learning over Trials (LOT) measure also provided a measure of 
total recall however it takes into account differences on immediate memory (Trial 1). 
As seen in Figure 7.5, The ecstasy users performed significantly poorer (M = 50.12, 
SD = 16.14) on LOT than the non-ecstasy users (M = 59.05, SD = 16.32) although 
this effect, g = -.54, was smaller in magnitude compared with the Total Recalled 
score once differences on Trial 1 had been considered.  
 
Measures of retention; delayed recall, recognition and forgetting rate 
As seen in Figure 7.6 the ecstasy users recalled significantly fewer words 
after the 25 minute delay (M = 13.29, SD = 3.21) relative to the non-ecstasy users (M 
= 16.64, SD = 3.25), and the effect size for this difference was large, g = -1.02. As 
seen in Figure 7.7, the corresponding Forgetting Rate scores indicated that the 
ecstasy users lost significantly more words between the final learning trial (Trial 8) 
and the Delayed recall relative non-users. Notably, these effects were independent of 
the presence of cannabis use. Indeed, for the non-significant main effect of Cannabis 
on delayed recall score, and power analysis revealed that 972 participants would be 
required to reliably identify an effect of this magnitude (g = .18) as significant. There 
were no drug related effects for Recognition, with all groups correctly identifying an 
average of 39 out of a possible 40 items (Ecstasy-present: M = 39.60, SD = .72, 
Ecstasy-absent: M = 39.72, SD = .73, g = .15). Additionally there were no significant 
differences between ecstasy users and non-users in false alarm rate on the 
recognition tests, F (1, 64) = .08, p = .75. 
Table 7.9 
Means, (Standard Deviations) and 2 (Ecstasy; Present, Absent)  2 (Cannabis; Present, Absent) ANOVA Results for Memory Measures 
on the Unrelated List Learning Task 
 Descriptives  ANOVA 
Measure Drug Naïve 
Controls 
(n=20) 
Cannabis only 
(n=15) 
Ecstasy only 
(n=16) 
Ecstasy and 
Cannabis 
(n=17) 
 Cannabis Ecstasy Ecstasy 
Cannabis 
  F p F p F p 
Trial 1 7.85 (3.31) 6.40 (2.50) 6.31 (2.08) 6.06 (1.81)  1.88 .175 2.29 .135 0.92 .339 
Total Recall 
120.30 
(13.68) 
111.80  
(15.60) 
97.81  
(21.13) 
101.41 
(19.15) 
 
0.33 .567 14.87 .001 2.01 .161 
Delay 17.55 (2.37) 15.73 (3.19) 13.00 (3.38) 13.59 (3.9)  0.60 .438 18.09 .001 2.33 .131 
Forgetting Rate 0.45 (1.67) 2.0 (2.56) 2.87 (2.65) 2.82 (2.10)  1.88 .175 8.84 .004 2.15 .148 
Recognition 39.85 (0.48) 39.60 (0.82) 39.50 (1.03) 39.71 (0.47)  0.22 .884 0.52 .475 1.765 .190 
Learning Over 
Trials 
57.50 (17.95) 60.60 (12.84) 47.31 (16.73) 52.94 (16.03) 
 
1.22 .273 5.11 .027 0.10 .750 
Subjective 
Clustering 
16.23 (8.03) 13.66 (8.92) 8.52 (5.96) 9.05 (6.18) 
 
1.53 .221 5.46 .023 3.15 .081 
Note: Degrees of Freedom for F are 1, 64 for all analyses 
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Figure 7.4. Mean total words recalled across the eight unrelated word list trials, for ecstasy 
and non-ecstasy users (error bars represent standard errors.)  
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 Figure 7.5. Mean learning over trials for ecstasy and non-ecstasy users (error bars represent 
standard errors.) 
 Chapter 7. Study 2. Effects of ecstasy on cognitive processes in multi-trial word recall 
 
  121 
 
No Yes
Ecstasy
0
5
10
15
20
N
u
m
b
e
r 
o
f 
w
o
rd
s
 r
e
c
a
lle
d
 a
t 
d
e
la
y
 
Figure 7.6. Mean words recalled in the delay trial for ecstasy and non-ecstasy users (error 
bars represent standard errors.)  
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Figure 7.7. Mean forgetting rate for ecstasy and non-ecstasy users (error bars represent 
standard errors.)
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Is ecstasy use associated with reduced ability to engage in subjective clustering? 
 
In addition to the learning measures described above, a measure of subjective 
organisation was included to assess the degree to which participants organised the 
words in a manner that would assist their recall.  A 2 (Ecstasy; present, absent)   2 
(Cannabis; present, absent) ANOVA with the mean subjective clustering index for 
the eight learning trials as the dependent variable showed a significant main effect of 
moderate magnitude for ecstasy F (1, 68) = 4.89, p = .03, g = -.53, with the Ecstasy-
present group clustering less (M = 9.02, SD = 7.55) than the Ecstasy-absent group (M 
= 13.4, SD = 7.57). There were no significant effects for Cannabis (F (1, 68) = 2.70, 
p = .37) or for the Cannabis x Ecstasy interaction (F (1, 68) = 2.7, p = .11). These 
results indicate that ecstasy users failed to utilize strategic processing of the 
subjective similarities of the list items to the same extent as non-ecstasy users.  
In addition to examining the subjective clustering index over the learning trials, the 
extent to which participants used this strategy to assist with delayed recall was also 
assessed.  2 (Ecstasy; present, absent)   2 (Cannabis; present, absent) ANOVA 
with the mean subjective clustering index for Delayed recall as the dependent 
variable showed a significant main effect for Ecstasy F (1, 67) = 7.37, p = .009, g = -
.65 ) a non-significant effect of  Cannabis F (1, 67) = .42, p = .52, g = .15 ) and a 
significant interaction between these variables F (1, 66) = 9.01, p = .004 (Figure 
7.8). Univariate breakdown analyses showed that the Drug naïve group clustered 
significantly more than the Ecstasy-only group, F (1, 34) = 16.85, p <.001, g = 1.31), 
however for those participants that used cannabis, there was no difference in 
clustering as a function of ecstasy use, F (1, 32) = .040, p = .84, g = .06, and for the 
Ecstasy-present group there was a trend for subjective clustering at Delayed recall to 
be influenced by a moderate effect of cannabis use, F (1, 32) = 3.48 p = .07, g = -.62. 
These results suggest that ecstasy and cannabis use are associated with poor 
engagement of subjective organisation at delayed recall.  
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Figure 7.8. Mean rate of subjective organisation as a function of Ecstasy and 
cannabis use at Delayed recall (error bars represent standard errors.) 
 
Summary 
These results indicate that although both ecstasy users and non-users are 
improving their recall scores as a consequence of multiple list presentations, ecstasy 
users are taking longer to obtain a consistently high level of recall compared with 
non-users. Thus, although ecstasy users’ scores do improve as the number of trials 
increase, they remain significantly lower than the others groups and would require a 
greater number of trials to achieve a level of recall that is comparable to the non-
ecstasy users. Moreover, the overall impairment in verbal learning among ecstasy 
users is of considerable magnitude. Similarly the measure of forgetting rate indicated 
ecstasy users are performing significantly poorer than non-users, suggesting that in 
addition to learning fewer words over the eight trials, ecstasy users are also 
forgetting more words between the final learning trial and delayed recall. Finally, the 
inclusion of the subjective organisation measure provides valuable information 
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which suggests that the lower recall scores for ecstasy users may be a consequence 
of their lack of self- initiated organisation of the presented words.  
 
Related list, traditional measures: The effects of ecstasy use on memory for related 
words. 
To examine the learning curve for each of the groups, the number of words 
recalled on the unrelated list task was first analysed using a 2 (Ecstasy; present, 
absent)  2 (Cannabis; present, absent)  8 [Trial; 1-5] mixed ANOVA. There was 
as expected, a significant main effect of Trial, F(4, 64) = 204.72, p <.001, with 
Bonferroni-adjusted pairwise comparisons showed that as the number of learning 
trials increased, so did the number of words recalled. 
 
There was no effect of Cannabis on the related learning trials, F(1, 64) = .33, 
p = .56, g = .14, and power analysis revealed that 1604 participants would have been 
required to reliably (Power = .8) identify an effect of this magnitude as significant. 
The Cannabis  Trial, F(4, 64) = .52, p = .75, and the Trial  Cannabis  Ecstasy 
interactions, F(4, 64) = .20, p = .96, were also statistically non-significant. 
 
The main effect of Ecstasy was significant and of large magnitude, F(1, 64) = 
20.23, p <.001, g = 1.1) with ecstasy users recalling fewer words on average (M = 
13.11, SD = 2.43) than non-ecstasy users (M = 15.78, SD = 2.46). This large effect 
for the Ecstasy-present group was independent of the effects of other drugs, with the 
Cannabis  Ecstasy interaction failing to achieve significance, F (1, 64) = 2.01, p = 
.16.   
 
The Trial  Ecstasy interaction was not significant, F(4, 64) = 1.25, p = .29, 
indicating that the learning curve profiles for ecstasy users and non-users have 
similar patterns. However, inspection of Figure 7.9, which shows recall across the 
five learning trials, indicates that although the ecstasy users are improving recall on 
the later learning trials, they are not achieving a recall response that is comparable to 
the non-ecstasy users.  
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Figure 7.9. Mean number of words recalled for each trial of the related list for 
ecstasy users and non-users (error bars represent standard errors.)  
 
Immediate Memory and Learning Variables 
As per the unrelated list, scores on Trial 1, Total Recall and Learning over 
Trials (LOT) were calculated for the related list, and subjected to a 2 (Ecstasy; 
present, absent) x 2 (Cannabis; present, absent) ANOVA. These results are presented 
in Table 7.10.
Table 7.10 
Means, (Standard Deviations) and 2 (Ecstasy; Present, Absent)  2 (Cannabis; Present, Absent) ANOVA Results for Memory Measures 
on the Related List Learning Task 
 Descriptives  ANOVA 
Measure Drug Naïve 
Controls 
(n=20) 
Cannabis only 
(n=15) 
Ecstasy only 
(n=16) 
Ecstasy and 
Cannabis 
(n=17) 
 Cannabis Ecstasy Ecstasy 
Cannabis 
  F p F p F p 
Trial 1 9.95 (4.12) 9.80 (3.91) 7.88 (3.26) 8.29 (2.59)  0.02 .877 4.28 .042 0.10 .743 
Total Recall 80.75 (8.42) 77.07 (11.61) 65.19 (14.68) 65.88 (13.71)  0.25 .616 20.29 <.001 0.54 .464 
Learning Over 
Trials 
31.00 (13.50) 28.06 (11.03) 25.81 (11.46) 24.41 (11.15)  0.55 .460 2.30 .134 0.06 .793 
Semantic 
Clustering 
7.84 (2.35) 7.08 (2.79) 5.15 (2.36) 4.71 (2.76)  0.90 .23 16.37 <.001 0.06 .80 
Note: Degrees of Freedom for F are 1, 64 for all analyses 
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The main effect of Cannabis was not significant for any of the related list 
measures. For Total recall, the dependent measure with the largest effect size, the 
cannabis effect was small in magnitude, g = -.18, and power analysis showed that 
980 participants would be required to reliably detect a difference of this small 
magnitude as significant. As shown in Table 7.10, Cannabis was also not involved in 
any significant interactions.  
 
In contrast to the unrelated list performance, on the related list ecstasy users 
recalled significantly fewer words at Trial 1 (M = 8.08, SD = 3.55) than non-users 
(M = 9.87, SD = 3.58), although this effect size (g = -.49) was relatively modest 
compared with some of the other measures. The magnitude of this effect was similar 
to that identified for unrelated words (g = -.36). To examine whether the effect of 
ecstasy on Trial 1 performance was generalised across lists or reflecting a particular 
impairment when categorical properties are present in a word list, a an Ecstasy  
Cannabis  List Type ANOVA was performed with Trial 1 as the dependent 
variable. The main effect of Ecstasy was significant, F(1,64) = 3.98, p =.050, with 
ecstasy users performing more poorly than non-users overall, though this effect was 
regardless of List type, with the Ecstasy x List type interaction, shown in Figure 
7.10, not significant, F(1,64) = 1.85, p =.18. There was no significant Cannabis 
(p=.60) main effect nor, Cannabis  List Type (p=.12), Cannabis  Ecstasy (p = 
.52), or Cannabis  Ecstasy  List Type interactions (p =.62).   
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Figure 7.10. Mean number of words recalled for Trial 1 for ecstasy users and non-
users on the related and unrelated word lists (error bars represent standard errors.)  
 
Returning to performance on the related word list, there was a very large and 
significant effect of Ecstasy on the total number of words recalled, with ecstasy users 
(M = 65.53, SD = 12.12) recalling fewer words than non-users (M = 78.90, SD = 
12.24, g = -1.10. However, there was no statistically significant effect of Ecstasy on 
the Learning over Trials score, F (1, 68) = 2.30, p =.134, g = -.36, despite ecstasy 
users scoring significantly lower on this index for the nonrelated list (g = -.54).  LOT 
provides an index of the extent to which participants benefit from repeated list 
presentations, relative to Trial 1 performance. As such, the absence of the usual 
ecstasy related effect may be attributable to ecstasy users benefitting to the same 
extent as the non-ecstasy users on the related list. However, as the LOT measure is 
calculated by subtracting five times the Trial 1 score from the total recall, and the 
ecstasy present group’s Trial 1 score was significantly lower than the ecstasy-absent 
group’s score, the lack of ecstasy related effect may be reflective of their lower Trial 
1 score.   
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Is ecstasy use associated with reduced ability to engage in semantic clustering? 
 
ANOVA with the mean list based clustering index for the five learning trials 
as the dependent variable showed a significant main effect of large magnitude for 
Ecstasy F (1,64) = 16.37, p<.001, g = -.97, with the Ecstasy-present group clustering 
less (M = 4.93, SD = 2.56) than the Ecstasy-absent group (M = 7.46, SD = 2.59) 
overall. There were no significant effects for Cannabis (F (1, 64) = .90, p = .34, g = 
.23) or for the Cannabis x Ecstasy interaction (F (1, 64) = .06, p = .80).  These 
results indicate that ecstasy users failed to utilize strategic processing of the semantic 
properties of the related list items to the same extent as non-ecstasy users, suggesting 
impaired functioning of frontal systems.  
 
Summary 
These results indicate that as with the unrelated list, although both ecstasy 
users and non-users are improving their recall scores as a consequence of multiple 
list presentations, ecstasy users are unable to obtain a level of recall that is 
comparable to non-ecstasy users over the five learning trials. There are variations in 
the way ecstasy users responded to the different list characteristics, with the 
magnitude of the effect for Trial 1 being larger for the related (g = -.49) than the 
unrelated list (g = -.36) list. There was also considerable difference in the magnitude 
of the effects for clustering, with the subjective organisation of unrelated list stimuli 
showing a moderate effect of ecstasy (g = -.57) although the semantic clustering 
index showed a large magnitude deficit for ecstasy users (g = -.97). The Learning 
over Trials measure also showed a non-significant effect for ecstasy users on the 
related list (g = -.36) however for the unrelated list, although the effect was lower in 
magnitude relative to some of the other summary measures (g = -.54) this effect was 
significant.  
 
Gained and Lost Access: Unrelated List 
To allow a more detailed consideration of inter-trial performance, ‘gained’ versus 
‘lost’ access to items was examined. Gained access was the number of words 
recalled on a given trial that were not recalled on the previous trial, and lost access 
was the number of words not recalled on a given trial that were recalled on the 
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previous trial. A 2 (Ecstasy; present, absent)  2 (Cannabis;  present, absent)  7 
[Interval; 1-2, 2-3, 3-4, 4-5, 5-6, 6-7,  7-8] was performed separately for each of the 
gained and lost access dependent variables.  
 
Gained access 
Mean number of words gained between trial intervals for each of the drug 
groups are presented in Table 7.11 below. The effect of Interval was significant, F(6, 
64) = 29.73, p <.001, with pairwise comparisons showing that participants gained 
significantly more words between intervals 1-2 and 2-3 than all other intervals, with 
all other intervals not significantly differing from one another. 
There was a significant and moderate magnitude main effects of Ecstasy F(1, 
64) = 5.68, p = .02, g = -.57 with ecstasy users gaining significantly more words (M 
= 3.94, SD = .77) between intervals than non-ecstasy users (M = 3.33, SD = .78) 
overall. There was no significant effect of Cannabis, F(1, 64) = 0.86, p = .0.36, g = -
.22, and the  Cannabis  Ecstasy interaction was not significant, F(1, 64) = 1.84, p = 
.18, as were all higher order interactions; Interval  Cannabis, F(6, 64) = .77, p = 
.58, Interval  Ecstasy, F(6, 64) = 1.2, p = .31, and Interval  Cannabis  Ecstasy, 
F(6, 64) = .48, p = .82.  
 
Table 7.11 
Means (and Standard Deviations) for Number of Words Gained Between Each Trial 
Interval for the Unrelated List 
Interval Drug Naïve 
Controls (n=20) 
 
Cannabis only 
(n=15) 
Ecstasy only 
(n=16) 
Ecstasy and 
Cannabis 
(n=17) 
Trial 1-2 5.80 (1.94) 6.20 (1.66) 5.19 (1.64) 6.12 (2.39) 
Trial 2-3  4.10 (1.86) 5.13 (1.88) 4.38 (1.40) 5.47 (1.84) 
Trial 3-4 3.35 (1.56) 3.87 (1.96) 4.19 (1.27) 4.29 (1.72) 
Trial 4-5 2.50 (1.53) 3.40 (1.63) 3.31 (1.49) 3.18 (2.21) 
Trial 5-6 2.55 (1.90) 3.33 (1.8) 3.69 (1.78) 3.59 (2.37) 
Trial 6-7 2.20 (1.19) 2.47 (1.50) 3.81 (2.45) 3.81 (2.32) 
Trial 7-8  1.75 (1.20) 2.60 (1.80) 2.44 (1.26) 2.35 (2.12) 
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Lost Access 
Mean number of words lost between trial intervals for each of the drug groups are 
presented in Table 7.12 below. There was a significant main effect of Interval, F (6, 
64) = 2.29, p = .041, although pairwise comparisons showed that the only difference 
between intervals was a trend (p = .057) for participants to lose more words between 
trials 2-3 compared to 1-2. 
 
Table 7.12 
Means (and Standard Deviations) for Number of Words Lost Between Each Trial 
Interval for the Unrelated List 
Interval Drug Naïve 
Controls (n=20) 
 
Cannabis only 
(n=15) 
Ecstasy only 
(n=16) 
Ecstasy and 
Cannabis 
(n=17) 
Trial 1-2 1.25 (1.07) 1.47 (0.99) 2.13 (1.02) 2.71 (1.76) 
Trial 2-3  2.00 (1.41) 2.87 (2.03) 2.31 (1.58) 3.06 (1.92) 
Trial 3-4 1.95 (1.73) 2.53 (1.55) 3.06 (1.57) 2.71 (1.65) 
Trial 4-5 1.80 (1.32) 2.33 (1.34) 2.25 (1.53) 2.41 (1.62) 
Trial 5-6 1.90 (1.52) 2.67 (1.35) 3.31 (1.92) 2.59 (1.97) 
Trial 6-7 1.64 (1.35) 2.20 (1.32) 2.44 (1.46) 2.35 (1.54) 
Trial 7-8  2.50 (1.15) 2.27 (0.88) 2.50 (1.71) 2.35 (1.76) 
 
The effect of Cannabis was not significant and was accompanied by a small 
effect size, F(1, 64) = 2.01, p = .16, g = .33, and power analysis revealed that 280 
participants would have been required to reliably (power = .8) identify an effect of 
this magnitude. The Interval  Cannabis interaction was also not significant, F(6, 
64) = .79, p = .56. 
 
There was a significant effect of Ecstasy which was moderate in size (F (1, 
64) = 7.75, p = .007, g = -.67). The Ecstasy-present group lost more words between 
intervals (M = 2.58, SD = .71) than the Ecstasy-absent group (M = 2.01, SD = .72) 
overall.  
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This Ecstasy effect occurred regardless of the effects of Cannabis or Interval, 
as the Ecstasy  Cannabis, F(1, 64) = 1.62, p = .21, Ecstasy  Interval, F (6, 64) = 
.90, p =.50, and Interval  Ecstasy  Cannabis interactions, F(6, 64) = .80, p = .57, 
were all non-significant.  
 
Delayed Recall 
Gained and Lost Access analyses provide a very specific measure of how 
many words were gained and lost between Trial 8 and delayed recall. As expected, 
between groups analyses showed no significant gains between Trial 8 and Delay for 
losses however, there was a significant moderate to large effect of Ecstasy, F(1, 63) 
= 9.68, p = .003, g = .75, and a non-significant effect of Cannabis, F(1, 63) = 1.76, p 
= .19, g = .45, though this was modified by a significant Ecstasy  Cannabis 
interaction, F(1, 63) = 4.13, p = .046. This interaction is shown in Figure 7.11. 
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Figure 7.11. Mean number of words lost between trial 8 and delayed recall on the 
unrelated word list, as a function of ecstasy and cannabis use. 
Figure notes: all drug groups differ significantly (p <.05) from drug naïve group (error bars represent 
standard errors.)  
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Univariate breakdown analyses showed that the Drug Naïve group lost 
significantly less words than the Ecstasy-only group, F(1, 34) = 16.17, p <.001, g = 
1.32, the Cannabis-only group, F(1,33) = 5.14, p = 0.03, g = .89, and the Ecstasy and 
Cannabis group, F(1,35) = 9.87, p = .003, g = 1.50. Thus all drug groups lost more 
words in the delay compared with the Drug Naïve group. The effect sizes indicate 
that the Ecstasy-only group (g = 1.35) contributed more to the very large Ecstasy-
plus Cannabis effect (g = 1.50) than the effect of Cannabis (g = .89), which was 
considerably smaller than the ecstasy related effects. For people who did smoke 
cannabis, there was no difference in the number of words lost as a function of 
ecstasy use, F(1, 29) = .47, p = .50, g = .21.  
 
Summary 
On all measures of lost access for the unrelated list, ecstasy users performed 
significantly poorer than non-users. This was particularly noticeable in the lost 
access between Trial 8 and delay, with very large effect sizes indicating more access 
is lost in ecstasy consuming groups than non-users, when there is delayed recall.  
 
Gained and Lost Access: Related List 
As per the unrelated list a 2 (Ecstasy; present, absent)  2 (Cannabis;  
present, absent)  4 [Interval; 1-2, 2-3, 3-4, 4-5] ANOVA was performed separately 
for gained and lost access. 
 
Gained Access 
Mean number of words gained between intervals on the related list are 
presented in Table 7.13. There was no significant effect of Cannabis, F(1, 64) = .03, 
p = .86, and Cannabis was not involved in any interactions; Ecstasy  Cannabis, F 
(1, 64) = .40, p = .53, Interval  Cannabis, F(3, 64) = 1.41, p = .24, Interval  
Ecstasy  Cannabis, F(3, 64) = .89, p = .35. 
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Table 7.13 
Means (and Standard Deviations) for Number of Words Gained Between Each Trial 
Interval for the Related List 
Interval Drug Naïve 
Controls (n=20) 
 
Cannabis only 
(n=15) 
Ecstasy only 
(n=16) 
Ecstasy and 
Cannabis 
(n=17) 
Trial 1-2 6.35 (2.00) 5.86 (2.10) 5.75 (2.20) 5.35 (1.96) 
Trial 2-3  3.65 (2.05) 3.73 (2.40) 5.06 (1.65) 4.76 (1.50) 
Trial 3-4 2.05 (1.87) 2.60 (2.02) 2.93 (1.94) 3.88 (1.73) 
Trial 4-5 1.10 (1.52) 1.80 (1.52) 3.31 (1.85) 2.58 (1.17) 
 
 
There was a significant effect of Interval, F(3, 64) = 58.41, p <.001, and a 
significant effect of Ecstasy, F(1, 64) = 9.56, p = .003, g = .74, though as depicted in 
Figure 7.12, these variables were involved in a significant interaction, F(3, 64) = 
4.84, p = .004). Follow up analyses showed no difference between ecstasy and non-
ecstasy using groups in the number of words gained between intervals 1-2 and 3-4, 
however ecstasy users gained significantly more words than the non-users between 
intervals 2-3 and 4-5. As shown in the figure, by the 4-5 interval, ecstasy users were 
still gaining an average of three words, whereas the Ecstasy-absent group were only 
gaining one. 
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Figure 7.12. Mean number of words gained across each interval ecstasy users and 
non-users on the related list (error bars represent standard errors.)  
 
Such differences in gains at the final interval may be because the ecstasy group was 
slower to encode and consolidate words, and therefore did not make significant gains 
until the later learning trials. It may also be because a larger proportion of the non-
ecstasy group had reached the maximum recall (i.e. were recalling all words, by this 
point. This is demonstrated in Figure 7.13, which shows that more drug naïve 
participants had reached maximum recall.  
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Figure 7.13 Percentage of participants reaching maximum recall across each trial for 
all four experimental groups    
 
Lost Access 
Mean number of words lost between intervals on the related list are presented 
in Table 7.14. The effect of Interval was significant, F(3, 64) = 4.22, p = .007. All 
participants lost more words between intervals 1- 2 and 2-3 compared with 3-4 and 
4-5.  The effect of Cannabis was not significant, F(3, 64) = .21, p = .65, g = .11, and 
power analysis showed that 2598 participants would be required to reliably detect a 
difference of this small magnitude. The Interval  Cannabis, F(3, 64) = .15, p = 
.92), Interval  Ecstasy, F(3, 64) = 2.02, p = .11, and Interval  Cannabis  
Ecstasy interactions, F(3, 64) = 1.25, p = .29, interactions all failed to reach 
statistical significance. 
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Table 7.14 
Means (and Standard Deviations) for Number of Words Lost Between Each Trial 
Interval for the Related List 
Interval Drug Naïve 
Controls (n=20) 
 
Cannabis only 
(n=15) 
Ecstasy only 
(n=16) 
Ecstasy and 
Cannabis 
(n=17) 
Trial 1-2 0.90 (1.41) 1.46 (1.55) 1.93 (1.38) 1.88 (0.99) 
Trial 2-3  1.55 (1.80) 1.40 (0.91) 1.93 (1.94) 2.35 (1.27) 
Trial 3-4 0.90 (1.12) 1.46 (1.45) 3.00 (1.93) 2.47 (1.84) 
Trial 4-5 0.50 (0.60) 0.53 (0.74) 1.93 (1.53) 1.88 (1.65) 
 
The magnitude of the main effect of Ecstasy was large and significant,  F(1, 64) = 
25.14, p <.001, g = 1.20. As depicted in Figure 7.14, ecstasy users lost, on average, 
significantly more words per interval (M = 2.17, SD = .90) than non-users (M = 1.09, 
SD = .90). The Ecstasy  Cannabis interaction was not significant (F (3, 64) = .51, p 
= .48) indicating that this large effect of Ecstasy occurred irrespective of Cannabis 
use. 
 
Summary 
The ecstasy consumers made significantly more gains between trials 2-3 and 
4-5, and lost significantly words between all intervals relative to non-ecstasy users. 
These results may reflect ceiling effects for the control participants, such that they 
had less unrecalled words, and therefore had fewer words to gain compared to the 
ecstasy-present group. Alternatively, when the losses are taken into account for the 
ecstasy group, these results suggest that although ecstasy users are able to make 
significant gains of words between pairs of trials, they tend to do so at the expense of 
other words. 
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Figure 7.14. Mean number of words lost across each interval ecstasy users and non-
users on the related list (error bars represent standard errors.)  
 
Levels of Forgetting: Unrelated List 
For the unrelated list, which had 8 recall trials, there are a possible 7 levels of 
forgetting. To examine the mean number of words forgotten at each level, 2 
(Ecstasy; present, absent)  2 (Cannabis; present, absent) ANOVAs were performed 
for each level of forgetting. The ANOVA results, along with the mean number of 
words forgotten at each level for each drug group are summarized in Table 7.15 
below. 
 
For Level 1, a significant and moderate to strong magnitude (g = .74) main 
effect of Ecstasy was found, with ecstasy users forgetting significantly more words 
(M = 6.71, SD = 3.05) than the Ecstasy-absent group (M= 4.41, SD = 3.08). There 
was no significant effect of Cannabis and power analysis revealed that 220 
participants would have been required to reliably identify an effect of this magnitude 
(g = .38). 
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The Ecstasy x Cannabis interaction was also not significant, indicating the tendency 
for ecstasy users to forget a word that had previously been recalled once occurred 
independently of other drug use.
Table 7.15 
Means, (Standard Deviations) and 2 (Ecstasy; Present, Absent)  2 (Cannabis; Present, Absent) ANOVA Results for Each Level of 
Forgetting for the Unrelated List 
 Descriptives  ANOVA 
Level of 
Forgetting 
Drug Naïve 
Controls 
(n=20) 
Cannabis only 
(n=15) 
Ecstasy only 
(n=16) 
Ecstasy and 
Cannabis 
(n=17) 
 Cannabis Ecstasy Ecstasy 
Cannabis 
  F p F p F p 
Level 1 3.70 (2.10) 5.13 (2.41) 6.25 (3.43) 7.18 (3.98)  2.50 .118 9.49 .003 0.11 .735 
Level 2 
 
2.80 (1.36) 4.07 (1.94) 5.00 (2.58) 4.29 (1.53)  0.37 .543 7.02 .010 4.63 .035 
Level 3 
 
3.20 (2.16) 2.93 (1.58) 3.44 (2.36) 2.88 (1.83)  0.69 .408 0.03 .851 0.85 .771 
Level 4 
 
1.40 (1.18) 2.40 (1.35) 1.44 (0.96) 2.06 (1.63)  6.46 .013 0.22 .635 0.35 .555 
Level 5 
 
0.90 (0.78) 1.00 (1.30) 0.69 (0.87) 1.00 (1.27)  0.62 .432 0.16 .685 0.16 .685 
Level 6 
 
0.45 (0.60) 0.33 (0.61) 0.75 (0.85) 0.59 (0.61)  0.70 .403 2.81 .098 0.01 .892 
Level 7 
 
0.35 (0.48) 0.13 (0.35) 0.06 (0.25) 0.24 (0.56)  0.04 .838 0.75 .388 3.32 .073 
Notes: Degrees of Freedom for F are 1,64 for all analyses 
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At Level 2, a similar significant and moderate to strong magnitude (g = -.63) 
main effect of Ecstasy was found, though at this level it as moderated by a 
significant Ecstasy  Cannabis interaction. This interaction is shown graphically in 
Figure 7.15. As can be seen, by level 2, all drug users preformed more poorly, 
tending to forget more words that they had successfully recalled twice relative to the 
drug naïve controls. 
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Figure 7.15. Mean number of words forgotten at level 2 for cannabis and ecstasy 
users and non-users (error bars represent standard errors.)  
 
Follow-up analyses to the interaction found that among those that had not 
used cannabis, ecstasy users (the Ecstasy Only group) forgot significantly more 
words at Level 2 than those that did not use ecstasy (the Drug Naïve group), F(1, 34) 
= 10.81, p = .002, g = -1.12. However, among those that had used cannabis, there 
was no significant difference in the number of words forgotten between those who 
did and did not use ecstasy (F, (1, 30) = 0.13, p = .714, g = .09). These results 
suggest that ecstasy users are less likely to encode a word successfully after one 
previous retrieval than the other drug groups, however both ecstasy and cannabis 
contribute to forgetting a word that had previously recalled twice. 
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For Level 3, there were no significant effects for Ecstasy or Cannabis. The 
higher levels of forgetting need to be interpreted with caution as they are dependent 
on recalling the same word on more than four occasions. This degree of recall 
consistency was not achievable for many participants, particularly as ecstasy use was 
associated with a greater rate of forgetting words at level one, indicating a deficit in 
consolidation and hence retrieval of a previously recalled word. It is therefore 
possible that the ecstasy group was not able achieve the recall consistency required 
to obtain interpretable forgetting at higher levels. This is because, for example, Level 
5 forgetting requires that the same word was consistently recalled five times. Indeed 
supporting this interpretation is that there were no significant effects for Ecstasy or 
Cannabis between levels 5 and 7. There was a significant and moderate magnitude (g 
= -.61) main effect for Cannabis at Level 4, suggesting that the Cannabis-present 
group forgot more words at level four (M = 2.22, SD = 1.30) relative to the 
Cannabis-absent group (M = 1.41, SD = 1.31) and this result was not modified by 
significant effects of Ecstasy nor an Ecstasy x Cannabis interaction. 
  
Levels of Forgetting: Related List 
For the five learning trials of the related list, there were a possible four levels 
of forgetting. ANOVA results and mean number of words forgotten at each level for 
each drug group are summarized in Table 7.16. As can be seen in Table 7.16, and as 
shown in Figure 7.15, the effect of ecstasy use was significant at all four levels. The 
magnitude of the ecstasy effect is large for level 1 (g = -.82) indicating that unlike 
the non-ecstasy users, for the ecstasy-present group,  previously recalling a word 
once did not strengthen consolidation so that it might be retrieved successfully. 
  
The effect size for level 2 was moderate (g = -.69) however the ecstasy effect 
was large in magnitude at level 3 (g = -.94) showing that even when a word had been 
recalled three times previously the ecstasy using group was more likely to forget it 
on a subsequent trial. This effect decreased to a moderate size at level 4 (g = -.49).   
The levels of forgetting analyses are largely consistent with the lost access analysis, 
both showing that ecstasy users have a tendency to forget more words than non-
ecstasy users, both between pairs of trials, as is the case with lost access, and 
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throughout succeeding trials, as is the case with levels of forgetting. As demonstrated 
for both list types, ecstasy users were more likely to forget a word that had 
previously been recalled once and twice. For the related list, this effect was also 
apparent at levels 3 and 4, although a caveat with regard to interpretation is relevant 
at these higher levels.  
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Figure 7.16. Mean number of words forgotten at each level for ecstasy users and 
non-users (error bars represent standard errors.)  
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Table 7.16 
Means, (Standard Deviations) and 2 (Ecstasy; Present, Absent)  2 (Cannabis; Present, Absent) ANOVA Results for Each Level of 
Forgetting for the Related List 
 Descriptives  ANOVA 
Level of 
Forgetting 
Drug Naïve 
Controls 
(n=20) 
Cannabis 
only (n=15) 
Ecstasy only 
(n=16) 
Ecstasy and 
Cannabis 
(n=17) 
 Cannabis Ecstasy Ecstasy 
Cannabis 
  F p F p F p 
Level 1 1.85 (2.05) 2.66 (1.95) 3.93 (2.61) 4.58 (2.89) 
 
1.56 .216 11.65 .001 0.02 .888 
Level 2 
 
1.40 (1.75) 1.26 (1.48) 2.87 (2.52) 2.41 (1.46)  0.43 .512 8.40 .005 0.13 .716 
Level 3 
 
0.45 (0.82) 0.66 (0.81) 1.87 (1.31) 1.29 (1.26)  0.48 .489 15.40 .001 2.32 .132 
Level 4 
 
0.15 (0.36) 0.06 (0.25) 0.37 (0.80) 0.35 (0.49)  0.17 .678 4.10 .047 0.05 .809 
Notes: Degrees of Freedom for F are 1,64 for all analyses
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Are differences on processing speed or word span contributing to the observed 
ecstasy related memory impairments?  
To evaluate the possible influence of differences in processing speed and 
word span on verbal learning and memory, 2 (Ecstasy; present, absent)  2 
(Cannabis; present, absent) ANOVAs were performed with highest word span 
achieved (maximum = 8) as the dependent variable for the word span task, and total 
number correct and mean reaction time (in milliseconds) as the dependent variables 
for the letter comparison task. Neither task scores were found to differ between 
groups, therefore a conservative approach to analyses was undertaken.  For the word 
span task, there were no significant differences between the Ecstasy-present (M = 
5.12, SD = .75) and Ecstasy-absent (M = 5.04, SD = .76, (F (1, 64) = .15, p = .69, g = 
-.09) groups. The effect of Cannabis was also not significant (F (1, 64) = 3.23, p = 
.07, g = -.42) with the Cannabis-present group (M = 5.20, SD = .75) scoring at a 
similar rate to the Cannabis-absent group (M = 4.91, SD = .75). To ascertain whether 
differences on word span were contributing to lower scores for ecstasy and cannabis 
users on total words recalled on the unrelated and related lists, ANCOVA was 
performed and revealed that a significant effect of ecstasy remained after controlling 
for word span on the unrelated (F(1, 63) = 15.57, p <.001) and related list (F(1, 63) = 
22.59, p <.001) and the cannabis effect remained non-significant for the unrelated (p 
= .39) and related lists (p = .32).  
For the letter comparison task, there were no significant differences in 
number correct for the Ecstasy-absent (M = 45.44, SD = 4.43) and Ecstasy-present 
groups (M = 44.61, SD = 4.43,  F(1, 64) = .60, p = .44, g = .18) and no significant 
differences between the cannabis absent (M = 44.98, SD = 4.41) and present (M = 
45.07, SD = 4.44, F(1, 64) = .01, p = .93, g = -.02) groups. There were also no 
significant differences for reaction time (milliseconds) between the Ecstasy-present 
(M = 2600, SD = 485.16) and Ecstasy-absent groups (M = 2723.75, SD = 491.81, F 
(1, 68) = 1.11, p = .29, g = .25) nor the Cannabis-present (M = 2552.95, SD = 
485.16) and Cannabis-absent (M = 2770.76, SD = 489.43, F (1, 68) = 3.42, p = .07, g 
= .44). Subsequent ANCOVA revealed a significant effect of ecstasy remained 
apparent for total recall after controlling for differences on speed of processing on 
the unrelated (F(1, 63) = 14.26, p <.001) and related lists (F(1, 63) = 19.32, p <.001) 
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and no significant effect of cannabis (p = .61 for the related list, p = .56 for the 
unrelated list). These results indicate that the ecstasy related deficits on the above list 
learning measures cannot be attributed to differences in overall processing speed or 
memory span ability.  
Examining possible dose dependence effects 
In order to evaluate whether there are dose dependent effects of drug use the 
main memory measures, bivariate correlations were conducted between Trial 1, 
Total and Delayed recall and clustering measures and possible covariates, including 
ecstasy, cannabis and methamphetamine consumption. Methamphetamine use was 
included in the table, as it was the most commonly used illicit drug behind cannabis 
and ecstasy in this sample. These are reported in Table 7.17 below. As expected, the 
extent of Ecstasy use was significantly negatively correlated with Total and Delayed 
recall and both measures of clustering, although only recent ecstasy use was related 
to subjective organisation. For Cannabis use, there were no significant relationships 
with any memory measures apart from semantic clustering, which was associated 
with recent cannabis use only. ANCOVA was performed and revealed that the 
significant effect of Ecstasy on semantic clustering remained after controlling for 
cannabis use in the preceding six months F (1, 67) = 15.10, p <.001.  
There were no significant relationships between the memory measures and 
methamphetamine use. These results are in accordance with the ANOVAs and 
indicate that the lower scores for ecstasy users compared with non-users can best be 
accounted for by ecstasy, rather than cannabis or methamphetamine use.  
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Table 7.17 
Bivariate Correlations between Ecstasy, Cannabis and Methamphetamine use and Summary List Learning Memory Measures 
 
 
Unrelated-
Trial 1 
Related-Trial 
1 
Unrelated-
Total recall 
Related-Total 
recall 
Delayed 
recall 
Semantic 
clustering 
Subjective 
clustering 
Lifetime occasions 
of  ecstasy use 
 
-.13 -.09 -.25
*
 -.22 .25
*
 -.24** -.14 
Days used ecstasy 
in last 6 months 
 
-.07 -.22 -.25* -.38** -33** -.39** -.24* 
Lifetime occasions 
of cannabis use 
 
-.14 -.01 -.04 -.01 -.06 -.13 -.11 
Days used cannabis 
in last 6 months 
 
-.21 -.13 .17 -.21 -.14 -.30* -.21 
Lifetime occasions 
of meth. Use 
 
-.22 -.15 -.20 -.19 -.10 -.12 -.09 
Days used meth. In 
last 6 months 
-23 -11 -20 -19 -.06 -.48 -.07 
Notes: * p < .05, 
**p < .01 
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Discussion 
The effects of ecstasy use on measures of learning- comparison with previous studies  
The between-lists analysis examined the effect of ecstasy and cannabis use 
over five learning trials of the related and unrelated list and revealed participants 
who had used ecstasy recalled significantly fewer words on each learning trial, with 
the exception of Trial 1. When Trial 1 was analysed within each list type, there was 
no ecstasy effect for the unrelated list although for the related list the ecstasy effect 
was moderate (g = -.49) in magnitude and significant at p = 0.042. Trial 1 is often 
not included in the ecstasy and list learning research and although an ecstasy related 
deficit on Trial 1 has sometimes been reported (Parrot & Lasky, 1998; Fox, Toplis, 
Turner & Parrott, 2001; Gouzoulis-Mayfrank et al., 2000) the effects of ecstasy on 
this measure is more often  non-significant (Bedi & Redman, 2008; Brown, McKone 
& Ward, 2010; Curran & Verheyden, 2003; de Sola et al., 2008; Golding, Groome, 
Rycroft & Denton, 2007; Halpern et al., 2004; Halpern et al., 2010; Hanson & 
Luciana, 2010; McCardle, Luebbers, Carter, Croft & Stough, 2004; Thomasius et al., 
2003, 2006). The meta-analysis reported in Chapter 6 found an ecstasy related effect 
for Trial 1 (g = -.36) although this was of much smaller magnitude than the effect 
sizes for the other list-learning measures.  
For Total recall, the number of words recalled over the learning trials, the 
magnitude of the ecstasy effect on the related (g = -1.10) and unrelated (g = -.92) 
was large, and previous studies also reported a significant ecstasy related deficit on 
this measure for unrelated word lists (Bolla et al., 1998; Parrott & Lasky, 1998; 
Reneman et al., 2001b: Thomasius et al., 2003; Quednow et al., 2006; Thomasius et 
al., 2006; Reneman et al., 2006; Lamers, Bechara, Rizzo & Ramaekers, 2006; Schilt 
et al., 2008; Schilt et al., 2010). These findings are also consistent with the meta-
analysis for this measure, which found a moderate (g = -.75) effect of ecstasy for 
Total recall. 
 
The consistency between the related word list findings from the current study 
and that from previous research using the CVLT is less clear however: while two 
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studies have reported significant deficits for ecstasy users compared with poly-drug 
users on Total recall (Semple et al., 1999; Brown, McKone & Ward, 2010), four 
studies have not (Medina, Shear and Cocoran, 2005; De Sola et al, 2008; Halpern 
2004, 2010). There are a number of methodological and interpretative issues that 
may contribute to such discrepancies. 
 
Medina, Shear and Corcoran (2005) did not report an overall deficit for their 
ecstasy/poly-drug group compared to a cannabis/poly-drug group. It is possible that 
the discrepancy with the current results on the related lists may partially reflect the 
effects of poly-substance use in their participants. In the Medina et al study, the 
ecstasy using group only reported having used an average of 12 pills in the previous 
12 months and their cannabis group had a high level of cocaine use in the preceding 
year (54 grams compared with 12 grams for the ecstasy users). The ecstasy using 
group also had a relatively high incidence of cannabis use in the preceding year 
(mean number of joints = 504, compared with 280 for the cannabis group). This 
pattern of poly-drug use differs considerably from the drug groups in the present 
sample, in which the ecstasy-plus cannabis group had minimal exposure to other 
illicit drugs and only reported 2.7 lifetime occasions of lifetime cocaine use on 
average.  Medina et al., statistically controlled for poly-drug use and subsequently 
reported a significant relationship between ecstasy use in the preceding year and 
verbal memory (r = -.39, p<.001) which is broadly consistent with the present 
results.  
 
De Sola et al., (2008), by contrast, found no effect of ecstasy compared to 
cannabis use for verbal memory assessed by CVLT performance. There were, 
however, a number of other ecstasy-related effects identified in their sample. De Sola 
et al reported dose-related effects for visual memory, with higher lifetime ecstasy 
consumption associated with reduced Immediate (r = -0.43, p = 0.008) and Delayed 
(r = 0.51, p = 0.001) recall on the Rey Complex Figure Test. This test involves a 
copy trial of a complex figure, followed by an Immediate recall trial after three 
minutes in which participants are required to redraw the figure, and a Delayed recall 
trial after 30 minutes.  When participants were divided into “heavy” (more than 100 
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tablets consumed) and “moderate” (less than 100 tablets consumed) sub-groups, de 
Sola et al., found the heavy group performed significantly worse than the moderate 
users and the cannabis control group on this test. They also reported a significant 
dose related effect of ecstasy (r = 0.49, p = 0.016) for performance on the letter-
number sequencing task  which a test of verbal working memory. Thus, although de 
Sola et al., did not find an ecstasy related effect on CVLT performance, they still 
argued that due to the deficits on Immediate and Delayed recall of information, the 
neurocognitive profile of their ecstasy using sample was consistent with alterations 
in the dorsolateral prefrontal cortex, medial temporal lobes and hippocampus.   
 
Two studies by Halpern et al., (2004; 2010) have failed to find an ecstasy 
related impairment for Trial 1, Total and Delayed Recall on the CVLT, however they 
suggested the lack of statistical significance for these differences may reflect Type II 
error due to small sample size. Similar to De Sola (et al, 2008), Halpern et al., (2004) 
did report a tendency for a subgroup of 11 “heavy users” (median lifetime use = 100) 
to perform more poorly than non-users on the CVLT. Both the present study and 
Halpern et al.’s study matched the different drug groups characteristics very closely 
to attempt to control for differences in poly-drug use, but despite this, there are large 
performance discrepancies between studies, with Halpern et al., only reporting a 
moderate, non-significant effect for ecstasy users on Total recall (d = -.49) and the 
present study reporting a large magnitude effect (g = -1.10). The Ecstasy-only group 
in the present study and Halpern et al.’s (2010) ecstasy using group have similar 
poly-drug profiles, both having median lifetime cannabis usage of 10.5 and 10 
occasions of use  respectively, and less than 10 occasions of other illicit drug use. 
The present study’s Ecstasy-only group had used cannabis an average of 0.38 times 
in the preceding 6 months, and the mean number of days abstinent from cannabis 
was 460 for this group. Thus their cannabis use was very minimal. Given the trends 
identified in De Sola et al. (2008) and Halpern et al. (2004), a likely key contribution 
to the discrepancy is ecstasy dose; the present study’s Ecstasy-only group had more 
lifetime occasions of ecstasy use (median = 87.5) compared to Halpern et al.’s study 
(median = 43.5). It is unlikely that poly-substance use in the current sample was 
responsible for a spurious effect: with the exception of inhalants (nitrous oxide), all 
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participants had fewer than 10 occasions of illicit drug use other than cannabis and 
ecstasy. In the current study, the Ecstasy-plus-cannabis group had 32 lifetime 
occasions of use (5 in the preceding 6 months) on average. It is unlikely that inhalant 
use is contributing to the verbal memory deficits in the present study however, as the 
extent of recent use was low and inhalant use was only prominent in the Ecstasy- 
plus cannabis group, and ecstasy and cannabis were not associated with any 
interactions for Total recall on the related list.  Furthermore there is limited existing 
literature on the long-term effects of recreational nitrous oxide use, although there is 
evidence that during acute intoxication there is short term memory loss, this effect 
subsides with discontinuation of use (Brouette & Anton, 2001). Overall, the 
similarly low levels of poly-substance use in the Halpern (2004; 2010) studies and 
the present sample, coupled with the present sample’s level of ecstasy use, which 
although relatively low is twice as high as Halpern’s sample, indicate that the 
discrepancy in findings between these studies may be due to ecstasy use.  
 
Another possible contribution to the disparity between the present study’s 
related list findings and those of de Sola et al., (2008) and Halpern et al. (2010) is the 
differences in task demands. In addition to the longer list length for the current task 
(20 items compared with only 16 in the CVLT) the current word list was presented 
visually, via a computer screen, rather than being read out by an experimenter as per 
CVLT administration. This allowed control over the duration of item presentation 
and the time participants had between words to memorise and/or strategise for better 
recall. There is also a reported superiority effect for auditorily presented words, such 
that words that are heard or articulated are more likely to be recalled compared to 
words that are seen (Craik, 1969; Levy, 1971). The order of word presentation was 
also different for each learning trial in the current study, which prevented 
participants from relying on serial order to assist with word recall. Thus, the shorter 
list length, greater variability in time spent memorising each word, serial 
organisation and the auditory presentation of the CVLT, in combination with 
participants who had lower lifetime occasions of ecstasy use in the Halpern et al., 
2010 study compared with the present ecstasy using group, may account for the 
considerable differences in findings.  
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The Ecstasy-present group recalled fewer words on each learning trial, and 
subsequently had lower recall scores overall, however the ecstasy effect for Learning 
Over Trials (LOT) was smaller in magnitude relative to the Total recall effect sizes. 
LOT is an estimate of an individual’s improvement over trials (Mitrushina, 2005). 
On the unrelated list, although scoring significantly lower on LOT, the effect size 
was moderate (g = -.54) whereas ecstasy use had a large effect on Total recall (g = 
0.92). For the related list, there was no significant difference between ecstasy users 
and non-users on LOT, and the ecstasy effect was small for this measure (g = -.36).  
These results indicate that the Ecstasy-present group were improving over trials to a 
level that was comparable to control participants for the related list, however the 
number of words they were able to retain from Trial 1 onwards was lower, hence the 
lower recall scores.  
The effects of ecstasy use on measures of retention- comparison with previous 
studies 
For the unrelated list, the current study failed to find any drug related effects 
for Recognition and this is consistent with previous literature (Back-Madruga et al., 
2003; Bedi & Reman, 2008; de Sola et al., 2008; Gouzoulis et al., 2000; Hanson & 
Luciana, 2010; Indlekofer et al., 2008; Wagner, Becker, Koester, Gouzoulis-
Mayfrank & Daumann, 2012). Recognition is a measure of how well items have 
been stored in memory, and is considered to be the domain of the hippocampal 
component in the Working with Memory model, as it provides a strong cue that does 
not require strategic involvement of the  frontal component (Moscovitch, 1992). This 
is consistent with neuroimaging data demonstrating substantial MTL involvement in 
recognition processes (Cabeza, Dolcos, Graham & Nyberg, 2002; Cohn, 
Moscovitch, Lahat & McAndrews, 2009). According to this model, in tests of free 
recall retrieval is guided by the frontal component to assist retrieval from MTL or 
other cortical areas when the cue needs to be self-initiated. Consistent with previous 
findings, the ecstasy related effect for Delayed recall (g = -1.02) was significant and 
very large in magnitude (Brown, McKone & Ward, 2010; Medina, Shear & 
Corcoran, 2005; Reneman, Booij, Scmand, van den Brink & Gunning, 1999; 
Reneman, Majoi, Schmand, van den Brink & den Heeten, 2001; Reneman et al., 
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2001b; Fox, Toplis, Turner & Parrott, 2001; Curran & Verheyden, 2003; Thomasius 
et al., 2003; McCardle, Luebbers, Carter, Croft & Stough, 2004; Yip & Lee, 2005; 
Reneman et al., 2006; Thomasius et al., 2006; Schilt et al., 2010). This was also 
consistent with the Rogers et al., (2009) meta-analysis (d = -1.04) and the previously 
presented meta-analysis, which found a large magnitude effect (g = - .98) for this 
measure when ecstasy users were compared with poly-drug and drug naïve controls, 
and a moderate effect (g = -.60) when only compared with other drug users.  Only 
one other study has reported a measure of Forgetting Rate (Quednow et al., 2006) 
which is the difference between the number of words recalled on the final learning 
trial and the number of words recalled at delay. Quednow and colleagues found the 
ecstasy using group lost significantly more words (M = 2.05 words) between the last 
learning trial and Delayed recall than the cannabis and drug naïve control groups, 
and the current study’s findings concurred, with the ecstasy present group losing an 
average of 2.08 words after the delay.  
In contrast with Forgetting rate, the measure of lost access between Trial 8 
and Delayed recall tracks the specific words that were recalled at Trial 8, but not at 
the delay. It is therefore a better indicator of retention over time, as it captures losses 
of specific words, rather than an aggregate number. Analysis of lost access revealed 
that participants who used any drug lost more words between Trial 8 and delay 
compared to the drug naïve participants, however ecstasy users did not exhibit 
greater lost access than the cannabis users, suggesting that this effect is due to the 
combined effects of cannabis and ecstasy.  
 
This is an interesting result, as the meta-analysis in Chapter 6 demonstrated a 
very large magnitude effect of ecstasy for Delayed recall when compared with poly-
drug and drug naïve controls, however when the drug naïve comparison was 
removed, this was reduced to a moderate sized effect. It appears as though the results 
from the unrelated list task are reflecting this poly-drug effect for impaired delayed 
recall performance.   
 
The effect of poly-substance use on verbal learning and memory in the present study 
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The present study specifically investigated whether it is ecstasy/poly-drug 
use that is responsible for the verbal memory deficits reported for ecstasy use, by 
comparing the Ecstasy-only and Ecstasy-plus-cannabis (poly-substance group) with 
Cannabis-only and a Drug naïve group.  The results showed a clear pattern: there 
were no interactive effects between cannabis and ecstasy, as the effect of ecstasy use 
on the verbal learning and memory measures was consistent between those 
participants who did and did not also use cannabis. That is, if a participant had used 
ecstasy, regardless of the extent of cannabis use, they were more likely to perform 
poorly on the tests of verbal memory. This finding suggests that in the current 
sample, poly-drug use cannot account for the verbal memory deficits reported for the 
Ecstasy-present group. Additionally, this lack of Cannabis x Ecstasy interaction 
indicates there were no protective effects of concomitant ecstasy and cannabis use.   
In summary, the results from the current study were in keeping with several 
previous findings from the ecstasy and memory literature, and were also consistent 
with the findings from the Rogers et al., (2009) meta-analysis which reported large 
magnitude effects for an ecstasy related deficit on Total and Delayed recall of the 
AVLT, and the current thesis’ meta-analysis which demonstrated a small magnitude 
effect of ecstasy on Trial 1, and moderate effects for Total and Delayed recall. The 
lack of interactive effects for ecstasy and cannabis use is a clear indication that the 
memory deficits for the Ecstasy-present group in the current study are not a result of 
poly-substance use. To attempt to better explain these results, the discussion now 
turns to examining the more specific patterns of learning that are demonstrated on 
list learning tasks.  
The contribution of acquisition, consolidation and forgetting to total recall scores 
for ecstasy users-evaluation of gained and lost access.  
The lower Total recall scores for ecstasy users compared to non-users 
suggests that their level and rate of acquisition was impaired, however a finer 
grained analysis of the learning curve can better inform as to whether this was the 
case. An inter-trial assessment of list learning performance provides information that 
is not available in the usual summary measures. If a participant scores 4 on the first 
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trial and 4 on the second, this would typically be interpreted as a failure to acquire 
more information. However, there are different possible underlying processes that 
contribute to this score. It is possible that the participant recalls an entirely different 
set of four items on the second trial, which suggests that they have been able to gain 
four items. This individual is clearly able to acquire information, but this is 
accompanied by a failure to consolidate what was learnt on the first trial. In 
comparison, another participant may consistently recall the same four items – 
possibly indicating that consolidation is intact but there is no acquisition from one 
trial to the next. By following which items are recalled from one trial to the next, it is 
possible to evaluate the separate contributions of failure of acquisition (assessed by 
gains) and failure of consolidation (assessed by losses).  
For the unrelated list, there were more gains made between trials 1-2 and 2-3 
for all participants, and this may reflect the rapid encoding of newly encountered 
words in these early trials. Interestingly, for ecstasy users, more gains were made 
throughout the five learning trials of the unrelated list compared to the non-ecstasy 
users, suggesting that ecstasy use is not associated with impaired 
encoding/acquisition. When considering lost access however, there was a significant 
effect of ecstasy of moderate magnitude, with ecstasy users also losing more words 
between trials. These findings indicate that ecstasy users were able to encode and 
acquire more words as the number of trials increased, however they were unable to 
consolidate these words, instead they were forgotten (lost access) and replaced by 
different words (gained access). Thus it appears as though ecstasy use is associated 
with poor recall consistency; words were only gained at the expense of others. The 
learning curve for the ecstasy users on the unrelated list was therefore lower than the 
non-ecstasy users because they were not building on a consistent recall pattern from 
trial to trial; instead they demonstrated a “slippery” and inconsistent learning profile, 
suggesting ecstasy use is associated with a deficit in word consolidation, rather than 
acquisition. This finding also highlights some of the problems associated with 
summary measure of list learning tasks; the learning curve for ecstasy users looks 
normal, the Learning Over Trials index suggests that their recall is improving over 
trials, however a more detailed assessment of the learning profile indicates that 
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although they are gaining words with increased trials, they are also losing more 
words than the other groups.  
For the related list, the pattern of gained and lost access for ecstasy users is 
more straightforward. Ecstasy users gained more words between Trials 2 and 3, and 
also between the last two trials (4-5). The increase in gains for Trials 2-3 is 
consistent with the lower Trial 1 scores for the Ecstasy-present group on the related 
list, these findings indicate the ecstasy users gained less than the non-ecstasy users 
initially, but then “catch up” after the first two learning trials. For the ecstasy using 
participants, there was a significant gain in the number of words recalled between 
Trials 4 and 5, which may be indicative of this group having more words remaining 
to be recalled compared with the non-ecstasy users. At trial 5, sixty per cent of the 
drug naïve, and thirty per cent of the cannabis users were achieving perfect recall. 
Thus, the reason for a lack of gained access for the non-ecstasy users relative to the 
ecstasy users is that many of the non-users were limited in the gains they could make 
because there were virtually no new words for them to recall between trials 4 and 5. 
For the related list overall, ecstasy users also exhibited significantly more lost access 
than non-users and this effect was very large in magnitude.  
Turning to levels of forgetting, across multiple trials as opposed to pairs of 
trials, ecstasy users tended to forget more words at levels 1 and 2 of the unrelated 
list, indicating they were forgetting words that had previously been recalled once and 
twice consecutively. “Forgetting” implies that the information has been stored, but 
subsequently lost, and it is difficult to establish whether ecstasy users are really 
forgetting, or not encoding effectively so that the memory trace has been 
consolidated. Forgetting at higher levels, which requires that word has been 
consecutively recalled over multiple list presentations, would be more likely to 
indicate forgetting, as recalling a word consecutively over four trials would suggest 
that the word has been effectively learnt. Cannabis and ecstasy use was associated 
with forgetting at level 4, however forgetting at higher levels could not be adequately 
assessed for the unrelated list due to the low incidence of forgetting at these higher 
levels, which may be a result of the low incidence of participants consecutively 
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recalling the same words on five or more occasions. For the related list however, 
ecstasy use was associated with greater forgetting at all levels. The magnitude of 
ecstasy related effect was large at level 3 (g = -.94) and still moderate at level 4 (g = 
-.49), indicating that even when a word had been consistently recalled four times, 
ecstasy users had a tendency to forget, which would suggest a retrieval deficit. One 
experimenter (the author) observed that when recalling words from the related list, 
there was a tendency for some participants to forget an entire category during trial 4 
or 5 (eg. forgetting all the words from the “types of material” category), which 
resulted in considerably lower recall. It is possible that this tendency has contributed 
to the larger magnitude effect of ecstasy use for forgetting on the related compared to 
the unrelated list.   
Overall, ecstasy use was associated with a higher incidence of lost access, in 
the absence of concurrent lack of gained access, which suggest that memory deficits 
for ecstasy users are not attributable to deficits in memory acquisition. This is in 
contrast to memory in the aging literature for example, which usually reports deficits 
in both gained and list access for older adults (Dunlosky & Salthouse, 1996; Moulin, 
James, Freeman & Jones, 2004; Woodard, Dunlosky & Salthouse, 1999). This 
pattern of inter-trial gains, in combination with inter-trial forgetting, suggests that 
deficits associated with ecstasy use impact on short term consolidation. Thus, the 
memory traces for words were not strengthened efficiently between trials, and were 
therefore lost. An abundance of research points to a role of the hippocampus in the 
consolidation of to-be remembered items, and previous ecstasy and memory 
literature has reported that the profile of verbal learning memory deficits is most 
consistent with dysfunction in the medial temporal lobes (Fox, Toplis, Turner & 
Parrott, 2001; Fox et al., 2002; Gouzoulis-Mayfrank, Thrimm, Rezk, Hensen & 
Daumann, 2003; Wagner, Becker, Koester, Gouzoulis-Mayfrank & Daumann 
(2011). Neuroimaging data have also indicated a role for the hippocampus in 
memory performance of ecstasy users (Becker et al., 2012; den Hollander et al., 
2011; Daumann et al., 2005; Jacobsen, Mencl, Pugh, Skudlarski & Krystal, 2004; 
Moeller et al., 2005).  
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The Working with Memory model (Moscovitch & Winocur, 2002) suggests 
that it is the interaction between the prefrontal and medial-temporal cortices that is 
crucial for the formation of memories. This interaction between the frontal and 
medial-temporal regions has been supported in the neuroimaging research, with co-
activation of the dorsolateral prefontal cortex and perihinal cortex (Staresina & 
Davachi, 2006) prefrontal cortex and left MTL (Alkire, Haier, Fallon & Cahill, 1998; 
Johnson, Saykin, Flashman, McAllister & Sparling, 2001) and hippocampus and 
perihinal cortex (Strange, Otten, Josephs, Rugg & Dolan, 2002) all being 
significantly correlated with free recall performance. According to the model, 
deliberately attending to a word increases the likelihood that it will be remembered, 
by virtue of the modular hippocampal component which automatically registers any 
information that is consciously processed in to memory. The likelihood of an item 
being strongly encoded and retrieved however is greatly improved if the frontal 
component has imposed some level of organisation to the words. In this sense, the 
frontal component confers ‘intelligence’ on a comparatively modular ‘stupid’ 
hippocampal component.  The more associations formed between words, via either 
semantic or subjective clustering, the higher likelihood of consistent recall. To 
ascertain the extent to which organisational strategies contributed to the learning 
profile of ecstasy users, semantic and subjective clustering of items were evaluated 
for the related and non-related tasks respectively.  
Alterations in prefrontal engagement for regular ecstasy users- semantic and 
subjective organisation contributes to poor verbal memory 
Ecstasy use was associated with a large magnitude deficit in semantic 
clustering on the related list, and although correlations identified recent cannabis use 
as a contributing factor, this effect remained when cannabis use was controlled for. 
This result is consistent with that of Brown, McKone and Ward (2010) who also 
reported poor semantic clustering for ecstasy users compared with drug naïve and 
cannabis using controls. For the unrelated list, there was a moderate effect of ecstasy 
use associated with poorer subjective clustering, and correlations showed this effect 
was related to recency of ecstasy use, but not lifetime use. This was an unexpected 
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finding; the semantic clustering strategy for the related list was embedded in the list, 
and as such it was presumed that this would have been a less cognitively demanding 
strategy to spontaneously engage with when compared to the unrelated list, which 
provided no obvious means to group words by.  In multi-trial, free recall list learning 
tasks, the number of words recalled over learning trials usually increases, and this is 
related to the level of organisation participants impose on the words. As each 
participant brings their own prior knowledge of the words to the task, and creates a 
subjective association between them, no word list is truly unrelated (Tulving, 1977).  
The results from the current study suggest that ecstasy use impairs strategic 
organisation, however limited strategic processing still occurs, and the smaller 
ecstasy related effect for subjective organisation may therefore be due to ecstasy 
users being able to utilise their personal knowledge of associations between words to 
a greater extent than they can mobilise a semantic clustering strategy that is imposed 
on them by the list properties. In this regard, there are more rules to the clustering 
strategy of the related list, and it is perhaps this confinement that impaired the 
ecstasy users to a greater extent than the freer associations that can be generated for 
the unrelated list. There is some support for this from ecstasy users’ performance on 
verbal fluency tasks, in which participants are required to generate semantically 
related items (such as naming different kinds of animals) and phonemic fluency 
tasks, which require participants to generate words beginning with the same letter. 
For successful performance, these tasks therefore require a strategy to assist in 
forming associations between words, but the task parameters are relatively loose. 
Ecstasy use does not consistently impair performance on these tasks (Murphy, 
Wareing, Fisk & Montgomery, 2009; Verbaten, 2010) however for fluency tasks that 
impose more rules to word generation, such as written fluency in which only words 
beginning with the letter “c” and that are four letters long can be generated, ecstasy 
related deficits are apparent (Murphy et al.,2009). Thus, it is possible that ecstasy 
users performed more poorly at semantic relative to subjective clustering due to the 
constrained nature of the strategic organisation required for the related list.  
 
An alternative view is that the ecstasy related effect for subjective 
organisation was reduced because the control participants were attempting to apply 
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multiple strategies simultaneously to the unrelated list to assist with recall. These 
strategies may include mental rehearsal/repetition, visualisation and making a story 
out of the words. These competing strategies may have hindered control participants’ 
ability to organise words as quickly as they did in the related list, which in turn may 
have increased their reliance on medial-temporal structures to consolidate the words.  
Lower scores for people with frontal lobe lesions have been reported for 
semantic  (Alexander, Stuss & Gillingham, 2008; Gersherg & Shimamura, 1995) and 
subjective (Alexander, Stuss, & Fansabedian, 2003; Gersherg & Shimamura, 1995) 
clustering indices compared with healthy controls on word list learning tasks, 
suggesting organisational strategies in list learning are supported by the frontal 
cortex. Prefrontal activations during encoding reflect the recruitment of specific 
executive processes that enhance encoding and retrieval of new episodic memories 
(Blumenfeld & Ranganath, 2007; Spaniol et al., 2009) and neuroimaging studies 
have demonstrated the involvement of the prefrontal cortex in semantic clustering 
for healthy adults. Fletcher, Shallice and Dolan (1998) used PET and a list learning 
paradigm that varied the degree of organisational difficulty in order to study the 
neural correlates of semantic clustering. During the condition that most closely 
matched the related list task in the current study, participants had to impose semantic 
clustering without being provided with a category cue. Fletcher and colleagues 
observed increased blood flow to the left dorsolateral prefrontal cortex during this 
condition, which was not apparent in the less demanding condition, in which words 
were already grouped in their categories.  These findings were later replicated in a 
very similar study which used fMRI to examine the neural processes associated with 
semantic clustering, with the addition of observed involvement of the inferior 
dorsolateral prefrontal cortex (Savage et al., 2001).  
Alterations to neural activity in the dorsolateral prefrontal cortex have also 
been reported for regular ecstasy users (Bosch et al., 2013; de Win et al., 2007; 
Moreno-Lopez et al. 2012) and markers of neuronal integrity have been shown to be 
reduced in the frontal cortex of ecstasy users, and this reduction was significantly 
correlated with previous exposure to ecstasy (Reneman et al., 2002). Neuroimaging 
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research has also linked memory updating to the dorsolateral prefrontal cortex 
(D’Espositio, Postle & Rypma, 2000; Jonides & Smith, 1997). Memory updating 
refers to processes that involve actively manipulating incoming information, and as 
such is not dissimilar to engaging in organisational strategies such as mentally re-
ordering a list of words to enhance consolidation and recall. Following a series of 
studies designed to assess which component (inhibition, switching or updating) of 
executive functions is most affected by ecstasy use (Fisk, Montgomery, Murphy & 
Waring, 2004; Montgomery, Fisk, Newcombe & Murphy, 2005), Fisk and 
Montgomery (2008) reported that regular ecstasy users were more impaired relative 
to cannabis users and drug naïve controls on tasks that require memory updating. 
Using PET to assess regional cerebral glucose metabolism (rMRGlu) and verbal 
memory performance (RAVLT) Bosch and colleagues reported decreased rMRGlu 
in the dorsolateral prefrontal cortex, bilaterally for ecstasy users (n = 19, mean 
lifetime dose = 457.9) compared with drug naïve controls. The decreased 
metabolism in the dorsolateral prefrontal cortex was negatively correlated with 
lifetime ecstasy use, and negatively correlated with ecstasy users scores on Total and 
Delayed recall of the RAVLT. Overall, the findings from the list learning indices 
indicate that ecstasy users were not as successful as non-users in self-initiating 
organisational strategies to assist with verbal learning and this limited strategising 
has contributed to the lower recall scores for ecstasy users relative to cannabis and 
drug naïve controls.  
Deficient organisational strategies and inter-trial consolidation contribute to verbal 
memory impairments associated with ecstasy use 
The present study has identified several cognitive processes that account for 
ecstasy users’ performance on list learning tasks. With the exception of impaired 
delayed recall, which was associated with poly-drug use, the drug related effects 
found for the various measures of list learning were related to ecstasy and not 
cannabis use. The Ecstasy-present group showed deficits of a large magnitude on 
Total recall, Forgetting rate, lost access to words and Semantic clustering. For Trial 1 
and Recognition however, the ecstasy group’s performance did not significantly 
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differ from the others, although the effect size for Trial 1 (g = -.36) was larger than 
that of Recognition (g = .15). Immediate memory span has limited capacity for 
elaborative processing as it is measured after the first list presentation, and reflects 
memory for the number of items that can be held in memory at one time, rather than 
ability to learn. Recognition tasks also require less effortful processing, as all the 
studies items are available at test, and participants can then rely on recent familiarity 
with the words to determine whether or not they were on the list. Alternatively, 
retrieving and learning words require a set of more complicated cognitive skills 
relative to a test of immediate span and recognition, suggesting that when these more 
demanding processes are required, the presence of a history of ecstasy consumption 
impairs task execution. Thus, these results suggest that for ecstasy users, basic 
memory span and recognition of familiar items remain intact, however 
organisational strategies, consolidation and retrieval of newly learnt verbal material 
is impaired. The finding that ecstasy use impairs the execution of these more 
complex operations is consistent with the suggestion that verbal memory deficits for 
ecstasy users are dependent on the cognitive complexity of the tasks (Brown, 
McKone & Ward, 2010).  
Evaluation of inter-trial gains and losses indicated that the lower recall for 
ecstasy users compared to non-users was a consequence of losing more words 
between learning trials, which is a consolidation or retrieval deficit. The ability to 
consolidate and retrieve words relies on a network comprising hippocampal/MTL 
memory mechanisms that enable associative and binding processes which support 
consolidation, as well as cognitive control processes mediated by the dorsolateral 
prefrontal cortex that enable strategic encoding and retrieval processes. During 
encoding, the interaction between frontal and hippocampal regions provides 
elaborated representations of target items that can be consolidated and stored. At 
retrieval, these interactions act to monitor stored information and specify retrieval 
cues. Thus, imposing organisation on to-be remembered items at either encoding or 
retrieval strengthens the memory trace in the hippocampus and increases the 
likelihood that words will be consistently recalled. Although the ecstasy users in the 
current study did initiate some semantic and subjective clustering, indicating that 
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they were aware this could be beneficial for task performance, they were unable to 
engage this strategy effectively enough to strengthen consolidation, and subsequently 
lost access to previously recalled words. 
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Chapter 8 
Study 3. The Effects of Ecstasy Use on Source Memory. 
 
Summary of the previous study 
The previous chapter investigated whether ecstasy use is associated with 
explicit verbal memory deficits, and if so, whether these deficits can be attributed to 
impaired strategic or storage processes equally. The results showed a clear pattern of 
deficient memory performance on a related and non-related list learning task for 
ecstasy users relative to drug naive controls, and that this result was not influenced 
by cannabis use. This was interpreted as indicating that lower recall scores for 
ecstasy users are due to a combination of reduced learning and storage capacity, as 
well as impaired ability to engage in strategic processes that can enhance verbal 
memory. Thus far, the results are suggestive of neurocognitive alterations in both the 
prefrontal and hippocampal networks associated with verbal learning.  
 
This chapter continues to investigate the relative contribution of different 
memory processes towards the verbal memory performance of ecstasy users. The 
present study considers the effect of ecstasy use on source memory, which has been 
researched extensively in the memory literature generally, but has thus far been 
neglected in the ecstasy and memory literature. The following section begins with a 
discussion of the difference between item memory and memory for source, as well as 
its neural correlates. A further review of evidence for memory deficits on two 
different types of source memory tasks, one which is primarily a hippocampal 
mediated task; the other which requires more involvement from the frontal strategic 
component of the Working with Memory model is then conducted. This precedes the 
aim of the present study, which is to investigate whether ecstasy users perform 
differently to controls on these two source memory tasks which place different 
demands on the neural components of the working with memory model.  
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What is source memory? 
In everyday events, multiple components of an event need to be bundled 
together to provide the context in which the event occurred. For example, it may be 
important to recall a story relayed by a friend (memory for content) and to also recall 
the person who relayed the story (the source of the story). Thus, memory systems are 
required to bind items and context together to form a complete episodic memory, and 
this additional contextual information allows a memory to be more deeply encoded. 
Binding is a cognitive process elicited by neural mechanisms that link, or associate 
different elements within or between a memory episode and its context (Naveh-
Benjamin, 2000). Contextual information, such as remembering where, when or by 
whom an action occurred, tends to be forgotten, perhaps because the context is not as 
well attended to as the item itself. Studies of verbal episodic memory in ecstasy users 
have investigated memory for items, such as words, numbers or pictures. Episodic 
memory however involves remembering the content (or item) and the context in 
which it was perceived. Memory for context is referred to as source memory, 
associative memory (Naveh-Benjamin, 2000) or source monitoring (Johnson, 
Hashtroudi & Lindsay, 1993).  
 
Is source memory distinct from item memory? 
The distinction between source and item memory appears to have good face 
validity. There are many instances where there is a failure to recall the source of 
information in the presence of intact recollection for the target item. Because such 
tasks require associating multiple components from a scenario into a unitary 
representation, source memory performance in the laboratory is typically poorer than 
that of item memory scores (Craik, Moris, Moris & Loewen, 1990; Glisky, Ploster & 
Routhieaux, 1995; Glisky, Rubin & Davidson, 2001; Janowsky, Shimamura & 
Squire, 1989; Johnson, 1992; Johnson, Hashtroudi & Lindsay, 1993; Moscovitch & 
Winocur, 1992; Shimamura & Squire, 1987; Yonelinas, 1999). Response times for 
making a source memory judgement are longer than recognition (old/new) decisions 
(Johnson, Koumios & Nolde, 1996; Nolde, Johnson & D’Esposito, 1998) and this 
time discrepancy has been attributed to the recruitment of multiple, simultaneous 
memory processes (Johnson, Hashtroudi & Lindsay, 1993; Johnson, 2005) and to the 
more effortful processing requirements of recollection as opposed to familiarity 
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(Curran & Hintzman, 1995; Eichenbaum, Yonelinas & Ranganath, 2007; Yonelinas, 
1999).  
 
In recognition tasks, the exact item presented during the study phase is re-
presented to the participant, who is required to recognise whether the item is old or 
new. This decision can be made using a general sense of whether or not the item was 
recently seen, without having to construct a detailed representation of the past 
episode, a process that is argued to rely on familiarity (Yonelinas, 1999). Source 
judgement tasks however, require the recollection of context-specific details that 
occurred at the time the item was originally presented, thus the item retrieval is 
supported by recollection of some contextual information. For example, the 
participant might be asked to remember whether the word “obey” was presented on 
the left or right side of the computer screen, or in red or blue coloured font.  Source 
memory has been investigated using a variety of different source contexts, including: 
perceptual features of the stimulus item (such as upper or lower case text, font colour 
or auditory qualities such as words presented in a male or female voice, eg. 
Doerkson & Shimamura, 2001; Drag et al., 2009; Troyer, Winocur, Craik & 
Moscovitch, 1999; van Niekirk et al., 2004), modality information (item presented 
via visual or auditory means, eg. Kausler & Puckett, 1981), spatial features (location 
of an item on the screen or in a matrix, eg. Cansino et al., 2012; Spaniol, Madden & 
Voss, 2006), cognitive operations performed at encoding (eg. Davachi, Mitchell & 
Wagner, 2003; Dulas & Duarte, 2011), location (such as in an experimental session 
or from a source outside of the testing session (eg. Craik, et al., 1990), temporal 
aspects (time of day or the temporal sequence of items among a list, eg. Kausler & 
Wiley, 1990) and self information (imagining a word or speaking a word, performing 
an action or saying a word, eg. Cohen and Faulkner, 1989; Hashtroudi, Chrosniak, 
and Johnson, 1989; Hornstein and Mulligan, 2004).  
 
Neural correlates of source memory 
There is also evidence that source and item memory are subserved by 
different neural networks.  A study of source memory in amnesic persons asked 
participants to recall fictitious facts about famous people and to judge whether they 
had learned the fact during the experiment or outside of the experiment. The authors 
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reported that those participants who had difficulty recalling the source of the fact 
also performed at a significantly lower level on tests of frontal lobe function 
(Schacter, Harbluk, & McLachlan, 1984). Many early studies of source memory 
were conducted with people with frontal lobe lesions. Janowsky, Shimamura and 
Squire (1989) examined memory for recently learned facts and memory for the 
source of the facts in persons with frontal lobe lesions and in age-matched older 
adults. They reported that the frontal lesioned group recalled as many facts as the 
controls, however they were less able to correctly identify when and where they had 
learned those facts.  A number of investigations with normally aging older adults 
have supported a role for the frontal lobes in source memory. In these experiments, 
source memory has been found to be disproportionately impaired compared to 
memory for items, and this effect is larger for older adults with reduced frontal lobe 
function (e.g., Craik, Morris, Morris, Loewen, 1990; Glisky, Polster, & Routhieaux, 
1995; Glisky, Rubin, & Davidson, 2001).  Further, studies of people with frontal 
lesions reported that frontal damage often resulted in deficits on source memory 
tasks, while item memory remained at a similar level to control participants 
(Ciaramelli & Spaniol, 2008; Duarte, Ranganath, Knight, 2005; Johnson, O’Connor, 
& Cantor, 1997; Schacter, Harbluk, & McLachlan, 1984; Shimamura & Squire, 
1987; Simons, Verfaellie, Galton, Miller, Hodges, & Graham, 2002).  These lesion 
studies led some researchers to argue that it was the frontal rather than temporal 
lobes that were crucial for accurate source monitoring (eg. Butters, Kaszniak, Glisky, 
Eslinger, & Schacter, 1994; Glisky, Polster & Roiuthieaux, 1995; Glisky, Rubin & 
Davidson, 2001; Milner, Corsi & Leonard, 1991).  
 
Consistent with lesion studies, neuroimaging results have provided evidence 
that the frontal lobes are very active during source memory performance for healthy 
young adults (e.g., Hayes, Ryan, Schnyer, & Nadel, 2004; Rugg, Fletcher, Chua & 
Dolan, 1999; Van Petten, Senkfor, & Newberg, 2000) with some research 
implicating the left prefrontal cortex in source monitoring (Duarte, Henson & 
Graham, 2011; Dulas & Duarte, 2011; Hayes, Buchler, Stokes, Kragel & Cabeza, 
2011; Mitchell, Raye, Johnson & Greene, 2006). To directly compare imaging 
results for item and source memory, Dobbins, Foley, Schacter and Wagner (2002) 
required participants to learn words during two different task conditions; judging 
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whether they are unpleasant or pleasant, or abstract or concrete. At the time of 
retrieval, participants were presented with three words; one word that was new, one 
that was seen during the pleasant/unpleasant task and the other during the 
abstract/concrete learning condition. In the item retrieval condition, participants had 
to determine whether or not the new item was new, and for the source retrieval 
condition, participants were required to determine which of the study conditions the 
word was originally presented in. This allowed a direct comparison of brain activity 
associated with item and source retrieval. The left inferior prefrontal cortex showed 
increased activation during source encoding and retrieval, and not during item 
retrieval, and this activation occurred regardless of whether the source judgement 
was accurate. Dobbins et al. thus argued that the areas of the left PFC are required to 
attend to and control aspects of source memory.  
 
Glisky and colleagues (1995) argued for a “double dissociation” between 
item and source memory, stating that memory for content was more reliant on the 
medial temporal lobes and memory for the source of the content required 
engagement of the frontal cortex. They classified older adults based on their 
performance of a battery of neuropsychological tests that assessed frontal lobe and 
medial temporal lobe function. Participants classified with ‘high’ and ‘low’ frontal 
function did not differ on a subsequent test of item memory (correct recognition of a 
target sentence) however the ‘high’ frontal function group outperformed the ‘low’ 
frontal function group on correctly identifying the source of the sentence (male or 
female voice). When the same participants were divided according to their medial 
temporal lobe (MTL) performance, the ‘high’ MTL function group outperformed the 
‘low’ MTL function group for item memory, but the groups did not differ on source 
accuracy. Gilsky and colleagues concluded that although the MTL is involved in 
episodic memory generally and therefore also in source accuracy, the level of frontal 
involvement is more important in determining source accuracy.  
 
However, especially important to source memory performance are processes 
that bind (or associate and organise) features that co-occur with the target item 
during encoding or retrieval. To demonstrate the role of the hippocampus in source 
memory, Starasina and Davachi (2008) devised an experiment that varied the extent 
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to which a target item was bound to its context. On each trial, a target item (eg. a 
shirt) and an associated context (eg. a colour) were presented under one of three 
different binding conditions; for the combined condition, the a blue shirt was 
presented, for the spatially discontiguous condition the target was presented within a 
blue frame (thus increasing the gap between the item and the context) and in the 
spatiotemporally discontiguous condition the colour was presented first, followed by 
a blank screen, followed by the target, thus temporally separating the target from the 
context. The encoding task and the type of association task (linking the target to a 
colour) were held constant, thus hippocampal modulation during encoding could be 
attributed more confidently to changes in the binding requirements of the trial. The 
results indicated that as the gap between the item and context increased in space and 
time, so did hippocampal activation during encoding. Consistent with this 
interpretation, Rugg and colleagues (2012) reviewed eight fMRI studies that 
investigated hippocampal activity during source memory tasks and concluded that 
hippocampal activity covaried with the degree to which source information was 
encoded or retrieved. Studies of episodic memory in general have long established 
the role of the hippocampus in this binding process (for reviews see: Bird & Burgess, 
2008; Simons & Spiers, 2003; Squire, Clark, Stark & Clark, 2004; Wixted & Squire, 
2011). fMRI studies have repeatedly demonstrated activation of the hippocampus 
during encoding to be associated with subsequent accurate source retrieval (Cansino, 
Maquet, Dolann & Rugg, 2002; Davachi, Mitchell & Wagner, 2003; Diana, 
Yonelinas & Ranganath, 2007; Dobbins, Rice Wagner & Schacter, 2003; 
Giovanello, Schnyer, & Verfaellie, 2009; Kensinger & Schacter, 2006; Mayes, 
Montaldi & Migo, 2007; Preston, Schrager, Dudukovnic & Gabrieli, 2004; Skinner 
& Fernandes, 2007; Starasina & Davachi, 2008; Ranganath et al., 2003) whereas 
increased activation of the perihinal cortex in the medial temporal lobe has been 
associated with item, but not source retrieval  (Davachi, Mitchell & Wagner, 2003; 
Diana, Yonelinas & Ranganath, 2010; Kensinger & Schacter, 2006; Starasina & 
Davachi, 2008; Ranganath et al., 2003).  
 
Overall, although their respective roles are not entirely clear, research to date 
indicates that both the hippocampus and the frontal cortex are required for successful 
encoding and retrieval of source memory. Evidence indicates that the prefrontal 
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cortex is needed for cognitive control processes such as attending to multiple aspects 
of a stimulus which involves increased deliberate monitoring of an episode (eg. 
Dobbins, Foley, Schacter & Wagner, 2002; Johnson, Hashtroudi, & Lindsay,1993). 
These frontal processes have been suggested to work concurrently with the 
hippocampus, which appears to be involved in the formation of rapid associations 
between item and context (eg. Diana, Yonelina & Ranganath, 2010; Starasina & 
Davlich, 2008).  
 
 
Source memory ability declines with age 
The formation of associations (the binding together item and context) is 
significantly compromised with increased age. This has been well demonstrated in 
studies of older adults, in which recognition memory and item memory have been 
shown to be more robust than source memory, which appears to be more vulnerable 
to the effects of aging. Age-related memory impairment begins in early adulthood 
(Raz, 2000; Raz et al., 2005) and has been extensively researched in older adults 
(usually defined as over 60).  
 
In an early meta-analysis, Spencer and Raz (1995) reported that source 
accuracy was significantly compromised by increased age. Their analysis included 
46 studies of source memory in older adults (mean age = 65) all of which included a 
younger aged control group (mean age = 35). They reported a moderate effect of age 
on memory for items (d = 0.58, CI: 0.48 - 0.67) and a large effect of age for source 
memory (d = 0.87, 95% CI: 0.78 - 0.96). The difference between these effect sizes 
was significant. Further, Spencer and Raz reported that age-related deficits in source 
memory were larger for source memory tasks where source information was only 
loosely associated with the target item. For example, it was more difficult for 
participants to recall the quadrant of the screen a word had been presented in than it 
was to recall the colour a word was presented in. They argued that more difficult 
source memory tasks were those in which there was distance between the item and 
the source of the item.  
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Old and Naveh-Benjamin (2008) conducted an updated meta-analysis 
comparing source memory performance between younger and older adults.  They 
reviewed 90 experiments that included 3197 young (mean age = 21) and 3192 older 
participants (mean age = 70). The authors also categorised source memory tasks 
according to the type and difficulty of the binding processes that were required for 
successful task performance. In order to investigate whether some source memory 
tasks were more difficult to perform as a function of increased age, as suggested 
previously by Spencer and Raz (1995) they generated separate effect sizes for each 
task category. The three easier tasks were labelled; Source memory (memory for 
which word was spoken by which voice); Context (memory for which word appeared 
in which font) and Modality (memory for whether a word was seen or heard) and the 
more difficult tasks were labelled Temporal (memory for which word was viewed 
first); Location (memory for where on a screen the word appeared) and Item pairs 
(memory for which two words appeared together). Results showed a significant 
source memory deficit for older compared to younger adults, and source memory 
performance was significantly lower than item memory scores for the older age 
group. Also consistent with Spencer and Raz’s earlier analysis, the age effects 
(weighted average effect sizes) were particularly large for the tasks that required 
more extensive binding processes, such as memory for Temporal order ( d = 1.07, 
CI: 0.65-1.19), Location (d = 1.01, CI: 0.89 – 1.13) and Item pairs (d = 1.02, CI: 0.83 
– 1.20). There were smaller, although still moderate effects of age for Source (d = 
0.73, CI: 0.64 – 0.82), Context (d = 0.82, CI: 0.66 – 0.97), and Modality (d = 0.71, 
CI: 0.49 – 0.94) although older adults scores on Modality tasks did not differ 
significantly from their item memory performance. The meta-analysis therefore 
demonstrated that age related deficits on source memory tasks are distributed 
unequally across task categories, such that variation in the type of item to context 
binding appears to modulate the degree of difficulty and therefore influenced age 
related impairment. Consistent with the meta-analytic findings, within-subjects 
samples have also showed differential effects of age on different types of source 
information. For example, older adults performed more poorly on a temporal source 
task compared to a spatial location source task (Parkin et al., 1995), older adults did 
not differ in the number of correct source judgments for the colour of items but made 
significantly more errors when trying to identify the screen location in which an item 
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was presented (Chalfont & Johnson, 1996) and older adults made fewer correct 
source judgements for the spatial location of pictures, but made a similar number of 
correct source judgements to younger adults for whether a statement was initially 
presented as true or false (Siedlecki, Salthouse, & Berish, 2005).  
 
Memory impairments in older adults have been demonstrated to be associated 
with neurological changes, including volumetric decreases in the hippocampus (Raz, 
Rodrigue, Head, Kennedy, & Acker, 2004) and frontal cortex (Giorgio et al., 2010). 
Studies of normal aging have also demonstrated reduced serotonin transporter in the 
frontal cortex, hippocampus and diencephalon (Blin et al., 1993; Goldberg et al., 
2004; McEntee & Crook, 1991; Meltzer et al., 1998; Meneses, 1999; Michelsen, 
Prickaerts & Steinbusch, 2008; Porter, Lunn & O’Brien, 2003; van Dyck et al., 
2000; Verhoeff et al., 2000; Wong et al., 1984). More recently, decreases of around 
10% per year of have been reported for 5-HT 1A (Bhagwagar et al., 2004; Moller, 
Jakobsen & Gjedde, 2007) and 5-HT 1B (Matuskey et al., 2012) receptor binding in 
both the frontal and temporal cortices in healthy human subjects.   
 
There is presently little doubt that serotonin modulates acetylcholine release 
of the central cholinergic system and plays a role in neurotransmission via 
cholinergic pathways to the hippocampus and frontal cortex and that experimental 
disruption to the serotonergic system, in rodents, produces spatial memory 
impairments (Decker & McGaugh, 1991; Richter-Levin & Segal, 1993; Steckler & 
Sahgal, 1995; Ruotsalainen et al., 1998). Serotonin induced neural plasticity, as 
shown in studies of long-term potentiation and long term depression, is believed to 
play a key role in the encoding and retrieving of memories (Buhot, Martin & Segu, 
2000; Michelsen, Prickaerts & Steinbusch, 2008). It is plausible therefore that 
perturbation in serotonergic transmission may alter frontal- and hippocampal- 
dependent source memory, and evidence from the effects of an acute tryptophan 
depletion (ATD) study suggests this may be the case. McAllister-Williams, Massey 
and Rugg (2002) investigated the effect of ATD on source memory. They required 
participants to learn words that were presented in a male or female voice. At test, 
participants completed a recognition task (old/new judgements) and if the word was 
judged as old, participants were required to recall the gender of the voice that had 
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presented the word (source test). There were no differences between the ATD 
condition and placebo for recognition scores, however ATD significantly reduced 
the number of correct source judgements. This result mimics the age-related effect of 
poorer source memory relative to recognition memory. Further, the neural correlates 
of episodic retrieval, measured by ERP amplitude and topography were not affected 
by ATD, leading the authors to suggest that processes other than retrieval (eg. 
encoding/consolidation) were impaired by reduction in serotonin synthesis.   
 
If the age related decline in serotonin availability is a catalyst for memory 
deficits for older adults (Chen et al., 2000; Hendricksen, Thomas, Ferrier, Ince & 
O’Brien, 2004; Meneses, 1999; Michelsen, Prickaerts & Steinbusch, 2008; Wong et 
al., 1984) and given the parallel between recognition and source memory 
performance between older adults and younger adults during conditions of reduced 
serotonergic functioning, it is plausible that serotonin transmission assists in the 
binding processes required for source memory. Further, in a review of the serotonin 
and learning and memory literature in rodent and human studies, Buhot, Martin and 
Segu (2000) suggest that serotonin plays a crucial role in situations of increased 
cognitive demand, thus explaining why memory deficits under conditions of reduced 
serotonin functioning are often observed for more difficult tasks. This suggestion 
could potentially explain the intact recognition performance of older adults in the 
presence of a pronounced source memory deficit.  
 
The reviewed research indicates that source memory is distinct from item 
memory and that part of this distinctiveness is the necessity to bind items together to 
form a unitary representation. This binding process requires additional processing 
than that of item memory and has been suggested to involve collaboration between 
the hippocampus and the frontal cortex. A number of studies have found 
disproportionate deficits in source memory compared to item memory in older 
adults, and this may be partially explained by a negative relationship between age 
and serotonin reserve. It could also be explained by reduced functional connectivity 
between these regions, reduced frontal functioning (Glisky et al., 2001) or cell 
atrophy in one or both of these regions. The age related deficit for source memory is 
not equal across tasks however, with two meta-analyses showing that the age related 
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impairments vary depending on the type of item to context binding required for 
successful task execution. This may be due to an increase in the distance between the 
to-be-remembered components, which increases the difficulty of the source task and 
therefore requires greater hippocampal involvement (Rugg et al., 2012; Starasina & 
Davachi, 2008).  
 
The variability in age related findings for source memory performance 
prompted Spencer and Raz (1995) and Moscovitch (1992) to distinguish two 
different types of source memory tasks. Some elements of source information are 
intrinsic to the target items, and this form of contextual detail is referred to as 
stimulus bound (Spencer and Raz, 1995) or associative (Moscovitch, 1992). 
Examples of stimulus bound features include the medium in which content 
information is presented (such as the font colour of a target word or the gender of the 
voice it is presented in). Associative source information is more directly connected 
to the target item, and is therefore more easily encoded because the content and 
context are concurrently encoded. Spencer and Raz (1995) suggest that this is the 
reason why the magnitude of age differences in associative memory were small and 
equivalent to age differences in item memory. In contrast, other source information 
is extrinsic to the target items, and this form of source is referred to as 
organisational (Moscovitch, 1992) or spatial temporal (Spencer & Raz). Examples 
of organisational source features include memory for spatial location or temporal 
order, both tasks for which there was a greater magnitude in age deficits. This 
information is further removed from the target item and therefore encoding is more 
effortful as it requires greater strategic binding together of content and context. Some 
researchers explain age deficits for these organisational tasks as indicative of the 
higher demands placed on strategic frontal functions for successful task performance 
(Troyer, Winocur, Craik & Moscovitch, 1999).    
 
According to the Working with Memory model, the hippocampal component 
is responsible for making associations among features within a discrete episode and 
binding these into a memory trace. The frontal component works with the 
hippocampus to engage in cognitive control processes that assist in encoding and 
retrieval. Moscovitch and Winocur (1992) suggest that source memory is a working 
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with memory task as it requires involvement of the frontal system to elaborate the 
link between the item and the context.  They argue that due to the predominance of 
frontal lobe changes in older adults, and the pattern of results from the meta analyses 
indicating a particular disadvantage for older adults on organisational rather than 
associative source memory tasks, that associative tasks may require less involvement 
of the frontal component than organisational tasks. This model therefore offers an 
explanation as to why the Spencer and Raz (1995) and Naveh-Benjamin and Old 
(2008) meta-analyses reported larger effects for the tasks that required an item to 
associated with a location, which presumably requires more frontal and hippocampal 
involvement, than those tasks where the source is more intrinsic to the item, such as 
words presented in a particular colour or font. Thus, although it is clear from the 
reviewed literature that both systems are required for accurate source memory 
performance, the relative contribution of each region may vary as a consequence of 
binding requirements.  
 
Associative learning deficits in regular consumers of ecstasy  
The present experiment was designed to investigate whether source memory 
is impaired for people who take ecstasy, and if so, to assess whether this impairment 
is equivalent between an organisational and associative source memory task. Both 
older adults and ecstasy consumers have been reported to have a reduction in 
serotonin markers in various brain regions, and given the poor source memory 
performance of older compared to younger adults, it is plausible that ecstasy users 
may be deficient in the binding processes required for successful source memory 
performance. Previous research has investigated the effect of ecstasy use on paired 
associates tasks, which require participants to form a link between two or more 
previously unrelated items, and thus require the binding processes that are inherent 
to source memory tasks. For example, Montgomery, Fisk and Newcombe (2005) 
found an ecstasy related deficit on various associative learning measures, however 
for a measure of forgetting they reported that cannabis use accounted for poorer 
performance amongst ecstasy users. Gallagher et al., 2012 also reported poorer 
associative learning for ecstasy users relative to poly-drug and drug naïve controls, 
however a higher frequency of false positives for recent cannabis users was also 
evident. The clearest evidence of an associate learning deficit for ecstasy and not 
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cannabis users has been reported by Brown, McKone and Ward, (2010) who 
reported poorer performance for ecstasy users compared with drug naïve and 
cannabis using controls on a Verbal Triplet Associates task. This task consisted of a 
learning phase whereby the same list of word triplets (eg. frog-chair-apple) was 
presented to participants five times, so that they may learn the associations between 
the words. At test, they were presented with the first word (eg.frog) and were 
required to free recall the remaining two (chair and apple). Thus, they were required 
to use binding processes to learn the associations between words. Despite multiple 
list presentations, Brown et al., found that ecstasy users were unable to improve their 
performance on the verbal triplets task to the level of the drug naïve and cannabis-
using control groups. To date, the limited literature on the effects of ecstasy on 
associative learning does not provide clear evidence for an ecstasy related 
impairment of the binding processes involved in executing source memory tasks.  
 
The present study further examines the effects of ecstasy on associative 
learning by comparing ecstasy users and non-users on source memory performance. 
The aim of the study was to assess for differences in performance between ecstasy 
users and non-ecstasy users on two source memory tasks that vary in difficulty of the 
item to context binding requirements. Previous research has identified a 
disproportionate deficit between associative and organisation source memory tasks 
for older adults, who typically perform worse on the more challenging organisational 
source memory tasks (Old & Naveh-Benjamin, 2008; Spencer & Raz, 1995). For the 
present study, a Location and Colour source memory task have been chosen as the 
organization and associative tasks respectively.  The reviewed literature on aging and 
source memory, and the Working with Memory model would predict that ecstasy 
users perform more poorly than the non-ecstasy users on the Location task compared 
to the Colour task, since both the hippocampal and frontal components are required 
for successful source memory performance.  
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Method 
 Participants 
The present study was conducted at the same time as the list learning experiment 
reported in Chapter 7. The participants are described in the Method section of that 
chapter. Table 8.1 below provides a summary of the group characteristics. The 
groups were well matched for sex, age and estimated IQ and the differences in 
cannabis and ecstasy use were consistent with group selection criteria.  
 
Table 8.1  
Selected Characteristics of the Drug Groups in the Source Memory Study 
 
 
 
 Drug 
naïve 
control 
 (n=20) 
Cannabis-
only (n=15)  
Ecstasy-
only 
 (n=16) 
Ecstasy- 
plus-cannabis 
 (n=17) 
 
 
 
 
F 
 
 
 
p 
 
Sex (% 
female) 
 
 
  
52.4% 
 
40% 
 
56.3% 
 
47.1% 
 
χ² = 
0.94 
 
 
0.81 
Age (years) 
 
 25.3 
(7.9) 
 
24.2 (5.2) 22.9 
 (2.2) 
21.2 
 (2.3) 
2.1 0.11 
 
General  
Intellectual 
Functioning 
(WTAR) 
 
  
109.6 
 (11.1) 
 
112.8 
 (11.2) 
 
109.5 
 (8.7) 
 
107.6 
 (12.3) 
 
0.6 
 
0.59 
Ecstasy-Days 
used in past 6 
months  
 
 0.00 0.00 13.69 
(7.09) 
16.12 
 (11.42) 
  
Cannabis- 
Days used in 
past 6 months 
Δ
 
 0.00 39.07 
(34.78) 
0.38 
(.71) 
49.76 
 (36.79) 
19.65 <.001 
EC, C 
> E, N 
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Source memory stimuli and apparatus 
 The stimuli used in both tasks consisted of 116 nouns, all six letters in length, 
selected from the Medical Research Council Psycholinguistic Database (Colthart, 
1981, available online at http://www.psy.uwa.edu.au/mrcdatabase/uwa_mrc.htm). The 
words (in Appendix B) were of moderate frequency with an average Kucera-Francis 
(Kucera-Francis, 1967) frequency of 61, ranging from 40 – 100. The average 
Concreteness rating was 432, ranging from 275 – 600 (with 100 being low and 700 
being high). These parameters were chosen to reduce the advantage for low 
frequency and highly concrete words in recognition tests (eg. Christian, Bickley, 
Tarka & Clayton, 1978; Gillund & Shiffrin, 1984; Gorman, 1961). From these 
words, six list blocks were created, matched for word frequency and concreteness; 
three for the Colour source task, and three for the Location source task. 
 
The experimental tasks were created and run in Inquisit (Version 2.0 ). Task 
administration was computerised, using an IBM compatible computer with a 40 
centimetre screen. All words were presented in Ariel, 36 point font. For the Location 
task, all words were presented in black. Viewing distance was approximately 65 cm. 
from the screen. The presentation order of the colour and location tasks was 
counterbalanced across participants within each group.  
 
Colour task procedure (associative source memory task) 
 This task required participants to learn and recall the colour associated with a 
word stimulus. There were three stages to this task: Due to the complex nature of the 
response requirements, there was an initial response practice phase to allow 
participants to become familiar with where the response buttons were placed on the 
keyboard. During response practice a colour word (eg.  “green”) was presented in the 
middle of the screen in congruent coloured, 36 point, Ariel font. Participants were 
asked to respond by pressing the same coloured button as the colour on the screen. 
There were 18 trials, three for each colour and colour names were presented 
randomly for each participant.  
 
 Following response practice, the encoding phase began. During this phase of 
the task, words (non-colour words, e.g. “show”) were presented one at a time, in a 
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different, pseudo random order on each trial (constrained so that words presented in 
the same colour were not displayed consecutively). Each word was presented once, 
in the middle of the screen in one of a possible six colours.  Words remained on the 
screen for a duration of 2000 milliseconds, with an inter-stimulus interval of 250 
milliseconds.  Participants were instructed to memorise both aspects of the stimuli 
(the word and the colour it was presented in).  
 
 In the recall phase, the same words were presented individually in black font 
in the middle of the screen and participants were asked to think back to when they 
saw the word the first time, and indicate which colour it was presented in by pressing 
the corresponding coloured button on the keyboard. The words remained on screen 
until participants responded. There were three blocks, the first of which was 
designated practice, consisting of 18 trials each, making the highest score achievable 
36. Participant responses (accuracy and reaction time) were recorded by the 
program.  
 
Location task procedure (organisational source memory task) 
 The structure of the location task was the same as for the colour task. During 
response practice, the name of one of six locations (upper left, upper middle, upper 
right, lower left, lower middle, and lower right) appeared in the corresponding 
position on the screen, and participants were asked to press the corresponding button 
on the keyboard. There were 18 trials, three for each location and location names 
were presented randomly for each participant.  
 
Following response practice, the encoding phase began. During the encoding 
phase of the task, words were presented one at a time, in a different, pseudo random 
order on each trial, so that words of the same location were not displayed 
consecutively. Each word was presented once only in one of six locations on the 
screen. Each word remained on the screen for duration of 2000 milliseconds, with an 
inter-stimulus interval of 250 milliseconds.  Participants were instructed to memorise 
both aspects of the stimuli (the word and the location it was presented in). 
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 In the recall phase, the same words were presented individually in black font 
in the middle of the screen and participants were asked to think back to when they 
saw the word the first time, and indicate which location it was presented in by 
pressing the button that corresponded to the location. There were six white buttons 
on the keyboard, the placement of which corresponded to the six locations the words 
were presented in (upper left, upper middle, upper right, lower left, lower middle and 
lower right. The words remained on screen until participants responded. There were 
three blocks, the first of which was designated practice, consisting of 18 trials each, 
making the highest score achievable 36. Participant responses (accuracy) were 
recorded by the program.  
 
Design 
The current study used a factorial design, with between-subject factors of 
Ecstasy-use (present, absent) and Cannabis-use (present, absent) and number of 
correct source judgments as the within-subjects factor.  
 
Results 
As expected, there was a significant effect of Task (F (1,65) = 12.35, p = 
.001, g = .53) with all participants making more correct source judgments on the 
Colour task (M = 19.02, SD = 5.17) compared with the Location task (M = 16.44, SD 
= 4.32).  
There was no effect of Cannabis use, F (1,65) = 0.20, p = 0.660, however 
there was a significant effect of Ecstasy use (F (1,65) = 4.49, p = .038, g = -.50) on 
source judgements. Overall, the Ecstasy-present group made fewer correct source 
judgments (M = 16.20, SD = 1.03) compared with the Ecstasy-absent group (M = 
19.26, SD = 6.03).  
The Task  Ecstasy (F (1, 65) = .68, p = .412) and Task  Cannabis (F (1, 
65) = 1.12, p = .294) interactions were not significant, however the Task  Cannabis 
x Ecstasy interaction approached significance (F (1,65) = 3.05, p = .085) and is 
presented in Figure 8.1.  To clarify the interaction, separate between subjects 
analyses were conducted for the Colour task and for the Location task. For the 
Colour task, the effects of Ecstasy (F(1,65) = 2.03, p = 0.159, g = -.43) and Cannabis 
use  (F (1,65) =0.67, p = 0.415, g = -.19) on source judgment accuracy were not 
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significant, and the Ecstasy x Cannabis interaction (F (1,65)=1.41, p = 0.239) was 
also non-significant.  
For the Location task, the effect of Cannabis was not significant (F (1,65) = 
0.01, p = 0.928) and Ecstasy and Cannabis were not involved in any interactions (F 
(1,65) = 0.11, p = 0.737). There was a significant, moderately sized effect of Ecstasy 
(F (1, 65) = 5.93, p = .018, g = -.57) however, with the Ecstasy-present group 
making significantly fewer correct source judgements than the Ecstasy-absent group.  
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Figure 8.1. Mean number of correct source judgements on the Colour and Location 
tasks according to Ecstasy and Cannabis use (error bars represent standard errors). 
 
Examining possible dose dependence effects 
In order to evaluate whether there are dose dependent effects of drug use on 
source judgements, bivariate correlations were conducted between mean number of 
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correct source judgements for the Colour and Location source tasks and possible 
covariates, including cannabis, ecstasy and methamphetamine consumption, the 
correlations of which are reported in Table 8.2 below. The extent of cannabis use 
was not significantly correlated with either Colour or Location source judgements. 
Consistent with the Ecstasy effect for the Location but not Colour task data, ecstasy 
use was significantly correlated with Location source judgements, with greater 
frequency of ecstasy use in the preceding six months associated with lower location 
source accuracy. Although methamphetamine use in the previous six months was not 
significantly correlated with performance on either source memory task, there was a 
significant correlation between lifetime methamphetamine consumption and source 
accuracy for the Location task. Partial correlations revealed that when lifetime 
methamphetamine use was controlled for, the correlation between ecstasy use in the 
preceding six months and Location scores was no longer significant (r = -.16). There 
was a significant, positive correlation between lifetime methamphetamine use and 
ecstasy use in the preceding six months (r = .34, p <.01), which indicates that when 
controlling for methamphetamine use, the effect of ecstasy use on Location scores 
are also partially removed. Methamphetamine use may therefore be partially 
responsible for the poorer Location task performance for the ecstasy using group, 
although it does not rule out the co-contribution of the effect of ecstasy.  
Further, lifetime methamphetamine consumption was entered as a covariate in 
ANCOVA but was not found to be a significant covariate of Location source 
judgments, thus the original, unadjusted, analyses are retained.  
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Table 8.2 
Bivariate Correlations between Ecstasy, Cannabis and Methamphetamine use and 
Source Judgements.  
 Colour Source Recall Location Source Recall 
 
Days used Ecstasy in last 
6 months 
 
-.13 -.26* 
Lifetime occasions of 
Ecstasy use 
 
.02 -.11 
Days used Meth. in last 6 
months 
 
-.12 -.22 
Lifetime occasions of 
Meth. Use 
 
-.13 -.32** 
Days used Cannabis in last 
6 months 
 
-.03 -.15 
Lifetime occasions of 
Cannabis use 
 
.05 .08 
Colour source recall 
 
 .60** 
Notes: * p < .05, **p < .01 
 
 
 
 Chapter 8. Study 3. The effects of ecstasy use on source memory 
 
  184 
 
Discussion 
The aim of the present study was to assess for differences in performance 
between ecstasy users and non-ecstasy users on two source memory tasks that vary 
in difficulty of the item to context binding requirements. In the Colour Task, the 
source (colour) was intrinsic to the item (the word) and this task is referred to as 
associative (Moscovitch, 1992) whereas in the Location task, referred to as 
organisational, the word was presented in a particular location on the screen, and 
thus the source is removed from the item to a greater extent that the colour task. 
Previous research has identified a disproportionate deficit between these tasks for 
older adults, who typically perform worse on organisational compared to associative 
tasks (Old & Naveh-Benjamin, 2008; Spencer & Raz, 1995).  
 
Summary of the present findings 
 Source accuracy was significantly reduced in the Location task compared to 
the Colour task, and this was evident for all drug using groups. This pattern of results 
is commonly reported in the source memory literature and confirms that the 
organisational (location) task was more difficult to execute than the stimulus bound 
(colour) task, supporting the efficacy of the experimental design.  The effect size 
indicated that on average, participants performed half a standard deviation lower on 
the Location task, which is a moderate magnitude effect.  
 
The between-groups comparison failed to reveal any effect of Cannabis, 
indicating that in the present sample, cannabis use did not affect source memory 
performance. The overall analysis showed a detrimental effect of ecstasy use on 
source memory performance, although there was a trend (p = 0.08) for an Ecstasy x 
Cannabis x Task interaction. When separate analyses were conducted for each task, 
there was a moderate magnitude (g = -0.43), non-significant effect of ecstasy for the 
colour task and a larger magnitude (g = -0.57), statistically significant deficit for 
ecstasy users on the location task. This result mirrors that of the source memory and 
aging meta-analyses, with both ecstasy users and older adults performing worse on 
the organisational compared with the associative task. The absence of a Cannabis 
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main effect and an Ecstasy x Cannabis interaction suggests that this effect was 
apparent for ecstasy users regardless of whether they used cannabis or not, indicating 
that this result is not related to cannabis use.   
 
Unexpectedly, results from the current study revealed that when lifetime 
methamphetamine use was controlled for, the negative relationship between ecstasy 
use in the preceding six months and Location scores was no longer significant. 
However, as there was also a significant relationship between ecstasy use in the 
preceding six months and lifetime methamphetamine use (participants who used 
more ecstasy in the last six months also had higher levels of lifetime 
methamphetamine use (r = .34) the partial correlations are not conclusive. 
Nevertheless, the possibility that higher rates of lifetime methamphetamine use are 
associated with poor source memory cannot be completely dismissed, and the cross-
sectional design of the current study cannot attribute any causality to either ecstasy 
or methamphetamine use.  
 
The present study has shown for the first time an ecstasy related deficit on 
source memory performance. Previous research has investigated the effect of ecstasy 
use on the broadly related methodology of paired associates tasks. These tasks 
require participants to form a link between two or more previously unrelated items, 
and thus require the binding processes that are inherent to source memory tasks. 
Consistent with the present study, ecstasy users have been reported to be impaired on 
various measures of verbal associates tasks (Brown, McKone & Ward, 2012; 
Gallagher, et al., 2012; Fisk, Montgomery, Wareing & Murphy, 2006; Montgomery, 
Fisk & Newcombe, 2005) although cannabis effects were also associated with higher 
rates of forgetting (Montgomery et al., 2005) and a greater number of false positives 
(Gallagher et al., 2012). In the present study, the potentially confounding effect of 
cannabis was controlled for by including a Cannabis group with very limited poly-
substance use, demonstrating no group effects of Cannabis for source memory and 
no significant relationships between cannabis use and source memory.  
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Source memory deficits are associated with alterations in prefrontal and 
hippocampal functioning 
 These results have demonstrated some similarities between regular 
consumers of ecstasy and older adults with regard to their source memory 
performance. The meta-analyses by Spencer and Raz (1995) and Old and Naveh-
Benjamin (2008) showed older adults performing more poorly overall, as well as 
having impairments of a smaller magnitude on the easier, associative tasks, such as 
judging whether a word was seen or heard (d = 0.71, 95%CI: 0.49 – 0.94), and larger 
magnitude effects for older compared to younger adults on the more difficult 
organisational (Location) source memory tasks (e.g. d = 1.01, 95%CI: 0.89 – 1.13). 
In the present study, ecstasy users also had poorer source memory performance 
compared with non-users, however separate task analyses showed an effect size that 
was small in magnitude, though non-significant for an ecstasy related deficit on the 
associative task (d = -0.43), and a significant deficit of moderate magnitude for the 
organisational task compared with cannabis users and drug naïve controls (d = -
0.57). As such, the trends apparent in both the ageing and ecstasy consumer data 
were consistent, with both older adults and ecstasy users showing more pronounced 
source memory deficits than control subjects on tasks that place greater demands on 
binding processes. Further, inspection of Table 8 shows that the age of the Ecstasy-
only group trends towards being lower than the age of the Drug naïve group. Despite 
their younger age however, the ecstasy using group are still performing worse than 
the older, non-ecstasy users. These findings raise the possibility that there are 
structural, functional and neurochemical similarities between regular consumers of 
ecstasy and older aged healthy adults.   
 
The prefrontal cortex has been posited as one of the structures underlying 
source memory performance and source deficits have been shown to be related to 
frontal lobe damage or impaired executive functioning (eg. Ciaramelli & Spaniol, 
2008; Duarte, Ranganath, Knight, 2005; Johnson, O’Connor, & Cantor, 1997; 
Schacter, Harbluk, & McLachlan, 1984;  Shimamura & Squire, 1987; Simons, 
Verfaellie, Galton, Miller, Hodges, & Graham, 2002) and neuroimaging has shown 
increased activity in prefrontal areas during encoding or retrieval of source 
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information (Duarte, Henson & Graham, 2011; Hayes, Ryan, Schnyer, & Nadel, 
2004; Mitchell, Raye, Johnson & Greene, 2006; Rugg, Fletcher, Chua & Dolan, 
1999; Van Petten, Senkfor, & Newberg, 2000). Impaired frontal functioning has also 
been indicated for regular consumers of ecstasy, who have been demonstrated to 
have deficits in some executive functions (eg. Montgomery, Fisk, Newcombe & 
Murphy, 2005; Murphy, Wareing, Fisk & Montgomery, 2009; Smith, Tivarus, 
Campbell, Hilier & Beversdorf, 2006; Reay, Hamilton, Kennedy & Scholey, 2006) 
and markers of general  neuronal loss in the frontal cortex of regular ecstasy users 
have been significantly correlated with previous exposure to ecstasy (Reneman et al., 
2002). Further, alterations to neural activity in the dorsolateral prefrontal cortex have 
also been reported for regular ecstasy users (Bosch et al., 2013; de Win et al., 2007; 
McCann et al., 2008; Moreno-Lopez et al. 2012.Similarly, age related 
neuropathology has been demonstrated for the prefrontal cortex (Craik, Morris, 
Morris, & Loewen, 1990; Dennis & Cabeza, 2008; Raz, 2000; Raz & Rodrigue, 
2006; West, 1996). Thus, it is possible that ecstasy users, like older adults have 
larger source memory impairments for organisational source tasks that require 
greater executive functions due to structural or functional changes to the prefrontal 
cortex.  
 
The other identified structure involved in source memory execution are the 
medial temporal lobes, and in particular the hippocampus, which has been suggested 
as the structure in which two or more elements of an event are associated or bound 
together to form a memory. For this reason, the hippocampus is considered an 
important structure for the formation of source memories, damage to the 
hippocampus results in significant source memory deficits (eg. Schwert & Dopkins, 
2001; Thaiss & Petrides, 2003) and neuroimaging data has also indicated increased 
activity in the hippocampus during encoding or retrieval of source information 
(Cansino, Maquet, Dolann & Rugg, 2002; Davachi, Mitchell & Wagner, 2003; 
Diana, Yonelinas & Ranganath, 2007; Dobbins, Rice Wagner & Schacter, 2003; 
Giovanello, Schnyer, & Verfaellie, 2009; Kensinger & Schacter, 2006; Mayes, 
Montaldi & Migo, 2007; Preston, Schrager, Dudukovnic & Gabrieli, 2004; Skinner 
& Fernandes, 2007; Starasina & Davachi, 2008). It has been suggested by various 
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authors that the memory impairments reported for ecstasy users may be due to 
functional changes to the hippocampus (Becker et al., 2013; Daumann et al., 2005; 
Fox et al., 2002; Gouzoulis-Mayfrank & Daumann 2009) Further, PET studies of 
regular ecstasy users have shown reductions in hippocampal volume (den Hollander 
et al., 2011) and reduced serotonin receptor binding in the hippocampus (eg. Kish et 
al., 2010).  Likewise, age related neural changes have also been demonstrated in the 
medial temporal lobes (Driscoll et al., 2003; Giorgio et al., 2010; Raz, 2000; Raz et 
al., 2005).   
 
Is there a role for serotonin in source memory deficits for ecstasy users? 
Both older adults and regular users of ecstasy therefore appear to experience 
neural alterations either in the prefrontal or medial temporal cortices, and it is these 
changes that may be responsible for their respective source memory deficits. 
Although the cause of the underlying pathology for these deficits cannot be 
demonstrated in the present research, one commonality between regular ecstasy 
consumers and aging adults is reduced serotonergic functioning. The most robust 
finding from studies using acute tryptophan depletion has been lowered central 
serotonin levels impairs memory consolidation (Mendelsohn, Riedel & Sambeth, 
2009; Scmitt, Wingen, Ramaekers, Evers & Riedel, 2006; Riedel, 2004).  In normal 
aging, there is a reduction in serotonin transporter availability in the frontal cortex, 
hippocampus and diencephalon (Blin et al., 1993; Goldberg et al., 2004; McEntee & 
Crook, 1991; Meltzer et al., 1998; Meltzer, 1999; Meneses, 1999; Michelsen, 
Prickaerts & Steinbusch, 2008; Porter, Lunn & O’Brien, 2003; van Dyck et al., 
2000; Verhoeff et al., 2000; Wong et al., 1984). More recently, decreases of around 
10% per year have been reported for 5-HT1A (Bhagwagar et al., 2004; Moller, 
Jakobsen & Gjedde, 2007) and 5-HT 1B (Matuskey et al., 2012) receptor binding in 
both the frontal and temporal cortices in healthy human subjects. Global reductions 
in SERT binding for people with Mild Cognitive Impairment compared with those 
age matched controls have also been reported (Hasselbalch et al., 2009: Rodriguez, 
Harun, Noristania & Verkhratsky (2012). As discussed in Chapter 3, reductions in 
SERT binding have been demonstrated for regular consumers of ecstasy and some 
studies have revealed an association between the degree of ecstasy use and reduction 
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in SERT levels (Buchert et al., 2003; McCann et al., 2005; Thomasius et al., 2003). 
These SERT reductions are sometimes of considerable magnitude, with Erritzoe et 
al. (2011) reporting SERT levels in medial inferior frontal cortex and superior frontal 
cortex to be 53% and 61% lower in ecstasy users compared with non-users, and 
SERT reductions were correlated with lifetime ecstasy consumption.   Both the 
hippocampus and frontal cortex are innervated by serotonergic axons originating 
from the dorsal and medial raphe nuclei (Buhot, Martin & Segu, 2000) and serotonin 
pathways project from the hippocampus to prefrontal cortex (eg. Berumen, 
Rodriguez, Miledi & Garcia-Alocer, 2012). These regions and the connections 
between them are thus well placed for a role in learning and memory (Michelsen, 
Prickaerts & Steinbusch, 2008) and executive functions (Madsen et al., 2011). The 
present research indicates that ecstasy users have similar source memory problems to 
healthy older adults, and there appears to be other similarities also. For example, 
older adults and regular ecstasy users have both been demonstrated to have deficits 
of prospective memory (remembering to remember, for example, remembering to 
carry out an intended action in the future, eg. Heffernan, Jarvis, Rodgers, Scholey & 
Ling, 2001; Rendell, Gray, Henry & Tolan, 2007; Zakzanis, Young & Campbell, 
2003, for a meta-analytic review of prospective memory and aging see Henry, 
MacLeod, Phillips & Crawford, 2004). Prospective memory is dependent on self-
initiated retrieval processes associated with frontal function (Burgess, Scott & Frith, 
2003; McFarland & Gilsky, 2009; Zakzanis et al., 2003). Ecstasy users have been 
demonstrated to be poor at self-initiating organisational strategies that may assist 
with encoding and retrieval (eg. Brown, McKone & Ward, 2010, reported poor 
semantic clustering for ecstasy users and this result was supported by the findings in 
Study 2) and collaboratively, deficits in source monitoring, organisational strategies 
and prospective memory are consistent with Craik’s (1994) self-initiated processing 
hypothesis which explains age related memory decline as a function of the degree of 
effortful and strategic processes required for successful performance (Craik & 
Salthouse, 2000). The possibility that alterations to serotonergic functioning are 
compromising prefrontal and hippocampal functionality in ecstasy consumers, in a 
similar manner to that of older adults, is one that could be further explored.  
  
 Chapter 8. Study 3. The effects of ecstasy use on source memory 
 
  190 
 
Source memory deficits for ecstasy users are consistent with impaired frontal and 
hippocampal components of the Working with Memory model  
According to the Working with Memory model (Moscovitch, 1992) the 
medial temporal component works in a relatively automated manner to bind events 
together and form a retrievable memory trace. This process is essentially automatic 
for information that is consciously attended to. The frontal component however, is 
strategic in that it is an effortful, self-initiated component that performs operations 
on the memory trace to assist with encoding and retrieval. The frontal component is 
not involved in the storage of information, but rather is involved in the “online” 
monitoring of input at encoding, and strategic retrieval processes, both of which 
work with the MTL to enhance memory performance.  This model would therefore 
predict that associative source memory deficits arise from hippocampal dysfunction, 
and strategic source memory deficits would arise as a consequence of 
disproportionate impaired function of the frontal, relative to the hippocampal 
component. The Ecstasy x Task interaction apparent in the current study appears to 
support this view; the finding that there was a small, non-significant ecstasy related 
effect for the Colour tasks suggests that in this associative task, the hippocampal 
component effectively bound the colour and the word concurrently, so that when the 
word was presented during recall this provided a sufficient cue for all drug groups to 
correctly recall the colour. For the Location task however, the word cue at recall was 
more distal to the context (screen location) and was not sufficient to enable retrieval, 
therefore the frontal component needed to initiate a search process to find an 
associative cue to recover an appropriate memory. There are multiple and reciprocal 
connections between the prefrontal and medial temporal cortices (Remper-Clower & 
Barbas, 2000; Simons & Spiers, 2003) and since both these areas are involved in the 
formation of episodic memories (eg. Cansino, Maquet, Dolan & Rugg, 2002; 
Dobbins, Rice, Wagner & Schacter, 2003; Lucas & Ranganath, 2010; Simons & 
Spiers, 2003) it seems plausible that more complicated strategic source tasks are 
dependent on the integrity of both. Likewise, given ecstasy related dysfunction has 
been reported for both regions and that new evidence is emerging  suggesting that 
functional connectivity between different cortical areas are impaired for ecstasy 
users (Karageougiou, 2011; Salomen, 2011)  the Working with Memory model can 
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theoretically explain the regions most associated with source memory deficits for 
ecstasy users.  
 
Is there a role for dopamine in impaired source memory? 
 Although there is some evidence to support the view that altered serotonergic 
functioning in the prefrontal and medial temporal cortices is the neuropathology that 
underlies source memory deficits in the current study, an alternative explanation 
should be considered, predominantly because of the finding of a significant 
relationship between lifetime methamphetamine use and Location task scores. 
Although MDMA causes release of dopamine acutely, its long term effects appear to 
be more selective to serotonin (Gudelsky & Yamamoto, 2008). Methamphetamine 
however, is a dopamine agonist which exerts its effects primarily via the 
dopaminergic system. Dopamine receptors are abundant in the prefrontal cortex and 
are believed to underlie some executive functions (Gonzalez-Burgos & Feria-
Velasco, 2008) that are related to source memory retrieval (Piloino, Lamidey, 
Desgranges & Eustache, 2007). Executive dysfunction is sometimes reported for 
regular methamphetamine users (eg. Nestor, Ghahremani, Monterosso & London, 
2011; Simon, Domier, Carnell, Brethen, Rawson & Ling, 2002 ) and PET studies 
have revealed reduced dopamine transporter densities (-33.3%) in the  prefrontal 
cortex of regular methamphetamine users compared with drug naïve controls (Sekine 
et al., 2003) and decreases in DAT have also been reported for the orbitofrontal and 
dorsolateral prefrontal cortex (Sekine et al., 2006). Furthermore, in a review of acute 
phenylalanine/tyrosine depletion (APTD) studies (a monoamine challenge procedure 
like acute tryptophan depletion, which reduces central dopamine availability) Booij, 
Van de Boes and Riedel (2003) concluded that acute tryptophan and ATPD 
procedures affect different cognitive functions, with ATD impairing long term 
memory consolidation, and APTD primarily impairing working memory. Since 
methamphetamine use was correlated with Location scores, which are more 
dependent on the integrity of the prefrontal cortex, and not the Colour task, which 
may rely primarily on the hippocampus which is more closely associated with verbal 
learning and memory, it is possible that dopaminergic fluctuations in the prefrontal 
cortex have impacted on source memory performance in the strategic Location task. 
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Aside from the cross sectional study design of the present study, which cannot rule 
out premorbid differences between the different drug groups, there was also a lack of 
urinary analysis which means self-reported drug use was unable to be verified 
(although the self-report method has been shown to have  sufficient reliability and 
validity (Darke, 1998; Harrison, Martin, Enev, & Harrington, 2007). A further 
limitation of the current study is the assumption that the particular source memory 
tasks employed do in fact correspond to the brain areas that are posited by the 
Working with Memory model to support associative and strategic source memory 
tasks, although the neuroimaging and lesion data do support roles for both the 
hippocampus and prefrontal cortex in these tasks. Similarly, as the tasks used were 
specific to this study, their validity with regard to measuring source memory, and not 
episodic memory in general, is untested. Nevertheless, the finding that participants 
performed more poorly on the Location, compared with the Colour task, and that 
ecstasy use was associated with poorer performance on the more difficult task lends 
some support for construct validity. With regard to future research, in addition to 
assessing source memory using a prospective study design, it may be useful to 
compare regular ecstasy users with healthy older adults and aged matched drug naïve 
persons on source memory performance to ascertain whether there are similarities in 
source monitoring deficits.  
 
In conclusion, the present study demonstrated significant source memory 
deficits for ecstasy users compared with cannabis users and drug naïve controls. The 
effect of ecstasy was larger for the more difficult organisational source task 
compared with the associative task, and this result mimics findings on the effects of 
healthy ageing on source memory. It was suggested that the source memory deficits 
for ecstasy users and older adults share similar underlying neuropathology, most 
likely reduced serotonergic transmission in the prefrontal and medial temporal 
cortices. These results are consistent with those of the previous two studies, which 
have showed ecstasy related impairments on verbal episodic memory as well as 
strategic processes associated with the frontal cortex. 
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Chapter 9 
Summary of Findings, Implications, Limitations and Directions for Future 
Research 
 
Summary of aims and findings across studies 
The studies reported in this thesis had three main aims. The first was to 
clarify which measure of verbal learning and memory, Trial 1, Total recall or 
Delayed recall, was most affected by ecstasy use. Narrowing down verbal memory 
deficits into these three measures allows greater specificity with regard to which 
cognitive processes may be impaired or spared as a consequence of ecstasy use. This 
was achieved by performing a meta-analysis of 23 studies that had reported data 
from list learning tasks for regular ecstasy users compared with non-users.  The 
second aim was to further examine the components of memory that were most 
affected by ecstasy use, and to evaluate the respective roles of the medial temporal 
and frontal lobes in the pattern of memory performance observed for regular ecstasy 
users compared with non-users. This was achieved by engaging the Working with 
Memory model as a framework from which to interpret the list learning and source 
memory data. Of particular interest was whether the memory impairments reported 
for ecstasy users were purely memory related, or whether they were also associated 
with poor use of memory support processes, such as initiating strategies for encoding 
and retrieval.  The final broad aim of this thesis was to investigate whether any 
observed differences between drug groups could be attributed to ecstasy or poly-drug 
use. This aim was largely achieved by including Ecstasy-only, Cannabis-only, 
Ecstasy-plus cannabis and a Drug naïve group in the design, thus allowing the 
independent and interactive effects of ecstasy and cannabis to be analysed.  
 
Numerous studies have employed the CVLT or RAVLT to investigate 
memory ability for ecstasy users, however until now there has been no evaluation of 
which measure: Trial 1, Total or Delayed recall was most affected by regular ecstasy 
use. The meta-analysis in Chapter 6 demonstrated that ecstasy use does not impact 
on these three measures equally, with only a trivial effect of ecstasy use (g = -.15) 
found for Trial 1 scores. Consistent with this finding, the list learning studies
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presented in Chapter 7 reported only small (g = -.36) to moderate (g = -.49) effects 
of ecstasy use on Trial 1 performance on the unrelated and related lists respectively, 
and both the meta-analysis and list analyses failed to identify a significant dose 
dependent relationship between ecstasy consumption and Trial 1 scores. Consistent 
with the small effect of ecstasy on Trial 1, there was no effect of ecstasy use on word 
span scores (g = .09) and word span performance did not significantly differ between 
groups. It is thus apparent that ecstasy use spares memory for a single presentation of 
words.  
 
The ecstasy related effect becomes apparent for multi-trial free recall 
however, with the meta-analysis showing a moderate magnitude ecstasy related 
deficit on this measure (g = -.71) which remained at this magnitude even with the 
exclusion of drug naïve comparison groups. Again the results from the list learning 
study were consistent with the meta-analysis; ecstasy use had a large magnitude 
effect for unrelated (g = -.92) and related (g = -1.10) list types. Furthermore, Total 
and Delayed recall scores and ecstasy consumption were associated with a 
significant dose related response for the list learning tasks. However, there was no 
ecstasy dose-related effect on Total recall performance identified in the meta-
analysis; this may be reflective of inconsistencies in the way in which ecstasy use is 
quantified which make it difficult for a consistent dose related effect to emerge 
between studies. In keeping with the significant ecstasy related deficits for verbal 
episodic memory, a more demanding test of episodic memory, source memory, was 
also impaired for regular ecstasy users. Though non-significant, there was a small 
ecstasy related effect for the easier, associative Colour task (g = -.43) and a 
moderate, statistically significant effect of ecstasy use for the more difficult, 
organisational, Location task (g = -.57).  
 
A specific role for poly-drug use in impairments to long-term memory consolidation 
It has been suggested that the memory deficits reported for ecstasy users are 
actually a consequence of poly-drug use (eg. Croft et al., 2001; Halpern et al., 2011; 
Hanson & Luciana, 2010). The findings from the series of studies in the current 
thesis however are not consistent with this, and demonstrated that regardless of the 
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extent of cannabis use, if a participant had used ecstasy they were more likely to 
have a memory deficit than if they had been ecstasy-naïve. Furthermore, many of the 
ecstasy related memory impairments were accompanied by effect sizes of moderate 
to large magnitude.  
 
The only meaningful exception to this was Delayed recall. On the unrelated 
list, there was a very large effect of ecstasy on Delayed recall (g = -1.02) however 
for the more specific measure of lost access, which indicates the number of specific 
words that were recalled on the final learning trial (Trial 8) and not recalled at the 
delayed recall condition, an effect of both cannabis and ecstasy use was apparent. 
Also during Delayed recall, poly-drug use was associated with lower subjective 
clustering, although this was not the case for cannabis use during the learning trials. 
In contrast, Ecstasy use was associated with greater lost access and lower subjective 
clustering throughout the learning trials and at Delayed recall. These results suggest 
that ecstasy use impairs subjective clustering within learning trials, and this reduced 
clustering effects both short, inter-trial consolidation (measured by lost access) and 
long term consolidation (delayed recall) . Alternatively, cannabis users’ ability to 
subjectively organise words to assist recall was only impaired during the 25 minute 
delay, and subsequently they lost more words in this condition only. This poly-drug 
effect for Delayed recall may explain why the meta-analysis showed the effect size 
for this measure reduced considerably when the drug naïve comparisons were 
excluded (from g = -.98 to g = -.60).  
 
To summarise, poly-substance use may impact on Delayed recall scores for 
ecstasy users, indicating that poly-drug use remains an important factor to consider 
when identifying cognitive processes that may be selectively impaired by ecstasy 
use. However this was the only memory component that was associated with any 
substantial poly-drug effect, with several other components of memory showing 
clear deficits associated with moderate to large magnitude ecstasy effects. 
Furthermore, the inclusion of the Ecstasy-only group, who reported lifetime ecstasy 
use twice as high as that of Halpern et al.’s 2010 study, challenges their conclusion 
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that poly-drug use, rather than ecstasy use is driving cognitive deficits reported for 
ecstasy users.   
 
The contribution of strategic and consolidation processes in verbal and source 
memory deficits for ecstasy users 
The findings from the current thesis consistently implicate processing deficits 
associated with an interaction between prefrontal and medial temporal brain regions. 
The lower word recall for ecstasy users on both related and unrelated word lists 
indicate deficits in consolidation and retrieval, which are associated with 
hippocampal dysfunction. For these deficits to be attributed purely to impaired 
hippocampal functioning however, it would not be expected that deficient 
organisational processes such as semantic or subjective clustering would also be 
present. Indeed, if ecstasy use primarily impaired hippocampal memory processes, it 
could be anticipated that there would be little difference between ecstasy and 
comparison groups on measures of semantic and subjective organisation. This was 
not the case, with ecstasy users performing poorly on memory measures and frontal-
strategic organisational indices, on both list types. The moderate to large magnitude 
effects for ecstasy use on the clustering indices suggest that deficient strategising is 
having an additive effect on poor inter-trial consolidation among the ecstasy 
consuming group. The findings of the source memory study are consistent with this 
interpretation. According to the Working with Memory Model, the item-to-source 
binding required in the Colour task would be a primary function of the hippocampus, 
the structure often postulated as the site for memory binding. This is because in the 
Colour source task, a word was presented in red for example, and participants were 
required to recall the colour of the word. Thus, the source was intrinsic to the item, 
and the strategising and organisational requirements were relatively low. Conversely, 
in the Location task, the words were presented in a specific location on the screen, 
the spatial location of a word was more extrinsic, or further removed from the item, 
and consequently there was a higher degree of organisation required from the 
prefrontal system to implement a strategy to assist the hippocampus to bind the item 
and source for correct recall. Thus the finding that ecstasy use did not significantly 
impair Colour task performance, but was associated with a moderate magnitude 
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deficit on the Location task again indicates memory deficits for ecstasy users are 
more likely to be found on tasks that require both hippocampal and prefrontal 
networks.  
 
This conclusion in itself is not novel, with previous authors also arguing that 
the frequently reported verbal memory deficits for ecstasy users are a consequence of 
frontal and medial temporal interactions (Brown, McKone & Ward, 2010; Quednow 
et al., 2006). The present thesis has attempted to clarify the interaction between 
strategic, frontal processes and consolidation/memory processes required for 
remembering semantically related and unrelated words as well as recollection for 
source, and it is apparent that the lower level of strategic processing at encoding, 
whether in a list learning or source memory task, has contributed to poor inter-trial 
consolidation and impaired source accuracy respectively for ecstasy users. This 
finding is consistent with the previously reviewed evidence for ecstasy- related 
alterations in prefrontal (eg. Bosch et al., 2013; de Win et al., 2007; McCann et al., 
2008) and hippocampal activity (Becker et al., 2013; Daumann et al., 2005; den 
Hollander et al., 2011).  
 
Are the verbal memory deficits reported for ecstasy users associated with serotonin? 
MDMA acutely increases the release and prevents reuptake of serotonin by 
SERT and at the residual level also inhibits tryptophan hydroxylase, an amino acid 
precursor of serotonin (Cadet, Jayanthi & Lyles, 2007). Since ascending serotonin 
neurons innervate the cortex and hippocampus, serotonin has emerged as an 
important neuromodulator of learning and memory (Ogren et al., 2008). Dopamine 
and noradrenaline are also modulated as a consequence of ecstasy consumption, 
however research has demonstrated that the sustained neural effects of ecstasy use 
impact the serotonergic system (Cadet et al., 2007). Although studies examining the 
impact of ecstasy use on the functioning of specific serotonin receptor subtypes is 
lacking, particularly with regard to the 5-HT1A subtype, for which there is increasing 
evidence of a role in learning and memory (Cowen & Sherwood, 2013) there are 
several independent findings of reduced SERT density for regular ecstasy users in 
the hippocampus, cerebral cortex, including prefrontal areas and in the thalamus.  
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When considered in light of evidence that the magnitude of SERT function in regular 
ecstasy users is correlated with poorer performance on tests of verbal memory (Kish, 
et al., 2010; McCann et al., 2008) and that even prospective cohort studies have  
identified that for people who began to use ecstasy use within a twelve month period 
had significantly poorer scores on the RAVLT at the follow up test compared to 
people who had not used ecstasy (Schilt et al., 2007; Wagner et al., 2012) the 
abundance of research speculating a role for serotonergic disruptions to the CNS as 
the mechanism by which cognitive deficits for regular ecstasy users emerge appears 
justified.  
 
Although the current thesis did not investigate the relationship between 
serotonin markers and memory performance for ecstasy users, it did evaluate the 
cognitive processes that underlie verbal memory deficits for this drug group, and 
found a specific effect of ecstasy use on short and long term consolidation and 
source memory binding. As serotonin receptors are involved in long term 
potentiation in the hippocampus (Berumen, Rodriguez, Miledi & Garcia-Alcocer, 
2012) and the most consistent effect of ATD is impaired verbal memory 
consolidation (Mendelsohn, Riedel & Sambeth, 2009) and the structure 
demonstrated to support both consolidation and source memory binding is the 
hippocampus (Winocur & Moscovitch, 2011) the results from the present thesis are 
consistent with the hypothesis that alterations to serotonergic neural-transmission, 
particularly in the serotonin receptor-dense hippocampus, is a highly likely candidate 
for the impairment in consolidation and source memory binding among regular 
ecstasy users.  
 
The present thesis also suggests that frontally mediated, strategic neural 
networks are not working effectively with the hippocampus to assist in encoding and 
consolidation among ecstasy users. Due to the recent neuroimaging studies that 
showed reduced functional connectivity between areas in the motor cortex and 
interactions between the thalamus and cortical areas for ecstasy users (Karageorgiou 
et al., 2009; Salomen et al., 2012) and noting the presence of the serotonergic 
pathways that project from the hippocampus to prefrontal cortex, this explanation 
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would be consistent with the view that there is a sustained down-regulation of 
serotonin and its markers (eg. SERT, Biezonski & Meyer, 2011; Kish, Fitzmaurice, 
Chang, Furukawa & Tong, 2008) among chronic ecstasy consumers, and this down-
regulation interferes with serotonergic transmission between medial temporal and 
frontal regions. Thus the pattern of results in the current series of studies may arise 
as a consequence of faulty neural transmission between these regions, rather than 
simply as a consequence of localised regions of neural dysfunction.  
 
An alternative view to the Working with Memory-model based explanation is that 
ecstasy use is associated with deficits on complex tasks that require efficient 
processing speed to maximise performance. This may provide a plausible 
explanation for performance on Trial 1, Recognition and the Colour source task 
being less affected by ecstasy use, as these tasks were all less cognitively 
demanding. This processing speed hypothesis could also account for why ecstasy 
users had poorer strategic engagement, as rapid processing would be required to 
quickly organise to be remembered items to enhance verbal recall. Thus, rather than 
the verbal memory deficits for ecstasy users reported in the current series of studies 
being attributed to impaired interaction between hippocampal and prefrontal activity, 
it might instead be the case that the deficits arise as a consequence of reduced global 
processing speed. This hypothesis was tested to some extent in Chapter 8 of the 
current thesis, by including a processing speed task (letter comparison) and 
controlling for processing speed statistically. There were no differences between 
groups on the letter comparison task however, and the effects of ecstasy use 
remained for the global list learning measures when processing speed was controlled 
for. The processing speed hypothesis has been considered previously, however 
differences in processing speed were unable to account for ecstasy users’ 
performance on a working memory task (Waring, Fisk, Montgomery, Murphy & 
Chandler, 2007) and meta-analyses reveal considerably smaller magnitudes for 
processing speed when compared with verbal learning and memory (eg. Kalechstein 
et al., 2007; Zakzanis, Campbell & Jovanovski, 2007). Thus, the position that 
deficits amongst ecstasy users are a result of reduced processing speed cannot be 
supported at present.  
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Another potential mechanism by which the pattern of memory and strategic 
deficits observed for ecstasy users in the current thesis is cortisol. Extreme levels of 
high or low cortisol are associated with memory deficits: prolonged cortisol 
dysregulation is associated with reduced hippocampal volume (O’Hara et al., 2007) 
and source memory deficits (Mitchell & Johnson, 2009). Regular poly-substance and 
cannabis users show blunted cortisol release compared to controls during acute drug 
intoxication (eg. Carson et al., 2012; D’Souza et al., 2008) which could thus explain 
potential poly-substance effects on verbal memory performance. Ecstasy use has also 
been demonstrated to elevate cortisol levels acutely (eg. Lamers, 2003). Recently 
however, the cortisol hypothesis was tested by Kuypers, de la Torre, Farre, Pujadas 
and Ramaekers (2012) who administered MDMA either alone or with a cortisol 
synthesis inhibitor (metyrapone) to regular ecstasy + poly-drug users. They reported 
metyrapone successfully prevented the MDMA induced blood cortisol elevation, 
however MDMA dose still resulted in lower scores on a word learning task. Thus the 
reduced impact of (MDMA induced) cortisol elevation did not reduce the memory 
deficits, indicating that elevated cortisol levels associated with ecstasy use are not 
modulating memory function, at least during acute intoxication.  This is the first 
study to directly assess the role of cortisol in memory dysfunction for ecstasy users 
however, and as such the role of cortisol in memory deficits remains inadequately 
tested. At present, the working with memory explanation, whereby memory deficits 
in ecstasy users arise as a consequence of impaired connections between frontal and 
hippocampal cognitive systems appears to be a more likely explanation than 
processing speed or cortisol related effects. 
 
  Practical and clinical implications 
 Over the eight learning trials of the unrelated list, the ecstasy group recalled 
an average of 22 words less than drug naïve controls, and recalled 15 fewer words 
over the five trials of the related list compared with drug naive controls. These 
deficits are significant and last beyond the acute phase of the ecstasy induced effects. 
According to the 2010 National Drug Strategy Household Survey, the best indicator 
of substance use in the general Australian community, 25% of males and 23% of 
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females aged between 20 and 29 had used ecstasy in their lifetime. As such, memory 
deficits associated with its use may have practical implications for those young 
adults who are undertaking vocational based or university level study, since 
assessment usually involves written tests which require adequate verbal memory 
skills. Chapter 7 showed however, that by Trial 8 of the unrelated list, ecstasy users 
were able to recall approximately the same number of words as the control 
participants at Trial 5. It will therefore be useful for regular ecstasy users to be aware 
of memory deficits arising from ecstasy use so as to allow themselves additional 
learning time for exams and maximising the likelihood of being able to pursue 
vocational interests.  
 
In Australia, regular ecstasy users rarely seek treatment for drug related 
problems (Matthews & Bruno, 2010; Topp, Hando, Dillon, Roche & Solowij, 1999) 
although a small percentage may present to health professionals with symptoms of 
low mood (Matthews & Bruno).  It will therefore be useful for health professionals 
to ensure that ecstasy use is included as part of their initial alcohol and other drug 
use assessment for clients, particularly those presenting with low mood or anxiety. 
Health professionals could subsequently provide psycho-education about ecstasy-
related residual  effects so that should these symptoms occur, ecstasy consumers 
recognise them as being drug related and take appropriate action. Targeted 
assessment of memory deficits will also be useful, as simple memory screens such as 
Digit Span Forwards, part of the Wechsler Adult Intelligence Test, which is 
correlated with Trial 1 performance (Lezak, 1995) and the Montreal Cognitive 
Assessment for Mild Cognitive Impairment (Nasreddine et al., 2005) which is a 
commonly used screening tool in the alcohol and other drugs sector will not capture 
the short term consolidation component that is particularly impaired by ecstasy use. 
Ideally, automated computerised memory assessments which can be quickly 
administered and scored and can accurately detect subtle impairments in strategic 
and consolidation memory processes could be developed for an ecstasy using 
population.  The measure of lost access in the current thesis for example, could be 
automatically scored by a computerised test.  
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 For the majority of ecstasy users who do not seek treatment, information on 
harm reduction practices that could reduce the neural harms associated with ecstasy 
use needs to be delivered via social media and consumer appropriate forums. These 
harm minimisation practices include; obtaining ecstasy from a reliable source, 
limiting the number of pills taken per session, spacing occasions of use so as to 
allow the CNS to recover and to prevent tolerance and subsequent increases in self 
dosing, and avoiding using other serotonergic agonists (such as SSRIs) during 
ecstasy use (Winstock, Marsden & Mitcheson, 2010) Other factors that may be 
helpful in reducing neurobiological harm include not using other stimulants during 
ecstasy use, taking regular breaks from dancing, avoiding dehydration and getting 
too hot, ensuring adequate sleep and nutrition for the days following ecstasy use 
(Parrott, 2005). In addition to providing information on these practices, it will be 
useful for the clinician to ascertain whether their client is concerned about potential 
memory problems, and if so, to work with the consumer to develop personalised 
memory strategies to assist recall. Studies that have administered the CVLT to 
recreational ecstasy users have reported that when a category cue is provided at 
recall, ecstasy users' recall scores do not differ significantly from control participants 
(Brown, McKone & Ward, 2010; Medina et al., 2005). The current thesis found that 
ecstasy users’ were less impaired at subjective, rather than semantic organisation, 
therefore ecstasy users could be encouraged to organise the to-be recalled 
information in a manner that is subjectively meaningful to them, and to practice 
retrieving the information based on their own subjective cues. This strategy could 
also be used in conjunction with standard memory enhancing strategies such as 
chunking large pieces of information into smaller units and using acronyms as cues, 
using imagery and repetition. Further, computer assisted cognitive rehabilitation has 
been indicated to be beneficial to treatment seeking substance users when delivered 
in inpatient programs and this may be transferable to an outpatient setting (Vocci, 
2008).     
 
Limitations and directions for future research 
 As discussed in Chapter 6, the potential confounds that are inherent to cross-
sectional studies in this field are well documented and as such, statements about 
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causation cannot be made. The current thesis did control for some potential 
confounds however, by matching participants on estimated IQ, including participants 
with minimal exposure to illicit drugs other than cannabis, which was also controlled 
for by its inclusion as an independent variable. The participants from the current 
studies were all self-selecting and recruited from Hobart, Tasmania, which is a small 
city and as such, there may be features of this local sample that are not generalisable 
to the larger ecstasy using population. For example, the estimated verbal IQ scores 
ranged from 107 to 112, which are slightly higher than the UK norms for this age 
group (103). Also, the exclusion of several participants on the basis of high lifetime 
exposure to other illicit drugs decreased the sample size as did the exclusion of a 
small number of participants based on failing the clinical screening for abstinence 
prior to testing, although urine tests were not administered for verification.  The 
current studies also relied on participants’ self-reports of drug use, although this 
method has been demonstrated to have adequate reliability and validity (Darke, 
1998; Harrison, Martin, Enev, & Harrington, 2007). At the time of testing, purity 
testing based on police seizures indicated the median purity was around 25% (Illicit 
Drug Data Report, 2008-2009) however whether the pills participants reported 
taking contained MDMA was not independently verified. Further, data on the 
environmental factors present during ecstasy use, and concomitant use of other illicit 
substances, were not obtained, and as interactions between ambient temperature, 
metabolic stress, concomitant drug use and memory deficits may occur, future, large 
scale prospective studies should systematically evaluate these factors.  Also, 
although it is clear from the one-way ANOVAs that the groups differed in the expected 
direction on the drug use variables, specific comparisons examining the difference 
between ecstasy and cannabis users using a non-parametric test such as the Mann 
Whitney-U tests could have been conducted. Finally, while the study was not blinded, 
the presentation of word stimuli in the list learning tasks was automated and source 
judgement accuracy was recorded by the Inquisit program, however testing would 
ideally have been undertaken by a double blind procedure to prevent potential 
experimenter bias.   
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The current thesis drew a parallel between ecstasy users and older adults on 
source memory performance, and found that the larger effect of ecstasy for the more 
difficult organisational source task compared with the associative task was consistent 
with the pattern of results obtained for healthy, older adults on these types of tasks. 
However, if ecstasy users’ memory deficits resembled those of older adults, the 
magnitude of the ecstasy effect for the organisational (Location) source task (g = -
.57) should have been of larger magnitude than those from the list learning tasks 
(unrelated; g = -.92, related (g = -1.10) as older adults consistently show a larger 
deficit for item rather than source memory.  It is possible, however, that these effects 
may reflect differences in difficulty levels between the tasks than inconsistency 
between older adults and regular ecstasy users, because in order to reduce the 
demands on recognition/retrieval processes and focus on the recollection of the 
source, the source memory tasks did not include a recognition test in the recall phase. 
Instead all 18 words that were presented during encoding were re-presented at test, 
and participants were required to recollect one of six possible colours or locations in 
which the word was originally presented. This procedure may have reduced the 
difficulty of the source memory tasks, thus accounting for the smaller effect sizes 
seen for ecstasy users in this study in contrast to the effect anticipated if ecstasy 
produces effects on memory function akin to advanced ageing.  
 
In order to examine this effect more thoroughly, it would have been 
advantageous to increase the number of words per trial from 18 to 24 to increase the 
number of word-source associations from 3 to 4. This limitation also highlights the 
need for future ecstasy and memory research to develop standardised assessments of 
cognitive functions, preferably based on neurocognitive concepts rather than using 
assessments designed for clinical populations which may be insensitive to subtle 
cognitive impairments. Nevertheless, the possibility that memory deficits for ecstasy 
users are similar to those observed for older adults is worthy of more attention, as in 
Australia, 24.1% of males and 19.8% of females aged between 30 and 39 have used 
ecstasy in their lifetime (with only 4.9% of this age bracket using in the past year: 
2010 Australian National Drug Strategy Household Survey). If ecstasy use is 
associated with long term serotonergic disruption, in combination with decreased 
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brain serotonin levels with increased age (Bhagwagar et al., 2004; Moller, Jakobsen 
& Gjedde, 2007) this statistic potentially represents a health concern for aging 
ecstasy users.  
 
It has previously been suggested that ecstasy users may share similar memory 
deficits to those of older adults (Morgan, 1998; Morgan, 2000; Wareing, Fisk, 
Montgomery, Murphy & Chandler, 2007) and this possibility has received some 
preliminary investigation (Schilt et al., 2009). Schilt et al. recruited a group of older 
ecstasy users (aged between 39 and 55) and compared their verbal memory effect 
size (d = 1.14) with younger ecstasy/poly-drug users (d = 1.06) from the Laws and 
Kokkalis (2007) meta-analysis. Schilt et al. noted that although the difference in 
effect sizes was small, they were in the expected direction and future 
prospective/longitudinal research will be better placed to differentiate between 
memory changes for older and younger ecstasy users. Information about the age of 
first use to determine whether early-onset ecstasy use is associated with altered 
development of the frontal cortex, as has been indicated for early onset cannabis use 
(Schweinsburg et al., 2008; Wilson et al., 2000) will be particularly useful.  
 
In conclusion, findings from the studies in this thesis indicate that while 
impairments in verbal memory function are a robust residual effect of recreational 
ecstasy use, not all memory measures are affected equally, with more cognitively 
demanding tasks which require strategic engagement and adequate inter-trial 
consolidation being more susceptible to ecstasy related impairment than single trial 
measures. Memory deficits associated with ecstasy use are related to the level and 
type of strategic engagement applied during encoding, with greater ecstasy effects 
for semantic than subjective organisation. Short and long term consolidations were 
effected by ecstasy use, with a specific ecstasy related effect apparent for inter-trial 
consolidation, such that ecstasy users were impaired in their ability to consolidate 
previously recalled items. This poor consolidation was consistent with the reduced 
item to context source binding evident in the source memory tasks, and altogether 
this pattern of deficits are consistent with deficits to both strategic and consolidation 
processes. In contrast to the conclusions of Halpern et al. (2010) the present thesis 
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found consistent moderate to large magnitude ecstasy effects, which in addition to 
the degree of control over potential confounds such as verbal IQ, cannabis, alcohol 
and methamphetamine use, suggest that the memory deficits were related to ecstasy 
and not poly-drug use. The present thesis has identified consolidation as a process 
which is particularly vulnerable to the effects of ecstasy, and future research and 
clinical interventions may be able to design and administer assessments that are 
sensitive to this. Finally, in light of an aging population of ecstasy users, longitudinal 
research will be useful in tracking changes in memory across their lifespan.  
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Appendix A 
Word list stimuli 
 
Unrelated list  Recognition test  Related list  
sunburn        pliers         asparagus    
oyster         referee         cabbage         
pillow         twilight         beetroot         
umbrella        harness         radish         
locker         tornado         beetle         
button        cement         mosquito      
pollen         bishop         termite         
salute       magician         spider         
puzzle        pepper         canyon         
timber       sofa         cliff         
scissors      scholar         waterfall         
umpire         duchess         glacier         
daylight         pyramid         trombone     
buckle         volcano         cello         
hurricane         dungeon         clarinet         
gravel        hurdle        violin         
cardinal        portrait         linen         
wizard         bacteria         velvet        
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paprika         chalk         suede        
couch         frost         flannel         
 
 
Appendix B 
Source memory task stimuli 
 
symbol credit estate battle weapon sought 
career double cousin lawyer impact escape 
honest avenue appeal speech leader review 
minute mobile happen bright  slight broken 
travel secret dearly decade poetry decide 
animal factor screen source remove author 
finger reduce create liquid budget weight 
excess cattle unlike garden silent regard 
wisdom highly design female ballet allies 
target narrow desire belief lights vision 
lovely annual firmly prison column booked 
switch useful dollar agency memory mental 
remain depend nobody crevice danger curled 
notice device search medium spread living 
appeal winter proper energy active matter 
caught notion burden accept afraid period 
wooden struck smooth league golden  
flight listen tissue beauty marine  
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detail famous master junior pocket  
handle wonder glance abroad crisis  
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